ID_PAPER	IRRELEVANT	COMMENTS	TIMESTAMP	CURATOR	DISEASE_NAME	SECONDARY_CHECK	PRIMARY_CATEGORY	SECONDARY_CATEGORY
19403253			2021-04-26T02:42:03.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
19410311			2021-05-08T15:41:29.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
20042635		I would label this with 2.2. Normal Biology		curator1	hereditary hemorrhagic telangiectasia			
20042709		Also 2.3. Non in-vivo Human or non-human model system	2021-04-23T04:45:49.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20067780			2021-05-08T15:31:27.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20093519		REVISITED 4/30 - NO CHANGE: this study looked at both mutations (2.1) and a diagnostic method (CT) (1.1)	2021-04-23T18:40:17.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
20141966		REVISITED 4/30 - NO CHANGE: discussion of presentation and diagnostic workup (1.1.) and thoracic endografting (1.3)	2021-04-26T03:12:31.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
20170910			2021-05-08T14:23:22.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20198988			2021-04-19T03:05:49.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20202952		"I added 1.1 Clinical Char... because the authors also suggest considering this presentation as a prompt to diagnose HHT
REVISITED 4/25 - no change, see comment above
REVISITED 4/30 - NO CHANGE"	2021-04-23T04:39:23.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
20224041		Also 2.3. Non in-vivo Human or non-human model system	2021-04-23T18:34:08.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20368796			2021-05-08T15:09:23.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20414677			2021-05-08T15:09:07.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
20458853			2021-04-23T04:40:42.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20461185		not about HHT but I would classify as 1.3		curator1	hereditary hemorrhagic telangiectasia			
20620301		"REVISITED 4/25 - CHANGED: Medical records and pathologic material - so I chose 1.1. Because treatment is also discussed, I have now added 1.3.
REVISITED 4/30 - NO CHANGE"	2021-04-25T17:18:22.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
20622729			2021-05-08T14:20:15.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
20739767		"REVISITED 4/25 - CHANGED: added 1.1 due to discussion of diagnostic workup
REVISITED 4/30 - NO CHANGE. intervention is described (closed PFO, then embolization) (1.3) and diagnosis (1.1)"	2021-04-26T01:49:43.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
20879701	True	I think this is a review		curator1	hereditary hemorrhagic telangiectasia			
21310938		Could this also be 3.4. Patient-Based Therapeutics , or does that have to be strictly for clinical use?	2021-04-26T02:16:20.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
21336824		and 2.4. In-vivo Human basic science study	2021-05-08T15:02:22.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21344445		not a clinical trial ...	2021-04-23T04:43:02.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21345778			2021-04-23T18:30:46.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21426754			2021-05-08T14:33:52.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
21484125			2021-04-26T03:12:54.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21740592		Not quite sure if the focus here is treatment of the stroke, or prevention of the stroke in HHT patients, or just describing the risk of stroke in HHT patients - I am thinking it's the last option, so I chose Clinical Characteristics etc.	2021-04-23T04:50:12.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21764776			2021-04-23T18:38:56.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
21792166			2021-04-19T03:05:05.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21816895		REVISIT - CHANGED: does not appear to be a clinical trial so changed from 3.4 to 1.3	2021-04-25T17:22:59.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21842025			2021-05-08T14:37:46.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
21855727	True	I think this is a review		curator1	hereditary hemorrhagic telangiectasia			
21861324			2021-04-23T18:45:49.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22120563		I chose Therapeutics in the Clinic over Patient-Based Therapeutics because I think this is more of a case series (retrospective analysis of charts) rather than a randomized, controlled clinical trial.	2021-04-19T03:47:16.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22196589			2021-04-23T18:45:14.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22227516			2021-04-19T04:18:40.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22229593			2021-04-19T02:58:47.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22240227			2021-05-01T00:53:17.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
22281938		This study is on health economics, which isn't really covered by any of the current labels. Most closely related might be 1.2. Quality of Life		curator1	hereditary hemorrhagic telangiectasia			
22331366		REVISITED 4/30 - NO CHANGE: genotyping (2.1) and clinical features (1.1) were described. The study could also be tagged with 0.2. Related Diseases however.	2021-04-26T03:16:38.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
22379273	True	review		curator1	hereditary hemorrhagic telangiectasia			
22385575			2021-05-01T00:54:30.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22421041		2.3. Non in-vivo Human or non-human model system	2021-04-23T18:35:57.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22469609		this might be considered a review, or else like a really long case series. I opted for the latter as it is at least specific to one intervention	2021-05-08T15:16:41.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22622516		Also 2.3. Non in-vivo Human or non-human model system	2021-04-23T04:52:09.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22670022			2021-05-08T14:33:12.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22671535		1.2. Quality of Life		curator1	hereditary hemorrhagic telangiectasia			
22706563			2021-05-08T15:23:07.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22707551			2021-05-08T15:21:56.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22727716			2021-05-08T15:40:09.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
22737832			2021-05-08T15:26:40.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22781769			2021-04-19T04:22:20.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22875690			2021-05-08T15:18:07.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
22920200		0.2. Related Diseases		curator1	hereditary hemorrhagic telangiectasia			
22991266			2021-05-08T15:24:39.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
23018639			2021-04-23T18:32:51.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23109496			2021-04-28T18:59:52.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23198241			2021-05-08T15:39:02.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23199770			2021-05-08T15:40:42.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23303231			2021-05-08T15:25:21.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
23312966			2021-04-26T02:26:41.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23320130		and 2.3. Non in-vivo Human or non-human model system	2021-05-08T14:36:31.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23323127			2021-04-23T18:38:09.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23401183			2021-05-08T15:26:08.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23439260			2021-04-23T04:55:42.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23568730		REVISITED 4/30 - NO CHANGE: this study looked at both mutations (2.1) and clinical features (1.1)	2021-04-23T18:22:05.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
23653583			2021-05-08T14:35:49.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23670536			2021-04-28T18:52:15.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23675457		Also 2.3. Non in-vivo Human or non-human model system (new cell line)	2021-04-28T18:58:39.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23676596			2021-04-23T18:44:57.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23702711		and 2.3. Non in-vivo Human or non-human model system	2021-05-01T00:51:48.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23729109			2021-05-08T15:13:01.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
23794345			2021-05-08T15:23:58.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
23805858			2021-05-08T14:39:59.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23888243			2021-04-19T03:43:50.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24098321			2021-05-08T15:34:01.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24146883			2021-05-08T14:42:36.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
24260769			2021-05-01T00:56:46.000Z	curator1	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
24267784			2021-05-08T15:27:17.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24268183		2.5. Computational Biology and Informatics research		curator1	hereditary hemorrhagic telangiectasia			
24273414			2021-04-19T03:58:38.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24305586			2021-04-23T04:50:59.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24458873			2021-04-19T04:13:37.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24489709		Also 2.3. Non in-vivo Human or non-human model system	2021-04-23T18:27:26.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24499751			2021-04-26T03:05:47.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24520391		and 2.3. Non in-vivo Human or non-human model system	2021-05-08T15:32:00.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24587130			2021-04-19T03:51:12.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24615664			2021-04-23T18:29:21.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24667223			2021-04-23T04:46:24.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24913291			2021-05-08T15:29:29.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24935454			2021-04-26T02:13:31.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24986705		review but also 3.1. Therapeutic Hypothesis, so not quite sure how to classify this		curator1	hereditary hemorrhagic telangiectasia			
24999773			2021-05-08T15:25:51.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25064693			2021-04-26T02:53:24.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
25082229		2.3. Non in-vivo Human or non-human model system	2021-04-23T18:35:05.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25172615			2021-04-19T04:07:22.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25420398		"This case report seems to describe the natural history of the disease over the patient's lifetime (so 1.1) but also discusses surgeries (so 1.3)
REVISTED 4/30 - NO CHANGE: reasons given above"	2021-04-26T02:33:24.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
25543221			2021-04-19T04:02:12.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25564593			2021-04-28T18:47:28.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25603856			2021-05-08T15:39:36.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
25815003			2021-04-23T04:52:48.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25839006			2021-04-28T19:00:03.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25847705			2021-05-08T14:18:22.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25862798			2021-05-08T14:31:04.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25873934	True	This is a review		curator1	hereditary hemorrhagic telangiectasia			
25909848			2021-04-23T04:43:54.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25931195			2021-05-01T00:55:30.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
25940942			2021-05-08T15:14:24.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25981877		3.1. Therapeutic Hypothesis		curator1	hereditary hemorrhagic telangiectasia			
26078760			2021-04-19T03:57:26.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26204445			2021-04-28T18:51:23.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26261842			2021-04-28T18:59:32.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
26340858		1.2. Quality of Life		curator1	hereditary hemorrhagic telangiectasia			
26376562			2021-05-08T15:34:21.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26393959			2021-04-23T18:31:05.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26401274			2021-04-19T03:15:58.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
26425624			2021-04-23T18:44:48.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
26448414	True	review		curator1	hereditary hemorrhagic telangiectasia			
26505940			2021-05-08T14:19:02.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
26608985			2021-05-08T15:27:55.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	2.1. DISEASE MECHANISM
26646071		and 2.3. Non in-vivo Human or non-human model system	2021-05-08T14:21:24.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
26873746			2021-04-23T04:55:24.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26998137			2021-05-08T15:28:45.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
27012295			2021-05-08T15:40:00.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
27027094			2021-05-08T14:43:54.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
27079134			2021-04-23T18:21:10.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27081547			2021-04-19T03:14:21.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
27141651			2021-04-19T03:06:17.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27168866		"Diagnosis
REVISTED 4/30 - CHANGED: added 1.3 due to ""Craniotomy with drainage of the brain abscess and endovascular embolization of the pulmonary AVMs"""	2021-05-01T00:37:44.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
27225226			2021-05-08T15:28:21.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
27323484	True	I think this is a review		curator1	hereditary hemorrhagic telangiectasia			
27334082		"I think both the diagnosis and the treatment of the condition were important here. However if I had to prioritize one, it would be diagnosis (1.1).
REVISITED 4/25 - no change: again, diagnostic workup and treatment were important in this case report. Mention of gene mutation did not appear novel but part of diagnosis, so I didn't tag 2.1
REVISITED 4/30 - NO CHANGE"	2021-04-19T04:04:51.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
27424345	True	sounds like a review		curator1	hereditary hemorrhagic telangiectasia			
27440131		REVISIT - CHANGED: retrospective study so changed from 3.4 to 1.3	2021-04-25T17:28:53.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27599328			2021-04-23T04:50:47.000Z	curator1	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
27646277			2021-04-26T03:21:22.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
27861387			2021-04-23T04:45:08.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27997001			2021-05-08T15:40:25.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
28004998		REVISIT - no change: I interpreted this study to be a follow up on a therapeutic intervention (in a non-clinical trial setting), so I chose 1.3	2021-04-19T03:05:33.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28031662			2021-04-19T02:50:42.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28070235			2021-05-08T15:42:40.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28188364		"This paper is more about the state of current practice rather than the disease itself, and we don't have a tag for that
REVISIT - CHANGED: added 1.3 as management is discussed"	2021-04-25T17:31:23.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
28490409		not sure about this one, it describes how to perform a surgical technique		curator1	hereditary hemorrhagic telangiectasia			
28564608		I think this is 2.2. Normal Biology as they are looking at the normal protein		curator1	hereditary hemorrhagic telangiectasia			
28578477		and 0.2. Related Diseases	2021-05-08T15:20:37.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28588815			2021-04-19T03:55:30.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28608633			2021-04-23T18:42:46.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28687708			2021-05-08T15:18:44.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
28759897			2021-05-08T15:41:56.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28973643		also 3.2. Drug Mechanism? or would that have to be in human?	2021-05-08T15:37:12.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
28989145			2021-05-01T00:58:06.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29080903		Also 2.3. Non in-vivo Human or non-human model system	2021-04-23T04:54:46.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29120072		and 0.2. Related Diseases	2021-05-08T15:22:48.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29171658			2021-05-08T15:07:28.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
29243366			2021-05-08T15:35:41.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29253907		and 2.3. Non in-vivo Human or non-human model system	2021-05-08T15:32:15.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29274888			2021-05-08T14:21:31.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29349377			2021-04-19T04:09:09.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
29416304			2021-04-19T03:54:03.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
29460088		Also 2.3. Non in-vivo Human or non-human model system	2021-04-23T04:50:27.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29469958			2021-05-08T15:36:56.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
29483005			2021-05-01T00:58:35.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
29515340		"It's not quite clear from the abstract, but I assume the patient received a liver transplant, so I also classified this paper as 1.3 Therapeutics in the Clinic
REVISIT - no change: medical imaging = 1.1, and see comment above for 1.3"	2021-04-19T04:14:30.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
29552242			2021-04-23T18:37:18.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29593101		and 2.3. Non in-vivo Human or non-human model system	2021-05-08T15:32:28.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29610574			2021-04-26T03:15:06.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29655863			2021-05-08T15:15:08.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30146556			2021-04-19T03:21:32.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30171179			2021-04-19T03:16:09.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
30260738			2021-04-23T04:51:18.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
30272025			2021-04-19T03:13:41.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
30279913			2021-04-19T04:25:26.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30596371		Also 0.2. Related Diseases	2021-04-23T18:32:35.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
30685840		and 1.4. Epidemiology	2021-05-08T15:07:49.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30704695			2021-04-23T18:36:16.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30705963	True	Review		curator1	hereditary hemorrhagic telangiectasia			
30717761		REVISIT - CHANGED: retrospective study so changed from 3.4 to 1.3	2021-04-25T17:28:32.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
30744395		and 2.3. Non in-vivo Human or non-human model system	2021-05-08T15:42:08.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
30853205			2021-04-26T02:09:09.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31006519			2021-04-26T02:51:44.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
31032126			2021-04-19T04:22:37.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31255500			2021-05-08T14:34:54.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31361678	True	review		curator1	hereditary hemorrhagic telangiectasia			
31400083			2021-04-19T03:14:38.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
31441079	True	systematic review		curator1	hereditary hemorrhagic telangiectasia			
31540324			2021-05-08T15:29:49.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
31566760			2021-04-23T18:43:07.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31615556			2021-05-01T00:55:54.000Z	curator1	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
31616764			2021-05-08T15:02:47.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31689244			2021-04-26T01:52:38.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
31828546		Also 2.3. Non in-vivo Human or non-human model system	2021-04-19T03:18:18.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
31905627			2021-04-23T18:33:41.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31910122	True	clinical practice guideline - I consider this a review		curator1	hereditary hemorrhagic telangiectasia			
32020296			2021-04-26T02:23:55.000Z	curator1	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
32059941			2021-04-19T04:09:57.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
32078368		and 2.3. Non in-vivo Human or non-human model system	2021-05-08T14:37:23.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32178330			2021-04-23T04:41:55.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32199058			2021-05-08T15:33:07.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
32255688			2021-04-28T18:47:17.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32341592			2021-04-26T02:55:22.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32503579			2021-05-08T14:45:09.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
32536092		diagnosis, no intervention	2021-04-26T02:55:12.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32538908		Also 2.3. Non in-vivo Human or non-human model system	2021-04-23T18:45:22.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32573726			2021-04-19T03:54:52.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32723034	True	review		curator1	hereditary hemorrhagic telangiectasia			
32723482			2021-05-08T15:32:42.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
32756122			2021-05-08T15:38:52.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.3. THERAPEUTICS IN THE CLINIC
32762495		2.3. Non in-vivo Human or non-human model system	2021-05-08T15:32:51.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32899377			2021-04-26T03:20:46.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32926701			2021-05-08T15:20:57.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
32954380			2021-05-08T15:22:34.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32992168			2021-04-23T18:34:35.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.3. THERAPEUTICS IN THE CLINIC
32998220			2021-04-19T04:10:15.000Z	curator1	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
33022056			2021-04-23T18:44:35.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33081831		this one is a bit strange since it's about diet rather than more typical sounding interventions, but I think it would still count as an intervention as it would inform patients/health care providers about something the patient can do to improve their health	2021-05-08T15:00:38.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
33090433	True	Review/opinion paper?		curator1	hereditary hemorrhagic telangiectasia			
33147670		0.2. Related Diseases		curator1	hereditary hemorrhagic telangiectasia			
33172103			2021-04-26T03:13:45.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33211216			2021-05-08T15:22:03.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33243256			2021-04-26T03:18:17.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33282178		and 2.4. In-vivo Human basic science study	2021-04-26T02:49:30.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
33511041			2021-04-26T03:15:31.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33539783			2021-04-26T02:24:13.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33652493		not sure.		curator1	hereditary hemorrhagic telangiectasia			
33661356			2021-04-26T02:53:18.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33671708			2021-05-08T15:17:43.000Z	curator1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33677851			2021-05-08T15:38:20.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
33691924			2021-05-08T14:31:44.000Z	curator1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
33754658		no abstract, so I looked at the paper	2021-05-08T15:19:35.000Z	curator1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
19942457		1.4. Epidemiology		curator1	Lennox-Gastaut syndrome			
19948417		1.2. Quality of Life		curator1	Lennox-Gastaut syndrome			
20008422			2021-05-10T03:01:18.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20023065			2021-05-10T16:01:42.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20041940		0.2. Related Diseases		curator1	Lennox-Gastaut syndrome			
20084538		3.2. Drug Mechanism		curator1	Lennox-Gastaut syndrome			
20126329	True	seems like a review		curator1	Lennox-Gastaut syndrome			
20151724		1.4. Epidemiology (cost analysis)		curator1	Lennox-Gastaut syndrome			
20169970			2021-05-10T02:35:58.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20185372	True	postmarketing		curator1	Lennox-Gastaut syndrome			
20384723		and 0.2. Related Diseases	2021-05-10T15:33:18.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
20384727	True	mention of pseudo-Lennox syndrome, doesn't seem to be relevant		curator1	Lennox-Gastaut syndrome			
20472190			2021-05-08T18:00:22.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20542434			2021-05-10T14:16:30.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
20598586			2021-05-10T15:02:35.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20610118			2021-05-10T03:14:26.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
20618411			2021-05-10T03:23:51.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
20647578	True	review		curator1	Lennox-Gastaut syndrome			
20666837		0.2. Related Diseases		curator1	Lennox-Gastaut syndrome			
20691934			2021-05-10T02:25:34.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20726879			2021-05-10T16:08:46.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20823030		and 0.2. Related Diseases	2021-05-10T15:09:49.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
20888268			2021-05-10T04:53:26.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
20957124	True	review		curator1	Lennox-Gastaut syndrome			
20970386			2021-05-08T17:50:38.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21038079			2021-05-10T04:48:56.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21146944			2021-05-10T04:43:57.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21227654			2021-05-10T14:34:02.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21256770		Not completely sure how we would want to classify this - I normally would reserve 3.4 for controlled clinical trials, but this is at least prospective and more rigorously planned than a case report/series, so I opted for 3.4	2021-05-08T17:45:27.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21275978			2021-05-08T17:50:26.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
21353345			2021-05-10T04:50:27.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21365309			2021-05-10T16:06:48.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
21383651		3.2. Drug Mechanism (PK)		curator1	Lennox-Gastaut syndrome			
21396833		sounds like a prospective study	2021-05-10T15:32:09.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21397780		3.2. Drug Mechanism		curator1	Lennox-Gastaut syndrome			
21464890		and 2.3. Non in-vivo Human or non-human model system	2021-05-10T02:48:54.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
21481742	True	meta-analysis, treating as a review		curator1	Lennox-Gastaut syndrome			
21513659	True	seems like a review		curator1	Lennox-Gastaut syndrome			
21515079			2021-05-10T03:24:55.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
21557146			2021-05-10T14:24:10.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21620771		0.2. Related Diseases; not really related		curator1	Lennox-Gastaut syndrome			
21638908			2021-05-08T17:59:14.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21688720			2021-05-10T16:05:16.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21763159			2021-05-08T17:53:05.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21790561	True	seems like a review		curator1	Lennox-Gastaut syndrome			
21792306	True	review		curator1	Lennox-Gastaut syndrome			
21862354			2021-05-10T04:49:58.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21924653			2021-05-10T03:25:20.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21947090			2021-05-10T02:17:06.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21956725			2021-05-08T17:44:03.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21982812		0.2. Related Diseases		curator1	Lennox-Gastaut syndrome			
22000954			2021-05-08T17:39:27.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
22071552			2021-05-10T03:08:15.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
22128252	True	seems like a review		curator1	Lennox-Gastaut syndrome			
22245794		sounds like a prospective study	2021-05-10T15:31:45.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
22255466		also 2.4. In-vivo Human basic science study	2021-05-08T17:32:08.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
22258042		not confident re: 1.3 vs 3.4 - seems like this was part of normal treatment and not a trial, so went with 1.3	2021-05-10T14:18:11.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22266062			2021-05-08T17:58:44.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22421185			2021-05-10T04:56:38.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
22422635		3.2. Drug Mechanism		curator1	Lennox-Gastaut syndrome			
22443637			2021-05-10T16:13:07.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22467791			2021-05-10T14:26:23.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
22476991		0.2. Related Diseases		curator1	Lennox-Gastaut syndrome			
22483538			2021-05-10T03:10:12.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22576075			2021-05-08T17:45:43.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
22629163			2021-05-10T14:33:47.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22633633			2021-05-10T02:23:17.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22677424			2021-05-10T16:12:13.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
22681320			2021-05-10T02:24:33.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22709423			2021-05-10T16:09:13.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
22729251			2021-05-10T02:29:40.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22746027			2021-05-10T14:13:40.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22780580			2021-05-10T03:14:55.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22813348			2021-05-10T16:04:53.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
22921514			2021-05-10T15:34:42.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22934193			2021-05-10T14:23:04.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
22944514			2021-05-10T15:02:45.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
22957240		0.2. Related Diseases		curator1	Lennox-Gastaut syndrome			
23083943			2021-05-10T16:04:29.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23099847		either 0.2. Related Diseases or just irrelevant		curator1	Lennox-Gastaut syndrome			
23143718			2021-05-10T04:57:02.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
23213494	True	review		curator1	Lennox-Gastaut syndrome			
23230532			2021-05-10T15:34:12.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23334068			2021-05-10T14:23:18.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23354062			2021-05-10T14:28:39.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
23409955			2021-05-10T03:12:56.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
23415449			2021-05-10T02:47:08.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
23465587			2021-05-10T02:22:05.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23471536	True	seems like a review		curator1	Lennox-Gastaut syndrome			
23490456			2021-05-10T16:17:14.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
23531645			2021-05-10T14:31:16.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
23634191	True	review		curator1	Lennox-Gastaut syndrome			
23647917		0.2. Related Diseases		curator1	Lennox-Gastaut syndrome			
23770633			2021-05-10T15:18:44.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23770680			2021-05-10T03:16:12.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23812912			2021-05-10T15:33:48.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
23827423			2021-05-10T02:16:45.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23850002			2021-05-10T14:22:04.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23864316			2021-05-10T03:04:40.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
23934111			2021-05-10T15:09:21.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
23936641	True	review		curator1	Lennox-Gastaut syndrome			
23973644		1.4. Epidemiology		curator1	Lennox-Gastaut syndrome			
23981349			2021-05-10T16:12:33.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
24105702			2021-05-10T02:20:45.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24117046			2021-05-10T02:46:59.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24122274			2021-05-08T18:01:49.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24228152			2021-05-10T02:24:39.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24237632		survey of parents using cannabidiol treatments on their children - outside of medical setting	2021-05-10T03:00:56.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24348133	True	guideline - I'm treating these as reviews		curator1	Lennox-Gastaut syndrome			
24400693			2021-05-10T16:12:04.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24479878			2021-05-10T03:10:36.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24553310			2021-05-10T04:48:22.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
24580023			2021-05-10T04:30:03.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
24594429			2021-05-10T04:43:17.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24614520			2021-05-10T04:34:07.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24630492			2021-05-08T18:01:18.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24635129		3.3. Preclinical Therapeutics		curator1	Lennox-Gastaut syndrome			
24649449			2021-05-10T03:15:14.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24649460			2021-05-10T15:15:07.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24649473		also 1.2. Quality of Life	2021-05-08T17:34:19.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24659735			2021-05-10T03:03:00.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24762861			2021-05-10T03:26:08.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24902608			2021-05-10T04:42:59.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24906615			2021-05-10T02:48:34.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24912732		not confident - 1.3 or 3.4. also 1.2. Quality of Life	2021-05-08T17:55:46.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25011392			2021-05-10T04:57:18.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25038129			2021-05-10T03:01:38.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
25051969			2021-05-10T04:56:32.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25219353			2021-05-10T03:06:16.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25262651			2021-05-10T16:09:05.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
25266269			2021-05-10T03:21:24.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
25266616			2021-05-10T02:49:04.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25282105			2021-05-10T15:29:54.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25511520			2021-05-08T18:00:46.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25530452		or 3.2. Drug Mechanism ?	2021-05-08T17:45:49.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
25616450			2021-05-10T02:14:53.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
25619447		more of a drug toxicity focus	2021-05-08T17:38:31.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25682573		clinical practice survey, there isn't really a category for this (not a review)		curator1	Lennox-Gastaut syndrome			
25687944			2021-05-10T03:21:56.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25730374			2021-05-10T03:05:55.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25814807			2021-05-10T03:10:33.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25845492		parental reporting again	2021-05-10T03:15:02.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25847334		and 0.2. Related Diseases	2021-05-10T16:15:51.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25890840		and 2.3. Non in-vivo Human or non-human model system	2021-05-10T14:29:50.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
25935511		survey of parent experience	2021-05-10T16:19:27.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25940107			2021-05-10T14:22:09.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26036975	True	drug being considered for repurposing in diabetic neuropathy		curator1	Lennox-Gastaut syndrome			
26057351			2021-05-10T14:24:00.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26093133			2021-05-10T02:47:32.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26167208			2021-05-10T03:09:13.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26224203		3.2. Drug Mechanism		curator1	Lennox-Gastaut syndrome			
26245776			2021-05-10T03:13:58.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26294172		3.2. Drug Mechanism (PK)		curator1	Lennox-Gastaut syndrome			
26474092			2021-05-10T15:17:31.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26513494			2021-05-10T14:09:58.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.3. THERAPEUTICS IN THE CLINIC
26606192			2021-05-10T04:56:46.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26611353			2021-05-10T04:44:03.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26645412			2021-05-10T14:31:33.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
26724101			2021-05-10T16:14:54.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26805435			2021-05-08T17:59:29.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26827266			2021-05-10T04:51:51.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26828692			2021-05-08T17:51:07.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26842220			2021-05-10T16:16:56.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26860718			2021-05-10T14:21:45.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26861566			2021-05-10T04:34:14.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26887412			2021-05-10T14:29:19.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26906013		adverse drug effect	2021-05-10T14:22:36.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26945476			2021-05-08T17:47:24.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26950270			2021-05-08T17:51:49.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26977407			2021-05-10T04:34:23.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26979179		not sure if 1.3 or 3.4		curator1	Lennox-Gastaut syndrome			
27145465			2021-05-08T17:47:44.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27363778			2021-05-08T17:51:29.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
27379172			2021-05-10T14:06:06.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27392921	True	seems like a review		curator1	Lennox-Gastaut syndrome			
27434073			2021-05-10T14:04:25.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27466475			2021-05-10T03:06:32.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27513375			2021-05-10T16:10:05.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27513709			2021-05-10T15:30:41.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27557111	True	sort of a review of orphan drug approvals in US vs Europe		curator1	Lennox-Gastaut syndrome			
27629372			2021-05-10T03:26:20.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27635610	True	meta-analysis, treating as review		curator1	Lennox-Gastaut syndrome			
27686687			2021-05-10T02:16:55.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27846468			2021-05-10T15:18:11.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27934621		disease pathogenesis (caused by a drug)	2021-05-08T18:02:42.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27994367			2021-05-10T15:29:47.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
28038390			2021-05-10T04:58:20.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28078312			2021-05-10T03:01:24.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
28186331		and 0.2. Related Diseases	2021-05-10T14:16:48.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28295228			2021-05-10T16:06:04.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28392943		parent experience of children using cannabis - not in medical setting	2021-05-10T14:05:03.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28431772			2021-05-10T04:55:04.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
28513609			2021-05-08T17:43:47.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
28528895		3.2. Drug Mechanism		curator1	Lennox-Gastaut syndrome			
28584915			2021-05-10T04:56:13.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28600632			2021-05-10T15:14:44.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28609734		and 1.4. Epidemiology	2021-05-10T04:55:46.000Z	curator1	Lennox-Gastaut syndrome			
28633092		and 0.2. Related Diseases	2021-05-10T04:45:32.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28635719	True	seems like a review		curator1	Lennox-Gastaut syndrome			
28715780			2021-05-10T16:12:55.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
28740620		1.4. Epidemiology		curator1	Lennox-Gastaut syndrome			
28782435		3.2. Drug Mechanism		curator1	Lennox-Gastaut syndrome			
28846756			2021-05-10T04:54:01.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
28874317			2021-05-08T17:46:33.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28927712			2021-05-10T15:32:39.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
28928710			2021-05-10T15:03:36.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.3. THERAPEUTICS IN THE CLINIC
29053577			2021-05-10T03:11:07.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	2.1. DISEASE MECHANISM
29121573		3.2. Drug Mechanism		curator1	Lennox-Gastaut syndrome			
29126048			2021-05-10T03:22:57.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29150892			2021-05-10T16:13:28.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
29202277			2021-05-10T02:21:01.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
29264397			2021-05-10T04:33:54.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
29314583			2021-05-10T02:24:53.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
29395273			2021-05-10T03:01:21.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
29467376			2021-05-10T04:49:44.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29558884		and 0.2. Related Diseases	2021-05-10T04:52:39.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29570389		surgical technique	2021-05-10T14:02:53.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29630738			2021-05-10T04:58:56.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
29740868			2021-05-10T15:32:59.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.3. THERAPEUTICS IN THE CLINIC
29746397		3.2. Drug Mechanism (PK)		curator1	Lennox-Gastaut syndrome			
29761022			2021-05-10T15:30:16.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
29768152			2021-05-10T16:14:44.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
29906696			2021-05-10T03:18:21.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29941151		3.2. Drug Mechanism (healthy subjects)		curator1	Lennox-Gastaut syndrome			
29948770		3.3. Preclinical Therapeutics	2021-05-10T16:11:18.000Z	curator1	Lennox-Gastaut syndrome			
29968450			2021-05-10T16:04:16.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29982584			2021-05-10T14:13:35.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30010275			2021-05-10T02:15:30.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30017619			2021-05-08T17:37:45.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
30057867		adverse drug effect	2021-05-10T02:36:52.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30146701			2021-05-10T02:19:51.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30166208			2021-05-10T03:01:01.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30194277			2021-05-10T16:15:39.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30199357			2021-05-10T02:48:17.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30213680			2021-05-10T03:23:31.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30241056		1.4. Epidemiology (cost analysis)		curator1	Lennox-Gastaut syndrome			
30286391		and 0.2. Related Diseases	2021-05-10T16:14:04.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30286409			2021-05-10T04:47:24.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30309816			2021-05-08T17:38:42.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30336805		3.2. Drug Mechanism (healthy subjects)		curator1	Lennox-Gastaut syndrome			
30364578			2021-05-10T02:36:37.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30368788	True	review		curator1	Lennox-Gastaut syndrome			
30403281			2021-05-10T04:51:45.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30405366	True	review		curator1	Lennox-Gastaut syndrome			
30442041		medicinal chemistry - maybe 3.2. Drug Mechanism		curator1	Lennox-Gastaut syndrome			
30537670			2021-05-10T02:23:07.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30552298			2021-05-08T17:36:35.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
30554497		0.2. Related Diseases	2021-05-10T16:10:01.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30564493			2021-05-10T04:52:31.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30616356	True	review		curator1	Lennox-Gastaut syndrome			
30676535	True	review		curator1	Lennox-Gastaut syndrome			
30740695			2021-05-10T16:14:59.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30788214			2021-05-10T15:34:29.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30804880			2021-05-10T04:36:03.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30816845	True	paper is about Generalized tonic status epilepticus, LGS was only mentioned as a usual cause for TSE but it did not pertain to the case	2021-05-10T14:19:18.000Z	curator1	Lennox-Gastaut syndrome			
30817475	True	review		curator1	Lennox-Gastaut syndrome			
30909854	True	some kind of news update?		curator1	Lennox-Gastaut syndrome			
30913948		and 1.2. Quality of Life	2021-05-10T15:16:54.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30955420			2021-05-10T14:34:38.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31008722			2021-05-10T15:29:59.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31022635		expanded access - similar to post-market monitoring; was performed prospectively	2021-05-10T04:32:11.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31082204		3.3. Preclinical Therapeutics	2021-05-10T03:02:47.000Z	curator1	Lennox-Gastaut syndrome			
31113280		0.2. Related Diseases		curator1	Lennox-Gastaut syndrome			
31161980	True	review		curator1	Lennox-Gastaut syndrome			
31176687			2021-05-10T15:15:44.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31190668			2021-05-10T04:47:07.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31227617			2021-05-08T18:03:08.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31255830		2.3. Non in-vivo Human or non-human model system		curator1	Lennox-Gastaut syndrome			
31279290		maybe 3.2. Drug Mechanism - technique for drug level analysis in mouse samples		curator1	Lennox-Gastaut syndrome			
31307608		seems like a review		curator1	Lennox-Gastaut syndrome			
31325430		3.3. Preclinical Therapeutics		curator1	Lennox-Gastaut syndrome			
31432588	True	review		curator1	Lennox-Gastaut syndrome			
31435640			2021-05-08T17:33:59.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31468518			2021-05-10T02:25:21.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31519475		3.2. Drug Mechanism		curator1	Lennox-Gastaut syndrome			
31563030		3.2. Drug Mechanism (PK)		curator1	Lennox-Gastaut syndrome			
31575436			2021-05-10T16:12:42.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31625159		3.2. Drug Mechanism (PK)		curator1	Lennox-Gastaut syndrome			
31678406		and 2.3. Non in-vivo Human or non-human model system	2021-05-10T04:51:28.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31708334	True	review		curator1	Lennox-Gastaut syndrome			
31755996		and 3.2. Drug Mechanism	2021-05-10T14:25:30.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31770718			2021-05-10T04:50:21.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31829726			2021-05-10T03:22:42.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31833952	True	review		curator1	Lennox-Gastaut syndrome			
31851997			2021-05-10T16:20:19.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31855252			2021-05-08T17:42:39.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31877501			2021-05-10T04:54:04.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31926846			2021-05-10T04:47:35.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31941643	True	review		curator1	Lennox-Gastaut syndrome			
31941644	True	seems like a review		curator1	Lennox-Gastaut syndrome			
31980515			2021-05-10T16:18:15.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
32020895			2021-05-10T14:10:56.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32082420			2021-05-10T04:57:40.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32096470	True	review		curator1	Lennox-Gastaut syndrome			
32207730	True	review		curator1	Lennox-Gastaut syndrome			
32334364			2021-05-10T15:04:22.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32350749		3.2. Drug Mechanism (PK; no efficacy evaluation)		curator1	Lennox-Gastaut syndrome			
32401350		"sounds like a prospective study ""patients were followed longitudinally"""	2021-05-10T15:28:56.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
32441821			2021-05-10T02:20:19.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32452532	True	SR/MA - review		curator1	Lennox-Gastaut syndrome			
32467926		and 2.3. Non in-vivo Human or non-human model system	2021-05-10T14:27:00.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
32477256		not sure, basically a study to characterize drug prescribing/use patterns, closest would probably be 1.3		curator1	Lennox-Gastaut syndrome			
32502686		3.2. Drug Mechanism		curator1	Lennox-Gastaut syndrome			
32592183	True	MA = review		curator1	Lennox-Gastaut syndrome			
32614070		adverse drug reaction	2021-05-10T16:11:03.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32623611			2021-05-10T03:08:47.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
32715412		1.4. Epidemiology		curator1	Lennox-Gastaut syndrome			
32736238			2021-05-10T02:35:49.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
32759067			2021-05-10T04:29:54.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32851114		and 3.2. Drug Mechanism  (PK)	2021-05-10T16:03:20.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32854045		and 0.2. Related Diseases	2021-05-10T04:52:02.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32860345			2021-05-10T15:17:52.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32910945		3.2. Drug Mechanism	2021-05-10T03:22:26.000Z	curator1	Lennox-Gastaut syndrome			
32920379			2021-05-10T16:18:22.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
32928027			2021-05-08T17:47:38.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
32944944			2021-05-10T16:09:29.000Z	curator1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
32945607			2021-05-10T03:22:36.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
32969022	True	meta-analysis type study		curator1	Lennox-Gastaut syndrome			
33002834			2021-05-10T02:28:43.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33026899	True	review		curator1	Lennox-Gastaut syndrome			
33188523	True	MA = review		curator1	Lennox-Gastaut syndrome			
33189068		0.2. Related Diseases		curator1	Lennox-Gastaut syndrome			
33224689			2021-05-10T02:25:03.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33241408		maybe 3.2. Drug Mechanism (analytical method)		curator1	Lennox-Gastaut syndrome			
33243487			2021-05-10T14:18:28.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
33313501		adverse drug reaction	2021-05-10T14:11:04.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33358132		1.4. Epidemiology		curator1	Lennox-Gastaut syndrome			
33376981		3.2. Drug Mechanism		curator1	Lennox-Gastaut syndrome			
33391157		and 0.2. Related Diseases	2021-05-10T16:02:57.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
33482642			2021-05-10T14:29:09.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33584793			2021-05-10T04:44:50.000Z	curator1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
33626200	True	SR and MA = review		curator1	Lennox-Gastaut syndrome			
33626436			2021-05-10T14:29:35.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33638459	True	review		curator1	Lennox-Gastaut syndrome			
33681663			2021-05-10T04:51:10.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
33718684			2021-05-10T02:19:37.000Z	curator1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33721709			2021-05-10T02:13:10.000Z	curator1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33745195	True	seems like a review		curator1	Lennox-Gastaut syndrome			
33746760		3.2. Drug Mechanism		curator1	Lennox-Gastaut syndrome			
19403253			2021-04-25T18:56:10.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20042709			2021-04-18T20:29:19.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20056902			2021-04-20T00:47:43.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20087969			2021-04-18T22:17:04.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20093519			2021-04-20T00:45:05.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20101697	True		2021-04-20T00:41:37.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20141966			2021-04-18T22:14:52.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20154077		Involves patients > testing was performed (CT)	2021-04-20T00:41:30.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20209594			2021-04-20T00:57:49.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20224041			2021-04-18T21:45:53.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20414677			2021-04-20T01:01:26.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20458853			2021-04-18T20:25:53.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20461185			2021-04-20T00:40:19.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20466398		"received treatment - embolization

This paper was marked as check. While I still feel that the abstract discussed treatments that the patient received (drainage of brain abscess, embolization), I suppose that the sentence ""He had no feature of HHT and no mutation in ENG and ACVRL1 genes"" indicates an investigation of the genetics of the disease. Using the flowchart, I'd answer ""Yes"" to ""Does the experimental work investigate the genetic mechanism of the disease"", which would change my selection to 2.1 Disease mechanism."	2021-04-25T15:47:40.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20544620			2021-04-18T22:13:56.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20620301		"Involves patients > received treatment (chemo)

This paper was marked as Check. Based on the flowchart, I would answer ""Yes"" to ""Does the abstract describe any treatments received by the patient"". Abstract states ""Chemotherapy was used in 23% (9) and radiation in 20% (8) of the patients"". Therefore, I'd like to leave this as 1.3 Therapeutics in the clinic."	2021-04-18T18:57:25.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20622729			2021-04-18T23:36:47.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20879701	True	This reads like a review or a guidelines paper		curator2	hereditary hemorrhagic telangiectasia			
21290179		"This paper was marked as check. 
The abstract mentions that therapy/treatment was administered and discusses ""response to treatment of patients with complicated hepatic vascular malformations""

For this reason, I would leave it as 1.3 Therapeutics in the clinic."	2021-04-20T01:01:51.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21336824		I think this is a clinical trial considering the protocol was approved by the HIC but there is no treatment. There are assessments (exercise stress test and 6MWT). So I could also see how this could be considered therapeutics in the clinic.	2021-04-20T00:57:24.000Z	curator2	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
21344445			2021-04-18T20:27:09.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21344447			2021-04-18T19:34:41.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21345778			2021-04-18T21:42:26.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21426754			2021-04-18T23:42:24.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21484125			2021-04-18T22:15:21.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21706320		"Seems to be a relatively new treatment. ""At the present time, only very few prospective trials have been performed, and many studies are based on patients' subjective assessment of the severity of epistaxis."" But it's not the development of a new treatment, so it could be therapeutics in the clinic.

This paper was marked as check. 
I would describe it as more Therapeutics in the clinic than Patient-based therapeutics. Therefore, I am removing Patient based therapeutics in my selection and leave just Therapeutics in the clinic."	2021-04-25T18:37:18.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21823360		Involves a patient > involves testing (x ray, CT scan)	2021-04-18T19:01:29.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21842025		"This paper was marked as check.

The patient received treatment - surgical therapy- and there were no complications. I would keep my answer as 1.3 Therapeutics in the clinic."	2021-04-18T23:44:22.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21855727		Does not actually mention a patient - so leave blank according to flow chart?	2021-04-18T20:03:08.000Z	curator2	hereditary hemorrhagic telangiectasia			
21861324		"This paper was marked as check. It does mention ""laparoscopy-assisted surgery"" - treatment given."	2021-04-18T21:59:14.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22120563		Patients > treated via endovascular and microsurgical modalities	2021-04-18T19:35:42.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22129679		It is testing a drug but it did not test it in patients - so leave blank according to flow chart		curator2	hereditary hemorrhagic telangiectasia			
22196589			2021-04-18T21:59:03.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22213836		"This paper was marked as check.

Since the abstract mentions ""two patients (29%) harbored a known mutation in the RASA1 gene, associated with a hereditary vascular syndrome: capillary malformation-arteriovenous malformation"", I have modified my selection to 2.1 Disease mechanism."	2021-04-25T18:41:53.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22240227			2021-04-18T23:00:24.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22379273	True	This seems to be a review		curator2	hereditary hemorrhagic telangiectasia			
22385575			2021-04-20T00:46:28.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22421041			2021-04-18T21:46:36.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22553411		"This paper is marked as check.

Because the abstract includes ""A genetic study revealed a mutation in exon 3 of ALK1 (c.199C > T; p.Arg67Trp) in the proband and his eldest son presenting epistaxis."", I have removed Therapeutics in the clinic from my selection and left 2.1 Disease mechanism."	2021-04-25T18:39:37.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22622516			2021-04-18T21:33:26.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22670022		"This paper was marked as check. It is really tough for me to decide between Disease Mechanism and Clinical Characteristics. The abstract says ""We concluded that there may be a temporal relationship between exposure to stimulants and development of PAH in a host with underlying gene mutation"" but the abstract does not mention any genetic/molecular/physiological mechanisms of the disease. I supposed that the patient would have had to undergo some genetic testing to determine that she has this underlying gene mutation. Therefore, I have remove 1.1. Clinical characteristics from my selection, so that only 2.1. disease mechanism remains."	2021-04-25T18:22:07.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22671535			2021-04-23T01:08:41.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22727716			2021-04-23T01:12:38.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22737832			2021-04-23T01:04:21.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22744870		"no treatment given....yet ""the patient is going to be liver transplantated within the next months.""

but the paper does mention ""genetic analysis revealed no mutations in the activin receptor-like kinase (ALK) 1 or endoglin genes"". so it does investigate a genetic mechanism, and for that reason, I have also selected 2.1 disease mechanism."	2021-04-25T18:46:01.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
22849993		"Did they treat her with embolization? or was this done before she was seen by them?

""Embolization of pulmonary AVF decreased the frequency of migraine attacks during 2-year follow-up after the embolization"""	2021-04-18T21:53:33.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22875690			2021-04-21T00:32:13.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22920200			2021-04-20T01:03:31.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22940655			2021-04-18T19:37:29.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22991266			2021-04-21T00:37:15.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23018639			2021-04-18T21:44:01.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23090737			2021-04-23T01:09:35.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23109496			2021-04-18T22:57:40.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23168156			2021-04-18T21:57:08.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23199770			2021-04-23T01:13:17.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23232196		This is a study in patients but no treatment was given - a sniff test was administered.	2021-04-18T23:12:46.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23246127			2021-04-18T21:46:30.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23303231		"This paper was marked as check. 

It describes that he ""underwent genetic analysis for HHT"". As such, I would leave my selection as 2.1 Disease mechanism"	2021-04-21T00:37:59.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23312966			2021-04-18T22:08:39.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23320130			2021-04-18T23:43:26.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23323127		Not sure if this should be left blank. It doesn't discuss tests or therapies but it is in clinical patients. Closest would be disease pathology	2021-04-18T21:49:33.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23351611		"This paper was marked as check. Given the sentence, ""Genetic analysis revealed a mutation in the endoglin gene"" and using the flow chart, I would mark ""yes"" to ""does this paper investigate the genetic mechanism of the disease"". Therefore, I have changed my selection to 2.1 disease mechanism"	2021-04-25T15:48:28.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23401183		This paper was marked as check. If I had to pick one, I'd stick with 2.1 disease mechanism due to the discussion of disease-causing mutations and remove 1.1. clin char.	2021-05-04T16:05:27.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23439260			2021-04-18T21:40:52.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23568730			2021-04-20T00:43:16.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23653583			2021-04-18T23:43:11.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23675457			2021-04-18T22:57:02.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23676596			2021-04-18T21:58:37.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23702711			2021-04-18T23:00:03.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23729109			2021-04-20T01:03:46.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23794345			2021-04-21T00:36:55.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23800974			2021-04-18T22:11:50.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24045083			2021-04-18T20:29:36.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24146883			2021-04-20T00:49:14.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24260769			2021-04-18T23:11:44.000Z	curator2	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
24267784			2021-04-23T01:05:12.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24268183	True	"Paper is about a new search method ""we describe an algorithm and web-based application which take into account both the probability that a variant damages the function of a gene as well as the relevance of the gene to a given phenotype."""		curator2	hereditary hemorrhagic telangiectasia			
24273414			2021-04-18T19:39:36.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24458873			2021-04-18T20:04:42.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24489709			2021-04-18T21:41:54.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24520391			2021-04-23T01:07:42.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24587130			2021-04-18T19:36:24.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24615664			2021-04-18T21:42:16.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24667223			2021-04-18T20:29:50.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24807278			2021-04-18T23:42:47.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24826466			2021-04-18T19:25:57.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24913291			2021-04-23T01:06:47.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24935454			2021-04-20T00:45:49.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24986705			2021-04-23T01:10:54.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24999773			2021-04-21T00:38:28.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25064693			2021-04-18T22:13:28.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
25082229			2021-04-18T21:46:09.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25140883		this paper discusses/focuses on a new method to map the microvasculature of the skin - leave blank?		curator2	hereditary hemorrhagic telangiectasia			
25298070			2021-04-18T21:43:20.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25387512			2021-04-21T00:34:47.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25420398		"Do you consider a case report about a man with the disease who had surgeries in the past as therapeutics in the clinic? ""A large pulmonary AVM necessitated a surgical intervention when the patient was in his thirties"". 

If you are also considering the responses he's had post-op, then I'd tag this paper as therapeutics in the clinic"	2021-04-25T18:49:24.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
25465912			2021-04-20T00:43:05.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25543221			2021-04-20T00:42:11.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25564593			2021-04-18T22:18:14.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25572952			2021-04-18T21:58:03.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25603856			2021-04-23T01:12:26.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
25763011			2021-04-23T01:10:06.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25815003			2021-04-18T21:39:27.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25839006			2021-04-18T22:59:26.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25847705			2021-04-18T23:34:23.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
25873934			2021-04-18T22:10:52.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25909848			2021-04-18T20:28:36.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25970827			2021-04-20T00:45:43.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25981877		Leave blank? It's about a drug - metformin - but it's not used on a patient		curator2	hereditary hemorrhagic telangiectasia			
26078760			2021-04-18T19:38:27.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26171128			2021-04-18T20:23:08.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26204445		"Not a clinical trial - ""We conducted a single-center cohort study of patients with confirmed HHT who underwent right-sided heart catheterization (RHC) and transthoracic two-dimensional echocardiography for suspected PH between June 1, 2003 and September 1, 2013 at Mayo Clinic Rochester, Minnesota"""	2021-04-18T22:28:56.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
26261842			2021-04-18T22:57:26.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
26376562			2021-04-23T01:09:51.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26401274			2021-04-20T00:41:49.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
26425624			2021-04-18T21:58:15.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
26505940			2021-04-18T23:35:47.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
26608985			2021-04-23T01:05:48.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.3. THERAPEUTICS IN THE CLINIC
26751606			2021-04-18T21:39:51.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
26801773			2021-04-20T00:46:32.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
26836699			2021-04-18T20:23:52.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
26873746			2021-04-18T21:40:41.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26998137			2021-04-23T01:06:15.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27027094			2021-04-20T00:49:54.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27114237		"It doesn't specify or discuss details about genetics tests, but it does say ""genetic testing was performed, which verified the clinical diagnosis"". For that reason, I have also selected 2.1 Disease mechanism."	2021-04-25T18:43:15.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	2.1. DISEASE MECHANISM
27141651			2021-04-18T19:15:12.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27168866			2021-04-18T21:55:46.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27225226			2021-04-23T01:06:03.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27424345	True	Review		curator2	hereditary hemorrhagic telangiectasia			
27440131		Patients > treatment	2021-04-18T20:03:50.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27599328			2021-04-18T20:30:21.000Z	curator2	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
27605480		"Therapeutic in the clinic bc ""they caused severe respiratory or cardiac failure and were treated via the embolization of the responsible vessel"""	2021-04-18T23:32:44.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27646277			2021-04-18T22:17:52.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
27727478		Involves patients > testing (CT)	2021-04-18T19:14:15.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27777480			2021-04-18T20:24:45.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27878613			2021-04-21T00:35:19.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28004998		Involves a patient > involves testing (MRI, angio)	2021-04-18T19:01:53.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28165669			2021-04-20T00:45:27.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
28267932			2021-04-18T21:33:57.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28297555			2021-04-18T19:40:41.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28407366		"observational cohort study
-received treatment - embolotherapy"	2021-04-18T19:44:12.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28430541	True	review		curator2	hereditary hemorrhagic telangiectasia			
28490409			2021-04-18T23:44:46.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28564608			2021-04-18T21:39:38.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
28578477			2021-04-21T00:35:45.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28670610			2021-04-18T21:41:09.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28671294			2021-04-18T21:58:52.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28687708			2021-04-21T00:33:59.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
28775059			2021-04-20T01:03:01.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28810087			2021-04-18T22:47:54.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28973643			2021-04-23T01:12:02.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29171658		"There is also mention of some genetic testing: ""60 had HHT confirmed by genetic testing"". Although this was done previously, it is part of the study as they stratified patients by genetic testing. Therefore, I have also selected 2.1 disease mechanism."	2021-04-25T18:53:08.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
29243366			2021-04-23T01:10:23.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29274888		"Leave blank? Describe a therapy/treatment, but not in human patients/trial. ""characteristics of TTCE"""		curator2	hereditary hemorrhagic telangiectasia			
29305977			2021-04-20T00:42:28.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29395350			2021-04-18T23:44:08.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
29416304			2021-04-18T19:37:02.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
29460088			2021-04-18T20:30:06.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29469958			2021-04-23T01:11:11.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
29480092		Includes patients > looking at clin char	2021-04-18T18:55:41.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29593101			2021-04-23T01:07:53.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29655863			2021-04-21T00:24:54.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29938556			2021-04-23T01:07:26.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30095617			2021-04-23T01:14:51.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30146556			2021-04-18T19:35:03.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30171179		"""Here we reported the successful outcome"" -- so patient received the treatment/surgery = therapeutics in the clinic"	2021-04-18T19:28:03.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
30191360		This is a clinical trial looking at the efficacy of pazopanib on HHT-related bleeding, and to measure safety. Votrient seems to be repurposed in this case.	2021-04-21T00:33:40.000Z	curator2	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
30260738		While this abstract does mention that the patient has a genetic mutation, it does not investigate the genetic mechanism of the disease. Therefore, I would select 1.3 Therapeutics in the clinic.	2021-04-18T21:33:14.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
30272025			2021-04-18T19:25:34.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
30512964			2021-04-20T00:49:34.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
30549294			2021-04-18T22:02:03.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30596371			2021-04-18T21:43:43.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
30704695			2021-04-18T21:46:59.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30705963	True	review		curator2	hereditary hemorrhagic telangiectasia			
30717761		retrospective capture, not a clinical trial	2021-04-18T19:42:05.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
30744395			2021-04-23T01:13:23.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
30853205		"Presuming scans were done to evaluate said PAVM growth ""although new PAVMs did not evolve in children with HHT, existing PAVMs exhibit quantitative growth over time highlighting the need for ongoing follow-up throughout childhood."""	2021-04-18T22:02:59.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30888464			2021-04-18T21:47:27.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30935812			2021-04-18T21:56:09.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31006519			2021-04-18T22:13:08.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31032126			2021-04-18T20:24:08.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31360828		A pilot clinical trial (EudraCT: 2016-003982-24) was performed with 12 HHT patients using a topical spray of etamsylate twice a day for 4 weeks	2021-04-18T22:00:23.000Z	curator2	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
31361678			2021-04-20T01:03:40.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
31441079	True	review		curator2	hereditary hemorrhagic telangiectasia			
31455059			2021-04-23T01:07:01.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
31566760			2021-04-18T21:54:07.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31615556			2021-04-18T23:11:05.000Z	curator2	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
31689244			2021-04-18T22:00:32.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
31828546			2021-04-18T19:33:51.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
31905627		"Could also consider this therapeutics in the clinic because ""required more transfusions"""	2021-04-18T21:45:31.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
31910122	True	"Like reviews, would guidelines be irrelevant?

""multidisciplinary guideline is to identify quality improvement opportunities in the management of nosebleeds and to create clear and actionable recommendations to implement these opportunities in clinical practice"""		curator2	hereditary hemorrhagic telangiectasia			
32059941			2021-04-18T19:42:44.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32178330			2021-04-18T20:26:43.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32199058			2021-04-23T01:08:03.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
32206359			2021-04-18T21:56:39.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32341592			2021-04-20T00:46:01.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32493237			2021-04-23T01:09:29.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
32556901			2021-04-20T01:02:28.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
32573726			2021-04-18T19:38:02.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32718529			2021-04-18T21:52:41.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32723034	True	review		curator2	hereditary hemorrhagic telangiectasia			
32756122			2021-04-23T01:12:11.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32774576		Involves a patient > involves testing (Radiologic workup)	2021-04-18T19:01:10.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32874383			2021-04-18T20:29:04.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
32904708		Involves a patient > testing (CT)	2021-04-18T19:00:34.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32926701			2021-04-21T00:35:59.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
32954380			2021-04-21T00:36:45.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32998220			2021-04-18T19:44:38.000Z	curator2	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
33081831			2021-04-20T00:50:09.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33090433	True	review		curator2	hereditary hemorrhagic telangiectasia			
33172103			2021-04-18T22:15:51.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33242965			2021-04-18T22:15:10.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33243256			2021-04-18T22:17:38.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33498134			2021-04-18T22:14:08.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
33511041			2021-04-18T22:17:21.000Z	curator2	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33539783			2021-04-18T22:08:12.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33652493		Leave blank - no abstract available		curator2	hereditary hemorrhagic telangiectasia			
33661356			2021-04-18T22:13:19.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33671708		"embolization therapy = therapeutic
not novel"	2021-04-21T00:28:41.000Z	curator2	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33754658		No abstract but can assume from the title that it is disease mechanism?	2021-04-21T00:35:11.000Z	curator2	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
19948417			2021-05-06T15:07:57.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20004858			2021-05-06T18:54:05.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20008422			2021-05-04T01:28:01.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20041940			2021-05-04T00:43:49.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
20149600			2021-05-04T15:40:31.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20150505			2021-05-06T15:07:27.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20151724		This paper focuses more on the economic costs of the treatment (pharmacoeconomics). I would leave it blank as it's a better fit for the Epidemiology category.		curator2	Lennox-Gastaut syndrome			
20169970			2021-05-04T01:23:27.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20185372			2021-05-06T18:04:01.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20199521		This is an extension of the clinical trial. As such, I would still consider this patient-based therapeutics.	2021-05-06T15:02:00.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
20345938			2021-05-06T18:01:11.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20384723			2021-05-06T18:49:49.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
20384727			2021-05-06T18:40:52.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
20472190			2021-05-04T00:40:07.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20472261		"Treatment was discussed. ""Single-drug therapy was the rule for first intention treatment (96.8%). Sodium valproate was the antiepileptic drug most widely used (82%). Treatment led to resolution of the seizures in 76% of the children""

This paper was marked as checked. Since they mention treatment and how it resolved seizures in 76% of the children, I would still categorize this as therapeutics in the clinic."	2021-05-04T00:30:49.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20533249			2021-05-04T16:08:16.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20598586			2021-05-06T17:53:57.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20610118			2021-05-04T15:11:05.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20666130			2021-05-06T16:23:24.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20666837			2021-05-06T14:37:32.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20691934			2021-05-04T01:09:32.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20823030			2021-05-06T18:03:15.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
20842588	True	Reads like a review.		curator2	Lennox-Gastaut syndrome			
20970386			2021-05-04T00:34:21.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21038079		This reads as a clinical trial.	2021-05-04T16:01:29.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21204804			2021-05-06T19:16:01.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
21227654		There's only brief mention of a treatment - surgery. My initial reaction was to categorize this as 1.1. Clin char, but I could see why someone would also tag it as 1.3 therapeutics in the clinic.	2021-05-06T17:16:41.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21243535			2021-05-06T16:38:26.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21269294			2021-05-04T01:23:05.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21341220		"Treatment was mentioned- ""They used an average of 7.5 different antiepileptic drugs."".

This paper was marked as Check. I would still say its therapeutic in the clinic as a section of the abstract discusses the patients' therapies."	2021-05-04T00:10:06.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21353345			2021-05-04T16:07:39.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21365309			2021-05-06T18:55:32.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21376637			2021-05-06T18:50:21.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21383651			2021-05-04T15:58:40.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21396833			2021-05-06T18:47:17.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21397780			2021-05-04T00:45:50.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21464890			2021-05-04T01:27:29.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
21481742	True	Meta-analysis		curator2	Lennox-Gastaut syndrome			
21513659	True	Review		curator2	Lennox-Gastaut syndrome			
21688720			2021-05-06T18:54:21.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21692791			2021-05-04T00:49:19.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21763159		Treatment = ketogenic diet (KD). Does appear to be some sort of clinical trial/study.	2021-05-04T00:37:59.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21790560	True	Reads like a review paper.		curator2	Lennox-Gastaut syndrome			
21790561	True	I think this is a review. It reads as a review paper		curator2	Lennox-Gastaut syndrome			
21790562		This is a survey paper about the transition to adult care from youth, but its not a case report. I am going to leave it blank for now.		curator2	Lennox-Gastaut syndrome			
21792306	True	Review		curator2	Lennox-Gastaut syndrome			
21862354			2021-05-04T16:02:18.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21956725			2021-05-04T00:16:53.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
22000954		Treatment is described - resistant to antiepileptic drugs.	2021-05-04T00:13:46.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22053552			2021-05-04T01:22:53.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22071552			2021-05-04T01:33:12.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22245794			2021-05-06T18:47:08.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22255466			2021-05-03T23:40:54.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22281384			2021-05-06T18:56:32.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22467791			2021-05-06T16:40:05.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22471338			2021-05-06T14:43:10.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
22476991		"This paper was marked as check. It discusses a mutation, specifically MECP2. ""A clear genotype-phenotype correlation was not found"". Based on that criteria, I would keep this as 2.1 disease mechanism."	2021-05-04T01:30:23.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
22576075			2021-05-04T00:24:34.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
22592511			2021-05-06T18:04:09.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22629163			2021-05-06T17:05:36.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22681320			2021-05-04T00:52:07.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22729251		Study to evaluate the efficacy of music therapy in SMDC using monitoring changes in the autonomic nervous system but not a clinical trial.	2021-05-04T01:21:59.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22746027			2021-05-06T15:07:18.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22780580			2021-05-04T15:12:18.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22813348			2021-05-06T18:53:01.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22934193			2021-05-06T16:11:46.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22944514		I'm leaving this blank for now. I think this paper would be categorized as pre-clinical studies. It's not disease mechanism as it isn't about the genetics, molecular, or physiological mechanism of the disease.	2021-05-06T17:57:01.000Z	curator2	Lennox-Gastaut syndrome			
22957240			2021-05-04T00:42:33.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23041289			2021-05-06T14:45:41.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23083943			2021-05-06T18:52:41.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23099847			2021-05-04T01:15:09.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23141144			2021-05-04T01:18:17.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
23252400			2021-05-04T00:49:24.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
23354062			2021-05-06T16:44:35.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23489890		There is mention of  medical treatments including ACTH therapy,, but I don't think it is the focus on the paper. The purpose is to  clarify their clinical characteristics and prevalence of seizure as well as epilepsy types. For this reason, I'm selecting 1.1. Clin char.	2021-05-06T17:13:06.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23583057		Treatment is mentioned. Treatment using Japanese foods	2021-05-03T23:45:48.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23634191	True	Review		curator2	Lennox-Gastaut syndrome			
23770633			2021-05-06T18:39:49.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23770680			2021-05-04T15:14:57.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23812912			2021-05-06T18:49:54.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
23850002			2021-05-06T16:07:47.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23864316			2021-05-04T01:30:54.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23927801			2021-05-04T00:47:15.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
23934111			2021-05-06T18:02:44.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
23973644		Would like to categorize this paper as Epidemiology. Therefore, I am going to leave it blank for now.		curator2	Lennox-Gastaut syndrome			
23981349			2021-05-06T19:11:09.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24012506		Treatment discussed -Corpus callosotomy	2021-05-04T00:44:30.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24045845			2021-05-04T00:42:21.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24113539		"This paper was marked as checked.

I changed it from 1.3 to 3.4 patient based therapeutics."	2021-05-08T20:00:12.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
24116958			2021-05-06T14:42:39.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24228152			2021-05-04T01:09:15.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24348133	True	Guidelines		curator2	Lennox-Gastaut syndrome			
24479878			2021-05-04T15:04:53.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24533090		I would leave this blank for now. I think it falls more into the Drug mechanism category. It's not about the disease mechanism but the drug mechanisms		curator2	Lennox-Gastaut syndrome			
24553310		Describing method used in patients: computational iEEG analysis methods have recently been used for the localization of epileptogenic zones	2021-05-04T16:00:13.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24594429			2021-05-04T15:57:49.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24630492			2021-05-04T00:40:28.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24635129			2021-05-04T15:39:36.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24649460			2021-05-06T18:21:08.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24649473		They received treatment, epilepsy surgery	2021-05-03T23:44:21.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24684645		"It discusses economics/pharmacoeconomics. I would categorize this paper as ""Epidemiology"". For now, I will leave it blank."		curator2	Lennox-Gastaut syndrome			
24762861			2021-05-04T15:34:49.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24809226		There is discussion of surgical resection but I think the main point of this paper is understanding if IVEEG (method) could work and help surgery procedures. With that said, I chose 1.1. as it focuses on clin char and and disease path	2021-05-06T14:59:45.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24902608			2021-05-04T15:57:29.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24906615			2021-05-04T01:27:12.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24912730			2021-05-04T01:33:23.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24912732			2021-05-04T00:39:07.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24949576			2021-05-03T23:43:45.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25011392			2021-05-06T14:52:34.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25038129			2021-05-04T01:28:20.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
25051969			2021-05-06T14:43:25.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25132372	True	Meta-analysis		curator2	Lennox-Gastaut syndrome			
25184741			2021-05-06T18:03:24.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25219353			2021-05-04T01:31:35.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25231724			2021-05-06T18:48:53.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25262651			2021-05-06T18:56:04.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
25266269		The paper was marked as check. It discusses the FOXG1 gene in the patient. I would consider this 2.1 dis mechanism.	2021-05-04T15:19:54.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
25266616			2021-05-04T01:27:43.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25282105		I would consider a paper that discusses post hoc analyses of both short- and long-term clobazam trials still a clinical trials paper. Therefore, I would categorize it as patient-based therapeutics.	2021-05-06T18:43:20.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25336963		It's more about QoL if that category was available.	2021-05-06T19:10:43.000Z	curator2	Lennox-Gastaut syndrome			
25511520			2021-05-04T00:40:16.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25530452			2021-05-04T00:24:41.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
25616450			2021-05-04T00:43:19.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25619447			2021-05-03T23:48:06.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25682573			2021-05-04T00:48:46.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25687944		"Treatments mentioned, ""tracheal intubation with Airtraq"""	2021-05-04T15:21:03.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25730374			2021-05-04T01:31:08.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25798598		"This paper was marked as check.

It is about drug mechanisms, not disease mechanisms. I have changed my answer and am leaving it blank."	2021-05-08T20:02:11.000Z	curator2	Lennox-Gastaut syndrome			
25814807			2021-05-04T15:04:43.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25845492			2021-05-04T15:14:40.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25847334			2021-05-06T19:16:08.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25890840		Preclinical study? The study is investigating the drug, AY-9944 (AY) in animals. I will leave this blank for now.		curator2	Lennox-Gastaut syndrome			
25940107			2021-05-06T16:08:27.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26036975			2021-05-04T15:10:03.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26068938			2021-05-04T15:39:45.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26125563			2021-05-04T15:21:24.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26139309			2021-05-06T14:43:41.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26167208			2021-05-04T15:03:49.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26224203		"This paper was marked as check.

Since the abstract discusses the mechanism of the drug and not the disease, I would change my selection to ""Drug mechanism"", which is currently not one of the 4 categories. So for now, I will leave it blank."	2021-05-08T19:56:29.000Z	curator2	Lennox-Gastaut syndrome			
26238894			2021-05-06T18:49:41.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26245776			2021-05-04T15:10:23.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26294172			2021-05-06T18:44:56.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26333833			2021-05-04T01:31:58.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26513494			2021-05-06T15:03:27.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26606192			2021-05-06T14:48:45.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26645412			2021-05-06T17:02:25.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26744634			2021-05-04T16:11:39.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26808205			2021-05-04T15:59:05.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26827266		I consider an open-label extension study still a clinical trial	2021-05-04T16:09:18.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26828692			2021-05-04T00:34:39.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26842220			2021-05-06T19:16:27.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26860718			2021-05-06T15:25:17.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26861566			2021-05-04T15:52:57.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26887412			2021-05-06T16:45:19.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26906013			2021-05-06T16:09:43.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26923380			2021-05-04T15:33:26.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26945476			2021-05-04T00:26:24.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26950270			2021-05-04T00:37:00.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26979179			2021-05-04T15:46:47.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26993353			2021-05-06T18:56:17.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27052529			2021-05-04T01:33:49.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27082650			2021-05-06T18:02:35.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27084975			2021-05-04T16:10:45.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27184676	True	Reads like a review		curator2	Lennox-Gastaut syndrome			
27199889			2021-05-04T00:41:45.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27345028		I dont believe this would fit in any of the existing 4 categories. It appears to be a computational study. For now, I will leave it blank.		curator2	Lennox-Gastaut syndrome			
27379172			2021-05-06T15:01:13.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27392921		Leaving blank as it does not appear to fall into any category according the flowchart.		curator2	Lennox-Gastaut syndrome			
27417063		Some of these patients (N=8) underwent surgery (treatment).	2021-05-06T14:46:35.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27434073			2021-05-06T14:57:03.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27466475			2021-05-04T01:32:25.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27475280			2021-05-06T19:15:42.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27504264			2021-05-06T18:51:43.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
27513375			2021-05-06T19:07:51.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27513709		Treatment was described - High doses of oral steroids were given in all nine children with infantile spasms	2021-05-06T18:46:15.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27557111		This paper is about orphan drug legislations. I don't believe it fits in any categories at the moment. I will leave it blank.		curator2	Lennox-Gastaut syndrome			
27629372			2021-05-04T15:35:05.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27635610	True	Meta analysis		curator2	Lennox-Gastaut syndrome			
27683846			2021-05-06T18:44:42.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27686687			2021-05-04T00:43:56.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27934621			2021-05-04T00:41:34.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28038390			2021-05-06T14:55:36.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28078312			2021-05-04T01:28:14.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
28210578			2021-05-04T00:12:00.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
28295228		"Treatment described - ""resection of a cortical dysplasia"""	2021-05-06T18:54:52.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28392943			2021-05-06T15:00:54.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28431772			2021-05-04T16:11:27.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
28471101			2021-05-04T15:16:04.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28479797			2021-05-06T19:03:18.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28584915		"There is mention of treatments but it is not described - ""good secondary response to treatments in 80% of cases"". For that reason, I think the main purpose of this study is to describe the clinical characteristics and EEG features of patients with the disease"	2021-05-06T14:30:12.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28589569			2021-05-06T16:23:15.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
28600632		This paper is a comparative study. It doesn't fit in any of the four categories. I will leave this blank for now.		curator2	Lennox-Gastaut syndrome			
28609734		This seems like a treatment economics papers - I'd consider the closest category being 1.1 clin char as it does discuss that in the beginning of the abstract	2021-05-04T16:13:28.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28635719	True	Reads as a review.		curator2	Lennox-Gastaut syndrome			
28667181			2021-05-04T15:04:24.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
28689466	True	Review		curator2	Lennox-Gastaut syndrome			
28740620			2021-05-04T15:57:12.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28782435		"Study is in gerbils, not in patients. I would categorize this as ""Preclinical study"". For now, I will leave it blank."		curator2	Lennox-Gastaut syndrome			
28846756			2021-05-04T16:10:27.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
28874317			2021-05-04T00:25:08.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28927712			2021-05-06T18:48:39.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
28928710			2021-05-06T18:00:07.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29053577		There is mention of mice as well as children treated with KD	2021-05-04T15:05:57.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29098688			2021-05-04T15:39:30.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29121573		It's about a drug. No patients are mentioned. I think this would fall into the drug mechanism category? I will leave blank for now.		curator2	Lennox-Gastaut syndrome			
29150892			2021-05-06T19:11:54.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
29156220			2021-05-04T15:32:37.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
29202277			2021-05-04T00:48:35.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29223473		treatment with vigabatri	2021-05-04T15:44:45.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29314583			2021-05-04T01:09:22.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
29363096			2021-05-06T18:59:59.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29443301	True	Reads like a review paper		curator2	Lennox-Gastaut syndrome			
29454607	True	This is a very.... interesting paper. I think it reads more like a review than a primary article.		curator2	Lennox-Gastaut syndrome			
29459061			2021-05-04T00:39:48.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29467376			2021-05-04T16:02:07.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29548728			2021-05-04T15:58:28.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
29558884			2021-05-04T16:10:17.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29570389			2021-05-06T14:56:33.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29630738			2021-05-06T14:56:06.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
29740868			2021-05-06T18:49:27.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
29746397			2021-05-06T16:39:01.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29768152			2021-05-06T19:12:59.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
29898974	True	Guidelines paper		curator2	Lennox-Gastaut syndrome			
29948770		I would say this is a Preclinical study. It isn't about the disease mechanism and it's in mice. For now, I will leave it blank.		curator2	Lennox-Gastaut syndrome			
29968450		"Since there is mention of treatment and the type of treatment, I am selecting 1.3 Therapeutics in the clinic "" treated or not with therapeutic hypothermia""."	2021-05-06T18:52:33.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29982584			2021-05-06T15:06:14.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30010275			2021-05-04T00:43:29.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30017619			2021-05-03T23:47:51.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30057867			2021-05-04T01:26:17.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30166208			2021-05-04T01:27:52.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30186023	True	Update/ pharmaceutical report		curator2	Lennox-Gastaut syndrome			
30194277			2021-05-06T19:15:54.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30199357			2021-05-04T01:26:44.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30213680			2021-05-04T15:22:50.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30241056			2021-05-06T15:15:02.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30255934			2021-05-04T15:40:18.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30286391			2021-05-06T19:12:42.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30309816			2021-05-04T00:12:14.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30336805			2021-05-04T15:34:05.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30357823			2021-05-06T17:15:31.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30364578			2021-05-04T01:24:38.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30368788	True	Review		curator2	Lennox-Gastaut syndrome			
30403281			2021-05-04T16:08:03.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30430534			2021-05-04T15:05:05.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30442041	True	Opinion piece, not a primary article. therefore, not relevant?		curator2	Lennox-Gastaut syndrome			
30537670		"This is actually a clinical study, but there is no drug/treatment. given. The thing that they are testing is this new screening tool. It's a unique case and I don't know what to select it as - patient-based therapeutics or disease path/clin char

this paper was marked as checked. since there is no treatment discussed, I have removed my selection of 3.4 patient-based therapeutics and have left 1.1. clin char."	2021-05-08T19:59:05.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30554497		Treatment is mentioned, but not described. I think the focus of the paper is more on clinic. characteristics and disease pathology.	2021-05-06T19:01:56.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30616356	True	Review		curator2	Lennox-Gastaut syndrome			
30673834			2021-05-06T18:08:27.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30788214			2021-05-06T18:50:05.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30804880			2021-05-04T15:54:05.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
30816845		"This paper was marked as check. Treatment was discussed - ""TSE was initially refractory to conventional anti-seizure drug therapy including levetiracetam and valproate but was finally controlled with lacosamid"". I would consider this 1.3 thera in the clinic."	2021-05-06T15:09:18.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30831398			2021-05-06T19:16:43.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30831405		This should fall in the epidemiology category as it is about economics related to the disease. I am going to leave this blank for now.		curator2	Lennox-Gastaut syndrome			
30870597			2021-05-06T15:07:06.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30909854	True	Update/opinion piece?		curator2	Lennox-Gastaut syndrome			
30913948			2021-05-06T18:37:23.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30955420			2021-05-06T17:53:03.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31022635			2021-05-04T15:43:44.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31082204			2021-05-04T01:28:41.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31113280			2021-05-06T17:17:30.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31168494			2021-05-04T00:24:24.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31176687			2021-05-06T18:25:38.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31179531		Could also be patient-based therapeutics.	2021-05-06T19:02:11.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31190668			2021-05-04T15:59:21.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31215313			2021-05-04T01:08:49.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31227617		This paper was marked as check. It discusses that EEG-fMRI was used. There's no mention of treatment. It is in patients. I believe this would fall under 1.1. clin char.	2021-05-04T00:42:12.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31255830			2021-05-04T15:59:15.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31279290			2021-05-06T15:07:41.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31286465	True	Review		curator2	Lennox-Gastaut syndrome			
31307608	True	Review		curator2	Lennox-Gastaut syndrome			
31325430		Not in patients.	2021-05-04T15:54:43.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31435640			2021-05-03T23:43:55.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31519475			2021-05-04T15:08:44.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31563030		This one was a tough one for me to decide. There is mention of patients, but the study is a simulated study using samples. It's a PK study  for CLB. Drug mechanism? I will leave it blank for now.		curator2	Lennox-Gastaut syndrome			
31603844	True	Review		curator2	Lennox-Gastaut syndrome			
31625159			2021-05-04T01:30:43.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31657863		I'm not sure what a clinical trial simulation is? Is it a clinical trial?	2021-05-04T00:38:14.000Z	curator2	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31677157			2021-05-06T19:13:08.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31678406			2021-05-04T16:07:44.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31708334	True	Review		curator2	Lennox-Gastaut syndrome			
31755996			2021-05-06T16:24:53.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31770718			2021-05-04T16:02:31.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31805047			2021-05-06T14:45:17.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31833952	True	Review		curator2	Lennox-Gastaut syndrome			
31851997			2021-05-06T19:17:27.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31855252			2021-05-04T00:16:17.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31879735		Treatment mentioned - Seizures remained drug-resistant despite multiple anti-seizure drugs	2021-05-04T00:46:53.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31916540	True	review		curator2	Lennox-Gastaut syndrome			
31926846			2021-05-04T15:59:26.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31941643	True	Review		curator2	Lennox-Gastaut syndrome			
31941644	True	Review		curator2	Lennox-Gastaut syndrome			
31980515			2021-05-06T19:17:07.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32020895		Paper assessed differences in treatment effects related to ACTH therapy - treatment discussed in abstract = therapeutics in the clinic.	2021-05-06T15:05:24.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32062104			2021-05-04T00:44:00.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
32096470	True	Review		curator2	Lennox-Gastaut syndrome			
32185791	True	Review		curator2	Lennox-Gastaut syndrome			
32334364			2021-05-06T18:00:51.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32401350		Treatment = callosotomy.	2021-05-06T18:41:32.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32452568	True	Review		curator2	Lennox-Gastaut syndrome			
32467926			2021-05-06T16:42:20.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
32502686		This paper is more about drug development and delivery. Would categorize it as Preclinical studies according to the flow chart. For now, I will leave it blank.	2021-05-06T16:15:49.000Z	curator2	Lennox-Gastaut syndrome			
32543253	True	Reads like a review		curator2	Lennox-Gastaut syndrome			
32544421		This paper is about drug development, but not used in any patients or animals. I will leave it blank for now.		curator2	Lennox-Gastaut syndrome			
32592183	True	Meta-analysis		curator2	Lennox-Gastaut syndrome			
32614070			2021-05-06T19:08:04.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32615417			2021-05-04T15:54:11.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32623611		I thought this could be the treatment: Isoflurane-Remifentanil Anaesthesia. But I don't think that it is treatment, rather it's a type of methodology/add-on with fMRI (anaesthetised fMRI)	2021-05-04T01:35:03.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32657695	True	Review		curator2	Lennox-Gastaut syndrome			
32715412		Would fall more into the Epidemiology category as this is about economics. I am going to leave blank.		curator2	Lennox-Gastaut syndrome			
32736238			2021-05-04T01:23:10.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
32759067			2021-05-04T15:35:59.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
32827745			2021-05-04T01:19:07.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32850532			2021-05-04T15:33:47.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32851114			2021-05-06T18:50:56.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32860345			2021-05-06T18:38:11.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32910945			2021-05-04T15:21:17.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
32944944		Treatment is discussed - Deep brain stimulation (DBS) surgery. But it was conducted as part of the ESTEL (Electrical Stimulation of the Thalamus for Epilepsy of Lennox-Gastaut Phenotype) trial. Not sure if this would be therapeutics in the clinic or if it's a clinical trial (patient-based therapeutics).	2021-05-06T18:59:24.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32959794	True	review		curator2	Lennox-Gastaut syndrome			
33002834			2021-05-04T01:19:22.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33046417			2021-05-04T01:33:57.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33113098	True	Opinion piece/ editorial?		curator2	Lennox-Gastaut syndrome			
33144805			2021-05-04T01:28:30.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33241408		Leaving this blank. According to the flow chart, I think this might be drug mechanism?		curator2	Lennox-Gastaut syndrome			
33243487			2021-05-06T15:07:49.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
33344590			2021-05-06T18:00:28.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33358132		I would consider this an Epidemiology study, which isn't one of the four categories we have to choose right now. Therefore, I am leaving this blank.		curator2	Lennox-Gastaut syndrome			
33372033			2021-05-04T00:28:51.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
33372424			2021-05-06T18:51:24.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33376981		Cannabidiol = treatment	2021-05-04T00:33:42.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33391157			2021-05-06T18:50:41.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
33398534			2021-05-04T15:58:54.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33406966			2021-05-06T14:55:20.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33626436			2021-05-06T16:48:14.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33638459	True	Review		curator2	Lennox-Gastaut syndrome			
33693596	True	Review paper?		curator2	Lennox-Gastaut syndrome			
33721709		"Treatment was provided. ""A vagus nerve stimulator was implanted into ten (50 %) patients and five reported 50-80 % seizure reduction. Ketogenic diet was administered to two (10 %) patients and epilepsy surgery was performed in two (10 %) patients with no significant benefit"""	2021-05-04T00:43:02.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33745195			2021-05-04T15:18:24.000Z	curator2	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
33746760		"Treatment is mentioned - ""Duration of CBD treatment averaged 4.2  2.9 months at 13.2  4.6 mg/kg/day"""	2021-05-03T23:42:34.000Z	curator2	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33764203			2021-05-04T00:47:40.000Z	curator2	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
19410311		"main finding not treatments
I stand by this, could be both since they mention 2 treatments received BUT the main finding is this rare occurrence of two clinical characteristics"	2021-04-20T15:44:14.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20042635			2021-04-18T18:59:57.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20042709			2021-04-18T20:42:27.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20056902		To me this is describing clinical characteristics of people with specific mutations. I dont think that is mechanism by which people with these mutations are causing the disease. I left as 1.1	2021-04-20T13:54:54.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20067780			2021-04-20T15:08:28.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20087969		"survey score development, kind of like clinical char, or even path (how the disease or treatment is affecting the body, or is this considered a ""therapeutic"".. I am unsure"	2021-04-20T13:05:53.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20101697			2021-04-18T19:01:14.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20141966		main finding is first treatment of someone with disease-treatment combo	2021-04-19T13:57:00.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20154077		I think this is more pathology, not describing a new drug or treatment? just a predictive value, therefore not a clinical trial	2021-04-18T18:59:29.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20170910		to be a clear a diagnostic/examination procedure is not 1.3 its 1.1?	2021-04-20T13:47:46.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20198988			2021-04-18T19:11:08.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20202952			2021-04-18T20:28:15.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20209594		QOL leaving blank		curator3	hereditary hemorrhagic telangiectasia			
20368796			2021-04-20T14:26:38.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20414677			2021-04-20T14:19:36.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20466398		could be treatments too, I think more focused on clinical characteristics though,	2021-04-18T20:03:06.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
20544620		changed off 1.3, I believe this could be close to an edge case since their finding includes the use of antiplatelet drugs, but I see why they are not part of the main finding	2021-04-26T20:36:05.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20739767			2021-04-18T20:46:07.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
21290179		"this cant be a clinical trial because no specific treatment was tested,
I guess because they dont mention what treatment I was confused, but it seems they are testing the standard treatment? so I guess it is 3.4 not 1.1"	2021-04-26T20:44:20.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
21310938		misread some of the abstract, thought they used the inhibitor in patients as well but only used it to tease out the mechanism	2021-04-26T20:34:58.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
21344445			2021-04-18T20:33:59.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
21344447			2021-04-18T19:17:13.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
21706320		"QOL
They are testing a new treatment so I think is 3.4, unless 3.4 cannot be new treatments that are not drugs?"	2021-04-20T14:35:58.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
21740592		unsure on this one, title suggests about better diagnostics and following them, feels like it could be therapeutics but they dont describe any so not added in	2021-04-18T20:49:29.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21764776			2021-04-19T13:02:25.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
21792166			2021-04-18T19:10:14.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21816895		our decision tree suggests this cant be patient based because it is not a drug, not sure if this was an established procedure, if so 1.4, if not then maybe couldve been 3.4, left as 1.4	2021-04-18T19:22:51.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21823360			2021-04-18T19:10:46.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21855727		more of a review of clinical characteristics but not presenting a case study		curator3	hereditary hemorrhagic telangiectasia			
22129679			2021-04-20T13:24:10.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22196589			2021-04-19T13:23:32.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22213836			2021-04-20T15:33:27.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
22227516			2021-04-18T20:14:58.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22229593			2021-04-18T19:00:26.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22281938		main point is economics of diagnostics, but diagnostics so put path	2021-04-19T13:04:53.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22331366		main finding of paper is not new mutations (2.1) but eh focus on how these mutations can be used for diagnostics and the pathology of these	2021-04-20T13:07:52.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22379273		review		curator3	hereditary hemorrhagic telangiectasia			
22469609		they don't call it a clinical trial but on multiple patients tested effects of a drug	2021-04-20T14:43:41.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
22553411		also mentioned treatments but not main point(s)	2021-04-20T15:00:43.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
22622516			2021-04-18T20:51:05.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22671535		survey - clinical characteristics - symptoms	2021-04-20T15:14:34.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22706563			2021-04-20T14:57:31.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22707551			2021-04-20T14:53:03.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22744870		characteristics (1.1) and liver transplant (1.3)	2021-04-19T12:46:32.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
22781769		mechanism through the exact mutation and pathology through the potential diagnosis	2021-04-18T20:18:35.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
22849993			2021-04-19T13:03:53.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22875690		point of paper is not the therapeutics used	2021-04-20T14:46:45.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22940655		again one treatment described, not enough to be 1.4	2021-04-18T19:24:22.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22991266			2021-04-20T14:57:59.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23090737			2021-04-20T15:22:39.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23109496			2021-04-20T13:19:23.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23168156			2021-04-19T13:12:49.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23198241			2021-04-20T15:41:01.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23232196			2021-04-20T13:34:17.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23246127			2021-04-19T12:58:43.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23303231		all about clinical char, and then disease causing mutation at the end	2021-04-20T14:58:45.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
23312966			2021-04-19T13:39:19.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23351611			2021-04-19T12:35:47.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23401183			2021-04-20T14:59:56.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23439260			2021-04-19T12:38:17.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23568730			2021-04-19T12:41:56.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23653583			2021-04-20T13:58:23.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23670536			2021-04-20T13:14:49.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23702711			2021-04-20T13:22:38.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23800974			2021-04-19T13:41:43.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23805858			2021-04-20T14:02:18.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23888243			2021-04-18T20:17:40.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24045083		main point was treatment not the clinical characteristics	2021-04-18T20:44:21.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24098321			2021-04-20T15:17:23.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24268183		diagnostic so path? should be 2.5 likely	2021-04-19T13:43:22.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24305586			2021-04-18T20:50:41.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24458873			2021-04-18T20:07:54.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24499751			2021-04-19T13:53:22.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24615664			2021-04-19T12:44:31.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24807278			2021-04-20T13:57:43.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
24826466			2021-04-18T19:15:29.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24935454			2021-04-19T13:34:25.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24999773			2021-04-20T14:59:28.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25064693		again not a new drug, so would this be considered 1.3? I think it is more like a clinical trial 3.4 even though its retrospective	2021-04-19T13:44:36.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
25082229		path??	2021-04-19T12:56:50.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
25140883			2021-04-20T13:32:04.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
25172615			2021-04-18T19:40:31.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25298070			2021-04-19T12:47:36.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25387512			2021-04-20T14:50:27.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25420398			2021-04-19T13:40:49.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25465912		observation of increase in cells in patients, did not find anything on the mechanism, mechanism not main finding???	2021-04-18T20:54:28.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25543221		mechanism but using these for potential diagnosis later, also mentioned some clinical characteristics	2021-04-18T19:33:00.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
25564593			2021-04-20T13:13:05.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25572952		genotype (mechanism) phenotype (patho), despite it being a negative finding for mechanism I left it labeled as both	2021-04-19T13:16:28.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
25763011			2021-04-20T15:28:21.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25839006			2021-04-20T13:20:13.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25847705			2021-04-20T13:42:09.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25862798			2021-04-20T13:52:19.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25873934			2021-04-19T13:41:34.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25909848			2021-04-18T20:34:54.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25931195			2021-04-20T13:25:50.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25940942			2021-04-20T14:37:58.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25970827			2021-04-19T13:27:32.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25981877		did this paper even run experiments or is it just an opinion? hypothesis paper so left blank		curator3	hereditary hemorrhagic telangiectasia			
26078760			2021-04-18T19:31:02.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26171128			2021-04-18T20:17:04.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26204445			2021-04-20T13:13:54.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26261842			2021-04-20T13:18:17.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
26340858		leaving blank not anything, more QOL		curator3	hereditary hemorrhagic telangiectasia			
26376562			2021-04-20T15:23:35.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26393959			2021-04-19T12:45:51.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26401274		main finding is the glaucoma, not the mutation in the gene which could be interpreted as mechanism.	2021-04-18T19:15:59.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26448414		review but kind of a review of 1.3 so could label as that	2021-04-20T14:10:28.000Z	curator3	hereditary hemorrhagic telangiectasia			
26505940			2021-04-20T13:44:05.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
26608985			2021-04-20T15:01:27.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
26646071			2021-04-20T13:44:45.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
26751606			2021-04-19T12:34:54.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
26801773		also talk about the treatment but not main finding? although rare case which they specifically mention the drugs patient is on	2021-04-20T13:26:50.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26836699		main focus is the treatment given, but they also talk so much of the pathology and how they achieved diagnosis I included both	2021-04-18T20:19:59.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
26873746			2021-04-19T12:37:48.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26998137			2021-04-20T15:02:41.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
27012295			2021-04-20T15:42:11.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27027094			2021-04-20T14:14:06.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27079134			2021-04-19T12:39:57.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27081547		diagnosis = pathology?	2021-04-18T19:09:58.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27114237			2021-04-18T20:32:16.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
27141651			2021-04-18T19:14:32.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27168866			2021-04-19T13:07:34.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27323484		review		curator3	hereditary hemorrhagic telangiectasia			
27334082		both about the treatments received by this patient and the diagnosis/tests done to get to that point	2021-04-18T19:37:08.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
27440131			2021-04-18T20:05:57.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27605480		main finding is about the pathology and not the treatments	2021-04-20T13:35:24.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27727478		weird one, one side effects of the treatment so marked as therapeutics in the clinic	2021-04-18T19:13:30.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27777480			2021-04-18T20:32:34.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27861387			2021-04-18T20:35:54.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27878613			2021-04-20T14:51:16.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27997001			2021-04-20T15:43:25.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28031662			2021-04-18T18:53:42.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28070235			2021-04-20T15:52:26.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28165669		main finding is the screening of the children, not the specific mutations	2021-04-19T13:13:47.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28188364		I would say its a survey looking into therapeutic in the clinic but doesn't actually describe any used on patients, rare paper. left blank no patients but could be 1.4		curator3	hereditary hemorrhagic telangiectasia			
28267932		because its diagnostic.monitoring not a new a therapy it belongs in pathology? also tons of path measurements	2021-04-18T20:52:19.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28297555		monitor clinical characteristics, could this be considered a therapeutic in the clinic? I do not think so.	2021-04-18T19:34:01.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28407366			2021-04-18T19:57:56.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28430541		review		curator3	hereditary hemorrhagic telangiectasia			
28490409			2021-04-20T14:03:03.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28564608			2021-04-19T12:34:18.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
28588815			2021-04-18T19:30:36.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28608633			2021-04-19T13:06:40.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28670610			2021-04-19T12:41:08.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28671294		main finding is side effect of drug used in clinic	2021-04-19T13:22:50.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28687708			2021-04-20T14:50:14.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
28759897		unsure if should be 1.3	2021-04-20T15:50:40.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
28775059			2021-04-20T14:32:30.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28810087		talks about the treatment but not the main finding of the paper	2021-04-20T13:16:33.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28973643			2021-04-20T15:36:10.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
28989145		disease causing mutation and diagnostics = 1.1 and 2.1	2021-04-20T13:40:11.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
29080903			2021-04-19T12:36:44.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29120072		novel mutation with focus on diagnosis and clinical signs	2021-04-20T14:54:54.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
29243366			2021-04-20T15:31:39.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
29253907			2021-04-20T15:09:03.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29274888			2021-04-20T13:45:30.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29305977			2021-04-18T20:08:46.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29349377			2021-04-18T19:41:14.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
29395350		this seems like a clinical trial (use of drug on multiple patients to see efficacy) despite small number of patients	2021-04-20T14:00:09.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
29469958			2021-04-20T15:32:28.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
29480092			2021-04-18T18:54:38.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29483005			2021-04-20T13:41:28.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
29515340			2021-04-18T20:08:13.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29552242		diagnosis main finding	2021-04-19T13:00:34.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29593101		researching new therapeutics but this is in a mouse model so cant label as 1.3, 3.4 - good mechanism stuff though	2021-04-20T15:09:48.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29610574			2021-04-19T14:02:00.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29655863			2021-04-20T14:43:11.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29938556			2021-04-20T15:06:18.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30095617			2021-04-20T16:00:21.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30146556			2021-04-18T19:18:13.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30191360			2021-04-20T14:47:19.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
30272025			2021-04-18T19:15:12.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
30279913			2021-04-18T20:25:56.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30512964			2021-04-20T14:03:48.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
30549294		recurrence of disease after treatment, either path or 1.3... I think 1.3 as its main finding revolves around the gold standard treatment	2021-04-19T13:32:58.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
30596371			2021-04-19T12:48:14.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
30685840		screening = diagnosis, more of an epid paper but I labeled as diagnosis --> path	2021-04-20T14:18:37.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30744395			2021-04-20T15:51:03.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
30853205			2021-04-19T13:34:05.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30888464			2021-04-19T13:01:38.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30935812		main focus is on the use of thrombolysis	2021-04-19T13:10:05.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31032126		could also be 1.1?? but short abstract with main focus based on the title towards the treatment	2021-04-18T20:22:18.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31255500			2021-04-20T13:55:31.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31360828			2021-04-19T13:27:16.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
31400083		diagnosis = pathology	2021-04-18T19:08:26.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31441079		review but of therapies in the clinic so I think its fair to label as 1.3?	2021-04-20T13:48:43.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31455059		epid, but looked at diagnosis	2021-04-20T15:03:56.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31540324			2021-04-20T15:07:36.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
31615556			2021-04-20T13:32:40.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
31616764			2021-04-20T14:15:59.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31910122		review		curator3	hereditary hemorrhagic telangiectasia			
32020296		comparing two non drug treatments, could 1.3 as its not drugs but it is a trial, should update the 3.4 definition to include things other than just drugs such as diagnostics, treatment comparisons (including not new treatments)	2021-04-19T13:37:57.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
32078368			2021-04-20T13:59:25.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32206359		finding was the unique way patient was diagnosed	2021-04-19T13:12:12.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32255688			2021-04-20T13:12:41.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32493237			2021-04-20T15:22:06.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32503579		not mechanism as they find no new mutations or research how these mutations cause disease, only how the mutations affect the body/tissues = pathology	2021-04-20T14:15:30.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32536092			2021-04-19T13:46:59.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32538908			2021-04-19T13:24:18.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32556901			2021-04-20T14:31:36.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
32573726		"feel like ""Sequencing with the purpose of diagnosis"" needs to be a talked about edge case as its likely frequent (mutations as both a mechanism and diagnostic) 
Here there is no mechanism talk so I left as a diagnostic and therefore pathology"	2021-04-18T19:29:44.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32718529			2021-04-19T13:03:07.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32723482			2021-04-20T15:13:25.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32756122			2021-04-20T15:39:42.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
32762495			2021-04-20T15:13:50.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32774576		could also be therapeutics?? describe one treatment received but I don't think thats the main point of the paper	2021-04-18T19:06:53.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32874383		while there is talk about the removal of the thrombus, focus of paper is on the diagnosis of this not on the treatment of it	2021-04-18T20:38:32.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32899377		also 1.1 because they are trying to use these as biomarkers	2021-04-20T13:10:17.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
32904708		could also be a therapeutics paper but less so as they only describe one treatment	2021-04-18T19:05:39.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32954380			2021-04-20T14:54:24.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32992168		could also be treatment and path/diagnosis but main finding is the novel mutation	2021-04-19T12:49:16.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
33022056		survey for patient response/outcome, left blank, its not a clinical trial, no new drugs or treatments	2021-04-19T13:18:52.000Z	curator3	hereditary hemorrhagic telangiectasia			
33147670		talks about treatments that could be used but did not use any in the paper	2021-04-20T13:09:06.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33172103		QOL/life expectancy, left blank		curator3	hereditary hemorrhagic telangiectasia			
33211216			2021-04-20T14:53:34.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
33242965			2021-04-19T13:59:25.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
33282178			2021-04-19T13:44:14.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
33498134			2021-04-19T13:51:34.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
33511041			2021-04-19T14:02:25.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33539783			2021-04-19T13:37:37.000Z	curator3	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33652493		no abstract also potentially a review left blank		curator3	hereditary hemorrhagic telangiectasia			
33671708			2021-04-20T14:45:52.000Z	curator3	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
33677851			2021-04-20T15:38:58.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33691924			2021-04-20T13:54:05.000Z	curator3	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
33754658		no abstract but new mutation = mechanism	2021-04-20T14:50:36.000Z	curator3	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
19942457		economics paper		curator3	Lennox-Gastaut syndrome			
20004858			2021-05-09T21:05:46.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20008422			2021-05-06T13:26:09.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20023065		epid		curator3	Lennox-Gastaut syndrome			
20041940			2021-05-03T14:23:17.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20084538		"""clinical trial"" to determine optimal dosage"	2021-05-03T13:47:39.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
20126329		review		curator3	Lennox-Gastaut syndrome			
20149600			2021-05-06T16:51:22.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20150505		drug pharmacokinetics - left blank		curator3	Lennox-Gastaut syndrome			
20199521			2021-05-07T18:11:58.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
20345938			2021-05-09T20:22:40.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20472190		again hard to distinguish clinical trial vs therapuetics used in clinic, this is not a trial but on a large number of patients (38), drug has already proven effective but now tested in this pediatric population, I think its more 3.4 as you could argue this further develops the drug	2021-05-03T14:00:22.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
20472261			2021-05-03T13:31:19.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20533249		epid study so not a clinical trial, left blank		curator3	Lennox-Gastaut syndrome			
20542434			2021-05-07T18:18:43.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20610118		maybe this is more epid than clinical characteristics?	2021-05-06T13:56:49.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20618411		no drug but a treatment used in a clinical trial manner so 3.4?	2021-05-06T15:56:44.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
20647578			2021-05-09T20:02:53.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20666130		kind of a review but also talks about therapeutics in the clinic, but doesnt actually test on patients itself	2021-05-09T20:06:54.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20666837			2021-05-07T17:40:46.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
20691934		developing the treatment beyond LGS, therefore a clinical trial and 3.4	2021-05-03T15:03:34.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
20726879			2021-05-09T21:07:16.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
20842588		review but on 1.3	2021-05-09T20:45:32.000Z	curator3	Lennox-Gastaut syndrome			
20888268			2021-05-07T17:35:22.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
20957124		review		curator3	Lennox-Gastaut syndrome			
20970386			2021-05-03T13:44:02.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21038079			2021-05-07T16:30:26.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21146944			2021-05-07T16:23:59.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21204804			2021-05-09T21:35:06.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
21243535			2021-05-09T20:08:50.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
21256770			2021-05-03T13:19:18.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21269294		not a trial because they are not developing the therapy in any way? just showing how it was used in the clinic, its not a clinical trial	2021-05-03T15:15:44.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21275978			2021-05-03T13:43:42.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21341220			2021-05-03T13:13:52.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21353345			2021-05-07T17:25:08.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21376637			2021-05-09T20:48:18.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21383651		testing on a drug used in the clinic on patients which is why its 1.3, main finding could be drug kinetics as well	2021-05-07T16:19:32.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21396833			2021-05-09T20:40:41.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21464890		drug mechanism? animal model?		curator3	Lennox-Gastaut syndrome			
21513659		review I think		curator3	Lennox-Gastaut syndrome			
21515079			2021-05-06T15:57:40.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21557146			2021-05-09T20:08:26.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21620771		testing drug in combo with multiple patients, multi centre study --> 3.4	2021-05-06T13:28:31.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21638908			2021-05-03T13:54:55.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21688720			2021-05-09T21:06:24.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21692791			2021-05-03T14:45:36.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21763159		ay what point is this a clinical trial? only when an actualy drug is used or does any treatment count	2021-05-03T13:45:28.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21790560		review		curator3	Lennox-Gastaut syndrome			
21790562				curator3	Lennox-Gastaut syndrome			
21792306		review		curator3	Lennox-Gastaut syndrome			
21862354			2021-05-07T16:31:02.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21924653			2021-05-06T16:01:21.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21947090			2021-05-03T14:25:28.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21956725			2021-05-03T13:18:55.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21982812		mention some therapeutics but main finding is the clinical and patho features	2021-05-03T15:14:10.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22053552			2021-05-03T15:15:17.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22071552		"kind of diagnostic as ""prior to surgery"""	2021-05-06T13:38:36.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22128252		review		curator3	Lennox-Gastaut syndrome			
22245794			2021-05-09T20:40:14.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22255466			2021-05-03T13:01:42.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22258042			2021-05-07T18:21:03.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
22266062		"at what point would this become 3.4? only if it was on the ""development of the drug""?"	2021-05-03T13:51:48.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22281384			2021-05-09T21:12:32.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
22421185			2021-05-07T17:49:19.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
22422635		also would be drug mech and drug-drug interactions?	2021-05-06T15:57:13.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
22443637			2021-05-09T21:26:47.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22467791			2021-05-09T20:09:20.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22471338		study in mice, left blank		curator3	Lennox-Gastaut syndrome			
22483538			2021-05-06T13:50:13.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22592511			2021-05-09T20:26:14.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22629163			2021-05-09T20:15:10.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22633633		feeels like using an established treatment not developing new one (which would be 3.4)	2021-05-03T14:54:50.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22677424			2021-05-09T21:24:34.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
22709423			2021-05-09T21:11:49.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22729251			2021-05-03T15:14:58.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22780580			2021-05-06T15:30:41.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22921514			2021-05-09T20:48:52.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22944514		social behavior in mouse model		curator3	Lennox-Gastaut syndrome			
23041289			2021-05-07T17:48:01.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23083943			2021-05-09T21:00:19.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23099847			2021-05-03T15:04:23.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23141144			2021-05-03T15:04:35.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
23143718			2021-05-07T17:50:22.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
23213494		review		curator3	Lennox-Gastaut syndrome			
23230532			2021-05-09T20:47:03.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23252400			2021-05-03T14:48:07.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
23334068			2021-05-09T20:05:14.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23409955		describes new mutation and treatment given, marked as both.	2021-05-06T13:55:10.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.3. THERAPEUTICS IN THE CLINIC
23415449			2021-05-03T15:20:56.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
23465587			2021-05-03T14:46:02.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23471536		"treatments recommendations are like reviews? but focus of paper is on therapeutics used in the clinic they just dont actually use anby on patients
I think it would be useful to have this tagged as 1.3 even though its a review?"	2021-05-03T13:37:38.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23489890			2021-05-09T20:15:53.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23490456			2021-05-09T21:37:49.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23531645			2021-05-09T20:13:50.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23583057			2021-05-03T13:09:10.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23647917			2021-05-09T20:22:22.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
23770633			2021-05-09T20:33:07.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23770680			2021-05-06T15:35:19.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
23812912			2021-05-09T20:46:41.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
23827423			2021-05-03T14:24:07.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23850002		surgery not a drug so 1.3	2021-05-07T18:27:36.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23927801		development of keto diet or should this just be a 1.3	2021-05-03T14:38:02.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
23934111			2021-05-09T20:24:26.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
23936641			2021-05-03T13:02:08.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23973644		economics		curator3	Lennox-Gastaut syndrome			
24012506		3.4 or 1.3, not developing a new treatment or drug so 1.3	2021-05-03T14:27:14.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24045845			2021-05-03T14:16:09.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24105702			2021-05-03T14:40:47.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24113539			2021-05-06T13:33:12.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
24116958			2021-05-07T17:41:53.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24117046		their hypothesis are guessing the mechanism but their experiments are pathological	2021-05-03T15:19:15.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24122274			2021-05-03T14:07:44.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24228152			2021-05-03T14:59:38.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24237632			2021-05-06T13:25:56.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24400693			2021-05-09T21:24:14.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24479878			2021-05-06T13:50:33.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
24533090		drug mechanism		curator3	Lennox-Gastaut syndrome			
24553310			2021-05-07T16:29:46.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24580023			2021-05-06T16:04:05.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
24594429			2021-05-07T16:17:55.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24614520			2021-05-07T16:09:11.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24630492			2021-05-03T14:03:17.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24635129		new drug but preclinical, thus blank		curator3	Lennox-Gastaut syndrome			
24649449			2021-05-06T15:35:05.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24649473			2021-05-03T13:06:41.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24659735			2021-05-06T13:32:02.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24684645		economics of drugs		curator3	Lennox-Gastaut syndrome			
24809226		talks some about the therapies but main point of the paper was describing phenotypes	2021-05-07T18:10:14.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24912730			2021-05-06T13:40:01.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
24912732		comparing two treatments, is this a clinical trial?	2021-05-03T13:51:15.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
24949576		still a clinical trial even if talking about adverse events	2021-05-03T13:03:38.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25038129		focus of the paper is on the clinical characteristics of patients with a specific mutation, so its 1.1 not 2.1	2021-05-06T13:28:04.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25132372			2021-05-09T20:25:24.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25184741			2021-05-09T20:25:46.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25231724			2021-05-09T20:44:49.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25262651			2021-05-09T21:07:46.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
25266269		new mutation for LGS (2.1) and clinical characteristics of patient (1.1)	2021-05-06T15:45:04.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
25336963		QOL		curator3	Lennox-Gastaut syndrome			
25511520			2021-05-03T14:02:36.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25530452		drug kinetics doesnt fit in any category		curator3	Lennox-Gastaut syndrome			
25616450			2021-05-03T14:16:51.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25798598		drug mechanism		curator3	Lennox-Gastaut syndrome			
25847334			2021-05-09T21:36:51.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25890840			2021-05-09T20:13:21.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
25935511			2021-05-09T21:39:21.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25940107			2021-05-07T18:29:16.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26057351			2021-05-09T20:07:49.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26068938			2021-05-06T16:06:10.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26093133			2021-05-03T15:22:00.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26125563		mouse model, preclinical work, left blank		curator3	Lennox-Gastaut syndrome			
26139309		drug pharmacokinetics		curator3	Lennox-Gastaut syndrome			
26238894			2021-05-09T20:46:22.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26333833			2021-05-06T13:37:37.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26474092			2021-05-09T20:29:21.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26611353			2021-05-07T16:24:28.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26645412			2021-05-09T20:14:30.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
26724101			2021-05-09T21:30:11.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26744634		review		curator3	Lennox-Gastaut syndrome			
26805435			2021-05-03T13:59:40.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26808205			2021-05-07T16:24:13.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26842220			2021-05-09T21:37:22.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26861566			2021-05-07T16:09:37.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26906013			2021-05-09T20:03:07.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26923380			2021-05-06T15:55:42.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26977407			2021-05-07T16:11:35.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26979179		if this was a drug would it have been 3.4?	2021-05-07T16:06:56.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26993353			2021-05-09T21:11:28.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27052529			2021-05-06T13:40:14.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27082650			2021-05-09T20:23:35.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27084975			2021-05-07T17:36:11.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27145465		from a phase 3 so its 3.4, even if retrospective	2021-05-03T13:33:35.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27184676		review		curator3	Lennox-Gastaut syndrome			
27199889			2021-05-03T14:15:47.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27345028			2021-05-09T21:33:23.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27363778			2021-05-03T13:44:36.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
27392921		drug kinetics - left blank		curator3	Lennox-Gastaut syndrome			
27417063			2021-05-07T17:48:57.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27434073		3.4 since it tested a therapy on multiple patients and evaluated efficacy?	2021-05-07T18:07:13.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27475280			2021-05-09T21:33:39.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27504264			2021-05-09T20:59:58.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27513375			2021-05-09T21:16:03.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27557111		review on drugs		curator3	Lennox-Gastaut syndrome			
27683846			2021-05-09T20:38:22.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27846468			2021-05-09T20:32:39.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27934621		drug resistant, main finding on therapeutics used in the clinical that can get neurotoxicity	2021-05-03T14:12:26.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27994367			2021-05-09T20:37:37.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28078312			2021-05-06T13:26:46.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
28186331			2021-05-07T18:19:49.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28210578			2021-05-03T13:14:47.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
28295228			2021-05-09T21:06:56.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
28392943		survey for drug given to patients	2021-05-07T18:11:16.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28471101			2021-05-06T15:40:04.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28479797			2021-05-09T21:15:49.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28513609			2021-05-03T13:18:40.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28528895		drug chemistry/making of the drug. left blank		curator3	Lennox-Gastaut syndrome			
28589569			2021-05-09T20:06:26.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
28633092		describe both characteristic of the patients and treatments that were effective	2021-05-07T16:28:28.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
28667181		there is some pathology in here but main finding is the mechanism/mutation	2021-05-06T13:49:27.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
28689466			2021-05-09T20:29:55.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28715780			2021-05-09T21:25:52.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28782435		drug in animal model		curator3	Lennox-Gastaut syndrome			
28874317			2021-05-03T13:23:40.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28928710		path after the treatment.	2021-05-09T20:19:25.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
29053577		keto diet in mice, left blank. preclinical work		curator3	Lennox-Gastaut syndrome			
29098688			2021-05-06T16:05:34.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29126048			2021-05-06T15:51:15.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29150892			2021-05-09T21:27:24.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29156220			2021-05-06T15:53:48.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
29223473			2021-05-07T16:06:32.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29264397		mew mutations but very in depth about clinical characteristics and pathology	2021-05-07T16:07:39.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
29363096			2021-05-09T21:13:03.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29395273			2021-05-06T13:26:18.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
29443301		review of drugs, classify as 1.3?	2021-05-03T13:24:32.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29454607		review on wiki searches		curator3	Lennox-Gastaut syndrome			
29459061			2021-05-03T13:54:36.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29548728		drug mechanism in animal model, left blank		curator3	Lennox-Gastaut syndrome			
29558884			2021-05-07T17:34:04.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29630738			2021-05-07T18:02:15.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
29740868			2021-05-09T20:45:39.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
29761022			2021-05-09T20:39:08.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29768152			2021-05-09T21:29:57.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
29898974		but also a review/recommendations for treatment so not sure we want to classify that here	2021-05-03T13:19:46.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29906696		not testing a drug so cant be clinical trial	2021-05-06T15:39:45.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29941151			2021-05-06T15:40:25.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
29948770		drug mechanism		curator3	Lennox-Gastaut syndrome			
29982584			2021-05-07T18:14:02.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30010275		only 13 patients but still a retrospective clinical trial	2021-05-03T14:17:16.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30017619			2021-05-03T13:10:47.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30146701			2021-05-03T14:36:46.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30186023		review no testing on patients, left blank (we could change the description of 1.3 to include any reviews on currently approved or available drugs, state of treatments etc. I think it falls into the same category, doesnt have to include a patient specifically in that paper)		curator3	Lennox-Gastaut syndrome			
30194277			2021-05-09T21:34:50.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30199357		"I think this is a retrospective clinical trial looking at what amount of patients go from West-->LGS while on a specific drug
could be 1.3 or 3.4 for the drugs.. then they also make mechanism hypotheses..I think its mechanism as their contribution to the research is only the mechanism hypothesis and the rest of the info is likely taken from another trial/study"	2021-05-03T15:25:58.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
30255934			2021-05-06T16:51:08.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30286391			2021-05-09T21:29:25.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30286409			2021-05-07T16:29:14.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30357823		also drug pharmacokinetics	2021-05-09T20:16:30.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30364578			2021-05-03T15:17:23.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30403281		not a drug but a retrospective study on the VNS treatment	2021-05-07T17:27:37.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30405366		review		curator3	Lennox-Gastaut syndrome			
30430534			2021-05-06T13:53:11.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30442041		drug making.. rare paper		curator3	Lennox-Gastaut syndrome			
30537670			2021-05-03T14:48:29.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30552298			2021-05-03T13:09:41.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30554497			2021-05-09T21:13:43.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30564493			2021-05-07T17:31:17.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30673834			2021-05-09T20:27:19.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30676535		review		curator3	Lennox-Gastaut syndrome			
30740695			2021-05-09T21:33:04.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30816845		important findings of both the characteristics and how to treat so marked as both	2021-05-07T18:24:07.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
30817475		more of a review do we classify here?	2021-05-03T13:23:52.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30831398			2021-05-09T21:38:07.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30831405		economics		curator3	Lennox-Gastaut syndrome			
30870597		would fit in the bioinformatics category too, but is a diagnostic/biomarker therefore fits into 1.1	2021-05-07T18:17:14.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30913948			2021-05-09T20:31:34.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31008722			2021-05-09T20:38:11.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31022635		despite not stating its a clinical trial, it is run like one	2021-05-07T16:05:47.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31082204		testing drug in mice, therefore left blank		curator3	Lennox-Gastaut syndrome			
31161980		review		curator3	Lennox-Gastaut syndrome			
31168494		didnt run the trial but still main finding is based on clinical trial	2021-05-03T13:20:39.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31179531			2021-05-09T21:15:00.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31215313		not a clinical trial even though done on quite a few patients so 1.3 not 3.4	2021-05-03T14:57:42.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31255830		in vitro model system - left blank		curator3	Lennox-Gastaut syndrome			
31286465		review		curator3	Lennox-Gastaut syndrome			
31307608		review		curator3	Lennox-Gastaut syndrome			
31325430		preclinical drug work, left blank		curator3	Lennox-Gastaut syndrome			
31432588			2021-05-07T17:39:33.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31435640			2021-05-03T13:05:27.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31468518			2021-05-03T15:01:04.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31575436			2021-05-09T21:25:30.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31603844		review		curator3	Lennox-Gastaut syndrome			
31625159		drug mechanism, left blank		curator3	Lennox-Gastaut syndrome			
31657863		simulated clinical trial, tested on patients	2021-05-03T13:49:15.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31677157			2021-05-09T21:32:48.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
31708334		you could mark as 1.3 but it is a review they did not test any drugs on patients as we define for 1.3		curator3	Lennox-Gastaut syndrome			
31770718			2021-05-07T17:24:42.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31805047			2021-05-07T17:46:15.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31829726			2021-05-06T15:47:33.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31833952		review		curator3	Lennox-Gastaut syndrome			
31851997			2021-05-09T21:39:43.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31855252		could also be path and clinical char from their recordings of synapse density/transmission etc. clinical features	2021-05-03T13:16:44.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31877501			2021-05-07T17:36:31.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31879735			2021-05-03T14:35:52.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31916540		review		curator3	Lennox-Gastaut syndrome			
31941644		review		curator3	Lennox-Gastaut syndrome			
32062104			2021-05-03T14:24:29.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
32082420			2021-05-07T17:57:27.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
32096470		review		curator3	Lennox-Gastaut syndrome			
32185791		review		curator3	Lennox-Gastaut syndrome			
32207730		review but would be 1.1 for diagnosis		curator3	Lennox-Gastaut syndrome			
32334364			2021-05-09T20:20:38.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32350749			2021-05-07T16:16:11.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
32401350			2021-05-09T20:37:21.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32441821			2021-05-03T14:39:40.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32452532		even though they used other trials info and the didnt have any patients themselves they analyzed different parameters in a clinical trial like manner thus 3.4	2021-05-06T15:54:08.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
32452568			2021-05-03T13:13:03.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32467926			2021-05-09T20:09:39.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
32477256		main finding is bioinformatics based?		curator3	Lennox-Gastaut syndrome			
32543253		drug production? no category left blank		curator3	Lennox-Gastaut syndrome			
32544421		drug making		curator3	Lennox-Gastaut syndrome			
32614070			2021-05-09T21:18:35.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32615417			2021-05-07T16:15:32.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32623611		is this a treatment(1.3) or a diagnostic(1.1)..I think more diagnostics and exploring pathology not a direct treatment or therapy. this seems obvious after I type it out.	2021-05-06T13:46:54.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32657695		Review		curator3	Lennox-Gastaut syndrome			
32736238			2021-05-03T15:16:34.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
32759067			2021-05-06T16:03:53.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32827745			2021-05-03T15:08:18.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32850532		survey people who HAD taken the drug, so 1.3	2021-05-06T15:58:05.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32854045			2021-05-07T17:29:20.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32910945		drug mechanism of action - left blank		curator3	Lennox-Gastaut syndrome			
32920379			2021-05-09T21:38:58.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32928027		lots on the new mutation 2.1 and lots on what it does to the body 1.1	2021-05-03T13:30:25.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
32945607			2021-05-06T15:47:20.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
32959794		review on pharm and law of CBD		curator3	Lennox-Gastaut syndrome			
32969022			2021-05-03T13:04:43.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
33002834		they do mention pathological findings but main point of paper is the surgery	2021-05-03T15:12:35.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33026899		review, but on drugs and current practices so if included reviews in to 1.3 this would fit.		curator3	Lennox-Gastaut syndrome			
33046417			2021-05-06T13:43:39.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33113098		maybe would fit therapeutics used?		curator3	Lennox-Gastaut syndrome			
33144805		cant include 1.1 because the test run is the drugs affect on the body, not the diseases affect on the body	2021-05-06T13:29:23.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33188523			2021-05-09T20:11:52.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33189068			2021-05-07T17:34:59.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33224689		thought it was going to be a review but appears to have 3 case studies	2021-05-03T14:59:54.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33243487		main finding this is the new clinical characteristics of patients with this mutation, mutation was already known so not 2.1	2021-05-07T18:22:52.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33313501			2021-05-07T18:12:47.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33344590			2021-05-09T20:20:19.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33372033		"on mice so not 1.3 pathology, but also not mechanism as all measurements are path based (how the disease/mutation affects the tissues) and had some mechanisms (reduced expressions..)
marked as a mechanism paper"	2021-05-03T13:28:55.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
33372424		how can we distinguish this from 1.3 is it a clinical trial it talks about looking for AEs etc.	2021-05-09T20:58:38.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33376981		also would be drug mechanism	2021-05-03T13:37:06.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33398534		retrospective study - classify as 3.4	2021-05-07T16:22:59.000Z	curator3	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
33406966			2021-05-07T18:01:37.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33482642		review	2021-05-09T20:12:17.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33584793			2021-05-07T16:25:57.000Z	curator3	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
33626200		review		curator3	Lennox-Gastaut syndrome			
33626436			2021-05-09T20:12:38.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33638459		review		curator3	Lennox-Gastaut syndrome			
33681663		main findings of paper are both clinical and path characteristics 1.1 and the treatment responses 1.3	2021-05-07T17:26:13.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
33693596		review + hypothesis? left blank		curator3	Lennox-Gastaut syndrome			
33718684			2021-05-03T14:36:18.000Z	curator3	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33721709			2021-05-03T14:16:31.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33745195		I think its a review		curator3	Lennox-Gastaut syndrome			
33764203			2021-05-03T14:38:55.000Z	curator3	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
19403253		physiological mechanism of disease??	2021-04-19T06:45:52.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
19410311		Removing TIC but should any abstracts that mention any treatment be tagged TIC?	2021-04-26T04:17:20.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
20042635			2021-04-18T23:19:18.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20056902			2021-04-20T16:40:23.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20067780		"how molecular signalling or metabolism (binding, activating, phosphorylation, concentration increase, etc.) are involved in the mechanism  of a disease;

the results of clinical tests that reveal pathology (including biomarkers)

Also disease mechanism???"	2021-04-22T01:06:43.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20087969			2021-04-19T06:56:51.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20093519			2021-04-20T16:09:07.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20101697			2021-04-18T23:23:24.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20154077			2021-04-20T15:27:02.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20170910			2021-04-20T16:37:07.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20198988			2021-04-18T23:44:05.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20202952			2021-04-20T15:46:41.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20209594			2021-04-22T00:28:10.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20224041			2021-04-20T16:04:36.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
20368796			2021-04-22T00:36:20.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20458853		initially tagged DM because of last sentence --> physiological mehcanisms of disease but removing as its not the focus	2021-04-20T15:50:04.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20461185			2021-04-20T16:28:01.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20466398		"Removed TIC. Is draining a brain abscess+embolization TIC?

He had no feature of HHT and no mutation in ENG and ACVRL1 genes--> should this clinical characteristic also be tagged DM?"	2021-04-23T23:49:12.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20544620			2021-04-19T06:51:30.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
20620301		Removed TIC	2021-04-23T23:48:16.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20622729		TIC?	2021-04-20T16:35:48.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20739767		Removed TIC and added DM	2021-04-23T23:50:37.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
20879701				curator4	hereditary hemorrhagic telangiectasia			
21290179		Was going to remove TIC but it is extensively discussed in the manuscript so leaving it	2021-04-22T00:35:53.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
21310938			2021-04-23T23:54:49.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21336824			2021-04-20T17:00:26.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21344447		"Can this also be tagged PBT? ""A phone interview was performed in July 2010 to assess for treatment complications."" Can this be considered post marketing drug surveillance?"	2021-04-19T04:47:33.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21345778			2021-04-19T05:36:59.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21426754			2021-04-20T16:41:00.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21484125			2021-04-19T06:55:43.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21706320			2021-04-22T00:40:20.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21740592			2021-04-19T01:21:33.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21764776			2021-04-19T06:02:51.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
21792166			2021-04-18T23:36:43.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21816895		"Evaluation of effectiveness and safety of endovascular treatment of epistaxis in HHT patients- Clinical trial????

Would tag is Therapeutics in the clinic if the words ""safety and effectiveness"" were not used"	2021-04-20T15:36:01.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
21823360			2021-04-18T23:39:18.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21842025		Removed TIC	2021-04-23T23:55:31.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21861324		gastrointestinal polyps are a GI manisfestation of HHT	2021-04-20T16:16:00.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22120563			2021-04-19T04:50:12.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22129679			2021-04-20T16:29:05.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22213836			2021-04-26T04:15:21.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	2.1. DISEASE MECHANISM
22227516			2021-04-19T05:07:38.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22229593			2021-04-18T23:20:19.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22240227			2021-04-20T16:28:43.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22281938				curator4	hereditary hemorrhagic telangiectasia			
22331366			2021-04-19T07:00:21.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22385575			2021-04-20T16:29:13.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22421041			2021-04-20T16:05:54.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22469609			2021-04-22T00:43:10.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22553411			2021-04-26T04:12:39.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.3. THERAPEUTICS IN THE CLINIC
22670022			2021-04-20T16:39:56.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22706563			2021-04-22T00:51:42.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22707551		went to manuscript--> case report	2021-04-22T00:48:30.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22727716			2021-04-22T01:21:20.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
22737832			2021-04-22T00:53:55.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22744870			2021-04-19T01:46:49.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22781769			2021-04-19T00:55:24.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
22849993			2021-04-20T16:09:59.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
22920200			2021-04-22T00:38:59.000Z	curator4	hereditary hemorrhagic telangiectasia			
22940655			2021-04-19T00:21:33.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23018639			2021-04-19T01:50:32.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23090737			2021-04-22T01:11:17.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23168156			2021-04-19T06:23:28.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23198241			2021-04-22T01:19:33.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23199770			2021-04-22T01:23:32.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23232196			2021-04-20T16:32:21.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23246127		"physiological mechanism of disease???

PH significantly reduces survival of HHT patients"	2021-04-19T05:48:01.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23320130			2021-04-20T16:47:36.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23323127			2021-04-19T06:01:56.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23351611			2021-04-19T05:34:14.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
23670536			2021-04-20T16:25:48.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23675457			2021-04-20T16:28:16.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23676596			2021-04-19T06:29:56.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
23729109			2021-04-22T00:39:52.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23794345			2021-04-22T00:51:54.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23800974			2021-04-19T06:46:15.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
23805858			2021-04-20T16:50:06.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23888243		"from paper:
mechanism: The molecular analysis of the genes responsible for JP, BMPR1A and SMAD4, had revealed a single nucleotide mutation IVS9 1139 +2 T>G on the SMAD4 gene. The mutation falls into the MH2 domain, the one most frequently involved in the development of the combined syndrome JP and HHT.10,14 Up to that date, he had not reported any symptoms or signs of hereditary hemorrhagic telangiectasia, which are presented in approximately 15-22% of SMAD4-related JPs.15

Extensive discussion clinical tests+symptoms in text"	2021-04-19T16:14:13.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24045083			2021-04-19T01:16:39.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
24098321			2021-04-22T01:09:25.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24146883			2021-04-20T16:53:49.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
24260769			2021-04-20T16:31:34.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24267784			2021-04-22T00:55:29.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24273414			2021-04-20T15:38:17.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24305586			2021-04-19T05:24:29.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24489709			2021-04-19T01:44:41.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24499751			2021-04-19T06:52:45.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24520391			2021-04-22T01:07:00.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24587130			2021-04-19T00:16:39.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
24667223			2021-04-19T05:22:45.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
24807278			2021-04-20T16:47:06.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
24826466			2021-04-18T23:49:59.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24913291			2021-04-22T00:57:26.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24986705			2021-04-22T01:12:17.000Z	curator4	hereditary hemorrhagic telangiectasia			
25140883			2021-04-20T16:31:05.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25172615			2021-04-19T00:35:40.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25298070		???? Diagnostic tool	2021-04-19T01:48:45.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25387512		went to paper--> its a case study	2021-04-22T00:45:15.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25465912		"removed CC+DP

physiological mechanism+assays"	2021-04-19T05:31:38.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25572952			2021-04-19T06:26:33.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25603856			2021-04-22T01:20:09.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
25763011			2021-04-22T01:11:27.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25815003			2021-04-19T01:33:10.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25862798			2021-04-20T16:38:14.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25931195			2021-04-20T16:29:52.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
25940942			2021-04-22T00:41:08.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25970827			2021-04-19T06:37:28.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
26171128			2021-04-19T00:52:55.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26340858				curator4	hereditary hemorrhagic telangiectasia			
26393959			2021-04-19T01:46:28.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26425624			2021-04-19T06:29:22.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
26448414				curator4	hereditary hemorrhagic telangiectasia			
26646071			2021-04-20T16:35:56.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
26751606			2021-04-19T05:32:48.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
26801773			2021-04-20T16:30:02.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
26836699			2021-04-20T15:45:05.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27012295			2021-04-22T01:20:57.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
27079134			2021-04-19T05:34:58.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27081547			2021-04-19T16:02:30.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
27114237			2021-04-19T01:09:42.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
27225226			2021-04-22T00:56:49.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
27323484				curator4	hereditary hemorrhagic telangiectasia			
27334082			2021-04-19T00:34:16.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
27424345		review/perspective		curator4	hereditary hemorrhagic telangiectasia			
27599328			2021-04-19T01:22:20.000Z	curator4	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
27605480			2021-04-20T16:33:25.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27646277			2021-04-20T16:24:50.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
27727478		Initially labelled TIC. Changing it to PBT. changing back to TIC	2021-04-20T15:30:12.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27777480			2021-04-19T05:18:35.000Z	curator4	hereditary hemorrhagic telangiectasia			
27861387			2021-04-20T15:54:14.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
27878613			2021-04-22T00:46:05.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27997001			2021-04-22T01:22:42.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
28004998		If liver transplant performed 19 years ago is considered a treatment, then also therapeutics in the clinic	2021-04-18T23:42:25.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28031662			2021-04-18T22:51:17.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28070235			2021-04-22T01:25:17.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28165669		"Gully Burns
1:07 PM Yesterday
sometimes authors will treat patient genotype as a clinical characteristic, but we put it into the mechanism bucket."	2021-04-20T16:11:34.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
28188364		survey in HCPs		curator4	hereditary hemorrhagic telangiectasia			
28267932		physiological mechanisms of a disease	2021-04-19T01:30:21.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
28297555			2021-04-19T00:31:48.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28407366		diagnosis	2021-04-19T00:43:26.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28430541		review	2021-04-22T00:42:35.000Z	curator4	hereditary hemorrhagic telangiectasia			
28578477			2021-04-22T00:47:09.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28588815		labeled based on text	2021-04-19T04:57:16.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28608633			2021-04-19T06:12:44.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28670610			2021-04-19T01:42:37.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28671294			2021-04-19T06:30:40.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28759897			2021-04-22T01:25:12.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28775059			2021-04-22T00:37:41.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28810087			2021-04-22T00:09:37.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
28989145			2021-04-20T16:34:13.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29080903			2021-04-19T01:36:37.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29120072			2021-04-22T00:50:50.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29171658			2021-04-22T00:30:01.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
29253907			2021-04-22T01:07:20.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29305977			2021-04-19T00:49:19.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29349377			2021-04-19T00:41:02.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
29395350			2021-04-20T16:48:04.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
29416304		"from paper
Ultrasound (US) of the heart revealed a left ventricle hypertrophy, with ejection fraction (EF) larger than 55 %, and a mild stenosis of the aortic valve, while the electrocardiogram (ECG) showed lateral cardiac wall ischemia. Blood tests were normal apart from a slightly low hemoglobin level (10.2 g/dL) while she reported her regular blood tests to show hemoglobin levels between 7 and 10 g/dL."	2021-04-20T15:37:00.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
29460088			2021-04-19T01:21:58.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29480092		*	2021-04-18T22:57:57.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29483005			2021-04-22T00:17:42.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
29515340			2021-04-19T00:48:24.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29552242			2021-04-19T05:59:18.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29610574			2021-04-20T16:22:21.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29938556			2021-04-22T01:00:00.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30095617			2021-04-22T01:26:03.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30171179		paper extensively discusses all therapies she was exposed to	2021-04-19T03:45:40.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30191360			2021-04-22T00:43:39.000Z	curator4	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
30260738		removed DM	2021-04-19T05:27:19.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
30279913		Removed DM. genetic testing (clinical test) revealed diagnosis	2021-04-20T15:46:08.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
30512964			2021-04-20T16:54:23.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
30549294			2021-04-19T06:39:12.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
30685840		whole paper is about mutations	2021-04-22T00:32:27.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
30704695			2021-04-19T05:56:31.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30705963			2021-04-19T01:44:02.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30717761		"Or PBT?? Drug repurposing?

chose TIC because even though its with a repurposed drug, the questionnaire is examining drug-related AEs (so HOW the drug works int he clinic)"	2021-04-19T00:40:19.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
30888464			2021-04-19T06:00:31.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30935812			2021-04-19T06:20:02.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31006519			2021-04-19T06:48:09.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31255500		or physiological mechanism of disease	2021-04-20T16:45:10.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
31360828			2021-04-20T16:16:44.000Z	curator4	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	2.1. DISEASE MECHANISM
31361678				curator4	hereditary hemorrhagic telangiectasia			
31400083			2021-04-18T23:29:16.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
31455059			2021-04-22T00:59:19.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
31540324			2021-04-22T01:00:24.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
31566760			2021-04-19T06:14:19.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31616764			2021-04-20T17:00:41.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31689244			2021-04-19T06:36:26.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
31828546			2021-04-18T23:56:40.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
31905627			2021-04-19T01:51:21.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32020296			2021-04-19T06:41:00.000Z	curator4	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
32059941			2021-04-19T00:41:48.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32078368			2021-04-20T16:47:46.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32178330		physiological disease mechanism	2021-04-20T15:51:56.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32199058			2021-04-22T01:09:17.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
32206359			2021-04-19T06:22:27.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32255688			2021-04-20T16:25:33.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32341592			2021-04-19T06:50:58.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32493237			2021-04-22T01:10:56.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
32503579			2021-04-20T16:56:45.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32536092			2021-04-19T06:50:24.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32538908			2021-04-19T06:31:25.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32556901			2021-04-22T00:36:51.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32718529			2021-04-19T06:06:08.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32723034				curator4	hereditary hemorrhagic telangiectasia			
32723482			2021-04-22T01:08:51.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
32762495			2021-04-22T01:08:59.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32774576			2021-04-18T23:27:36.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
32874383			2021-04-19T01:16:11.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
32899377			2021-04-20T16:24:38.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32904708			2021-04-19T03:32:42.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
32926701			2021-04-22T00:48:26.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
32992168		removed CC+DP	2021-04-20T16:05:33.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32998220			2021-04-19T00:45:23.000Z	curator4	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
33022056			2021-04-19T06:29:04.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33081831			2021-04-20T16:57:34.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33090433				curator4	hereditary hemorrhagic telangiectasia			
33147670			2021-04-20T16:24:27.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33211216		drug repurposing	2021-04-22T00:50:25.000Z	curator4	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
33242965			2021-04-19T06:55:11.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33243256			2021-04-20T16:23:29.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33282178			2021-04-19T06:47:27.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
33498134			2021-04-19T06:51:47.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
33661356			2021-04-19T06:48:50.000Z	curator4	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33677851			2021-04-22T01:18:50.000Z	curator4	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
33691924			2021-04-20T16:39:02.000Z	curator4	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
19942457				curator4	Lennox-Gastaut syndrome			
19948417				curator4	Lennox-Gastaut syndrome			
20004858			2021-05-10T02:26:46.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20023065			2021-05-10T02:19:17.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20084538		????		curator4	Lennox-Gastaut syndrome			
20126329		review		curator4	Lennox-Gastaut syndrome			
20149600			2021-05-09T01:54:29.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20150505				curator4	Lennox-Gastaut syndrome			
20151724				curator4	Lennox-Gastaut syndrome			
20169970			2021-05-03T02:12:13.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20185372			2021-05-10T01:49:52.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20199521			2021-05-09T02:42:13.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
20345938			2021-05-10T01:45:27.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20384723			2021-05-10T02:15:13.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
20384727			2021-05-10T02:07:55.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
20472261			2021-05-02T21:33:54.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20533249			2021-05-09T02:14:46.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20542434			2021-05-09T02:47:23.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20598586			2021-05-10T01:42:02.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20618411			2021-05-03T02:59:55.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
20647578			2021-05-09T02:52:46.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20666130				curator4	Lennox-Gastaut syndrome			
20726879		Removed CC	2021-05-15T13:27:01.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
20823030		removed CC	2021-05-15T13:25:16.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
20842588				curator4	Lennox-Gastaut syndrome			
20888268			2021-05-09T02:17:08.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
20957124		review	2021-05-09T01:53:11.000Z	curator4	Lennox-Gastaut syndrome			
21146944			2021-05-09T02:05:21.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21204804			2021-05-10T02:40:06.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
21227654			2021-05-10T01:35:13.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21243535			2021-05-10T01:26:08.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21256770			2021-05-02T21:24:02.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21269294			2021-05-03T02:11:26.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21275978			2021-05-02T21:39:21.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21341220			2021-05-02T21:13:15.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21365309			2021-05-10T02:27:04.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21376637			2021-05-10T02:16:46.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21397780			2021-05-02T22:05:36.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21481742			2021-05-03T02:53:17.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
21515079			2021-05-03T03:01:36.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21557146			2021-05-09T02:58:12.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21620771			2021-05-03T02:27:07.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	2.1. DISEASE MECHANISM
21638908			2021-05-02T21:50:04.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21692791		After check- removed TIC and added CC+PD	2021-05-09T01:40:48.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21790560				curator4	Lennox-Gastaut syndrome			
21790561		"Review or metaanalysis?
Extensive review of clinical trials"	2021-05-02T20:59:25.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21790562				curator4	Lennox-Gastaut syndrome			
21924653			2021-05-09T01:48:34.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21947090			2021-05-02T22:03:31.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
21982812			2021-05-03T02:08:24.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
22000954			2021-05-02T21:19:40.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22053552			2021-05-03T02:10:26.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22128252		review	2021-05-10T02:34:28.000Z	curator4	Lennox-Gastaut syndrome			
22258042			2021-05-09T02:48:27.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22266062			2021-05-02T21:46:31.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22281384			2021-05-10T02:30:02.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22421185			2021-05-09T02:33:06.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
22422635			2021-05-03T03:00:14.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
22443637			2021-05-10T02:37:51.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22471338		mice- preclinical models	2021-05-09T02:27:00.000Z	curator4	Lennox-Gastaut syndrome			
22476991		"after check- removed DM because its not the focus but 
""sometimes authors will treat patient genotype as a clinical characteristic, but we put it into the mechanism bucket.""
- need more clarification"	2021-05-09T01:43:21.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22483538			2021-05-03T02:41:26.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22576075			2021-05-02T21:28:22.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
22592511			2021-05-10T01:50:03.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22633633			2021-05-02T22:19:45.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22677424			2021-05-10T02:35:26.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
22681320			2021-05-03T02:01:03.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22709423			2021-05-10T02:29:20.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22746027			2021-05-09T02:45:25.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
22813348			2021-05-10T02:26:00.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22921514			2021-05-10T02:18:17.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22934193			2021-05-09T02:52:58.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22957240			2021-05-02T21:58:31.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23041289			2021-05-09T02:32:03.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23141144			2021-05-03T02:06:23.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
23143718		seems to be a prospective clinical trial	2021-05-09T02:34:22.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
23213494				curator4	Lennox-Gastaut syndrome			
23230532			2021-05-10T02:15:33.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23252400			2021-05-02T22:19:27.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
23334068			2021-05-09T02:53:50.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23354062			2021-05-10T01:30:05.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23409955			2021-05-09T01:46:35.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.3. THERAPEUTICS IN THE CLINIC
23415449			2021-05-03T02:14:34.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
23465587			2021-05-02T22:18:46.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23471536		opinion piece		curator4	Lennox-Gastaut syndrome			
23489890			2021-05-10T01:33:53.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23490456			2021-05-10T02:40:54.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23531645			2021-05-10T01:32:34.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23583057			2021-05-02T21:01:29.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23634191				curator4	Lennox-Gastaut syndrome			
23647917		removed DM	2021-05-15T13:24:29.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23827423			2021-05-02T21:59:37.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
23864316			2021-05-03T02:30:11.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23927801			2021-05-02T22:10:27.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
23936641		Review		curator4	Lennox-Gastaut syndrome			
23981349			2021-05-10T02:36:09.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24012506			2021-05-02T22:03:46.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24045845			2021-05-02T21:57:50.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24105702			2021-05-02T22:13:13.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24113539			2021-05-03T02:28:15.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
24116958			2021-05-09T02:25:39.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24117046		physiolofical mechanism of disease	2021-05-03T02:13:42.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24122274			2021-05-02T21:53:00.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24237632			2021-05-03T02:25:45.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24348133			2021-05-03T02:05:46.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24400693			2021-05-10T02:34:40.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24533090		drug MOA		curator4	Lennox-Gastaut syndrome			
24580023			2021-05-09T01:50:37.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
24614520			2021-05-09T01:59:01.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24649449			2021-05-03T02:51:55.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24649460			2021-05-10T02:03:13.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24659735			2021-05-03T02:27:37.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24684645				curator4	Lennox-Gastaut syndrome			
24762861			2021-05-09T01:49:14.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
24809226			2021-05-09T02:41:39.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24902608			2021-05-09T02:03:54.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24906615			2021-05-03T02:24:51.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24912730			2021-05-03T02:35:45.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
24949576			2021-05-02T20:56:59.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25011392		****	2021-05-09T02:37:18.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25051969			2021-05-09T02:28:13.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25132372			2021-05-10T01:47:12.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25184741			2021-05-10T01:48:37.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25219353			2021-05-03T02:32:22.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25231724			2021-05-10T02:13:54.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25266616			2021-05-03T02:25:09.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25282105			2021-05-10T02:09:00.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
25336963				curator4	Lennox-Gastaut syndrome			
25619447			2021-05-02T21:07:48.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25682573				curator4	Lennox-Gastaut syndrome			
25687944			2021-05-03T02:54:43.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25730374			2021-05-03T02:30:41.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25798598		drug mechanism		curator4	Lennox-Gastaut syndrome			
25814807			2021-05-03T02:41:51.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25845492			2021-05-03T02:51:03.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
25935511			2021-05-10T02:43:34.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26036975		Drug mechanism		curator4	Lennox-Gastaut syndrome			
26057351			2021-05-09T02:57:41.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26068938			2021-05-09T01:52:35.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26093133		after check- removed TIC because its not the focus	2021-05-09T01:42:04.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26125563			2021-05-03T02:55:41.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26139309		PBT since clinical trial data used?? not sure so leaving it blank	2021-05-09T02:30:29.000Z	curator4	Lennox-Gastaut syndrome			
26167208			2021-05-03T02:38:31.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26224203		Check: Removed DM	2021-05-09T01:36:24.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26238894			2021-05-10T02:14:55.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26245776			2021-05-03T02:49:45.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26294172			2021-05-10T02:10:17.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26333833		"This finding may reflect common mechanisms that underlie both the syndrome and the phenotype associated with LGS

- physiological mehcanism of a disease

After check- removed DM"	2021-05-09T01:44:49.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26474092			2021-05-10T02:00:53.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26513494			2021-05-09T02:42:43.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26606192			2021-05-09T02:33:24.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26611353			2021-05-09T02:06:02.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26724101			2021-05-10T02:38:27.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26744634		review	2021-05-09T02:24:12.000Z	curator4	Lennox-Gastaut syndrome			
26805435			2021-05-02T21:50:45.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26808205			2021-05-09T02:05:50.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26827266			2021-05-09T02:15:34.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
26828692			2021-05-02T21:41:07.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26860718			2021-05-09T02:51:38.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26887412			2021-05-10T01:32:14.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26923380			2021-05-03T02:59:24.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
26945476		physiological mechanism of disease	2021-05-02T21:29:59.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26950270			2021-05-02T21:41:36.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
26977407			2021-05-09T01:59:27.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26993353			2021-05-10T02:28:23.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27052529			2021-05-03T02:36:01.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27082650			2021-05-10T01:46:11.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27084975			2021-05-09T02:19:08.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27145465			2021-05-02T21:34:27.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27184676		review?	2021-05-03T02:44:46.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27199889			2021-05-02T21:53:46.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27345028			2021-05-10T02:39:41.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27363778			2021-05-02T21:41:19.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
27379172			2021-05-09T02:41:46.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27417063			2021-05-09T02:32:33.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27466475			2021-05-03T02:34:50.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27475280			2021-05-10T02:39:54.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27504264		no changes	2021-05-10T02:22:48.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
27513709		removed CC	2021-05-15T13:25:59.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27629372			2021-05-09T01:50:10.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27635610			2021-05-03T02:31:41.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27683846			2021-05-10T02:09:42.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
27686687			2021-05-02T22:02:11.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27846468			2021-05-10T02:04:39.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
27994367			2021-05-10T02:08:11.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28038390			2021-05-09T02:40:05.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28186331			2021-05-09T02:48:01.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
28210578		Pilot studies have to be registered with clinicaltrials.gov so PBT	2021-05-02T21:14:05.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
28431772			2021-05-09T02:22:36.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28471101			2021-05-03T02:53:22.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28479797			2021-05-10T02:33:55.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
28513609			2021-05-02T21:23:09.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
28528895			2021-05-03T02:39:48.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28584915			2021-05-09T02:25:09.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28589569			2021-05-09T02:57:07.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
28600632			2021-05-10T02:01:59.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28609734				curator4	Lennox-Gastaut syndrome			
28633092			2021-05-09T02:06:40.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28635719		Review??		curator4	Lennox-Gastaut syndrome			
28667181			2021-05-03T02:40:28.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
28689466		review		curator4	Lennox-Gastaut syndrome			
28715780			2021-05-10T02:37:35.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28740620			2021-05-09T02:03:05.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
28846756			2021-05-09T02:18:06.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
28927712			2021-05-10T02:13:34.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
29098688			2021-05-09T01:51:50.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29121573				curator4	Lennox-Gastaut syndrome			
29126048			2021-05-03T02:56:39.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29156220			2021-05-03T02:58:41.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
29202277			2021-05-02T22:14:32.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
29223473			2021-05-09T01:55:55.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
29264397			2021-05-09T01:58:27.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
29314583			2021-05-03T02:01:55.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
29363096			2021-05-10T02:32:32.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29395273			2021-05-03T02:26:31.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
29443301		review		curator4	Lennox-Gastaut syndrome			
29454607				curator4	Lennox-Gastaut syndrome			
29459061			2021-05-02T21:49:05.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29467376			2021-05-09T02:11:41.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29548728		DRUG MOA		curator4	Lennox-Gastaut syndrome			
29570389			2021-05-09T02:40:47.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29746397			2021-05-10T01:26:56.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
29761022			2021-05-10T02:11:14.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
29898974		Review/Guidelines	2021-05-02T21:27:14.000Z	curator4	Lennox-Gastaut syndrome			
29906696			2021-05-03T02:52:40.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29941151			2021-05-03T02:53:51.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
29968450			2021-05-10T02:23:34.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30057867			2021-05-03T02:13:08.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30146701			2021-05-02T22:09:09.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30166208			2021-05-03T02:26:16.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30186023				curator4	Lennox-Gastaut syndrome			
30213680			2021-05-03T02:58:07.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30241056			2021-05-09T02:50:17.000Z	curator4	Lennox-Gastaut syndrome			
30255934			2021-05-09T01:53:59.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30286409		retrospective study	2021-05-09T02:09:51.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30309816			2021-05-02T21:15:46.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30336805			2021-05-09T01:48:55.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30357823			2021-05-10T01:34:37.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30368788				curator4	Lennox-Gastaut syndrome			
30405366		review		curator4	Lennox-Gastaut syndrome			
30430534			2021-05-03T02:42:38.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30552298		"first instinct was CCDP but recalled GBs comment
""sometimes authors will treat patient genotype as a clinical characteristic, but we put it into the mechanism bucket"""	2021-05-02T21:05:58.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
30564493			2021-05-09T02:16:13.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30616356		Review		curator4	Lennox-Gastaut syndrome			
30673834			2021-05-10T01:51:17.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30676535		review		curator4	Lennox-Gastaut syndrome			
30740695			2021-05-10T02:38:56.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
30788214			2021-05-10T02:16:19.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30804880			2021-05-09T02:00:55.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.3. THERAPEUTICS IN THE CLINIC
30817475		Review		curator4	Lennox-Gastaut syndrome			
30831398			2021-05-10T02:41:55.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
30831405				curator4	Lennox-Gastaut syndrome			
30870597				curator4	Lennox-Gastaut syndrome			
30909854				curator4	Lennox-Gastaut syndrome			
30955420			2021-05-10T01:36:13.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31008722			2021-05-10T02:09:10.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31113280			2021-05-10T01:35:56.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31161980				curator4	Lennox-Gastaut syndrome			
31168494			2021-05-02T21:27:38.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31176687			2021-05-10T02:03:49.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31179531			2021-05-10T02:33:39.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31190668			2021-05-09T02:07:07.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31215313			2021-05-03T02:01:42.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31227617		"Also physiological mechanism of a disease?

After check- removed DM"	2021-05-09T01:39:12.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31279290				curator4	Lennox-Gastaut syndrome			
31286465		review		curator4	Lennox-Gastaut syndrome			
31432588			2021-05-09T02:22:18.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31468518			2021-05-03T02:05:38.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31519475			2021-05-03T02:46:38.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31563030		******	2021-05-09T03:01:48.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
31575436			2021-05-10T02:36:43.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31603844		review		curator4	Lennox-Gastaut syndrome			
31657863		????		curator4	Lennox-Gastaut syndrome			
31677157			2021-05-10T02:38:35.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31678406			2021-05-09T02:14:20.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31755996			2021-05-09T02:59:48.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	2.1. DISEASE MECHANISM
31805047			2021-05-09T02:31:16.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
31829726			2021-05-03T02:55:26.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
31877501		clinical trials (other than meta analyses) are prospective	2021-05-09T02:19:47.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31879735		"(C) the physiological mechanism of disease at the level of tissues, organs, and body systems.

After check- removed DM"	2021-05-09T01:40:04.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31916540		review		curator4	Lennox-Gastaut syndrome			
31926846			2021-05-09T02:11:02.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	3.4. PATIENT-BASED THERAPEUTICS
31941643				curator4	Lennox-Gastaut syndrome			
31980515			2021-05-10T02:42:53.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
32020895			2021-05-09T02:43:09.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
32062104			2021-05-02T22:02:39.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
32082420			2021-05-09T02:38:08.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32185791		review		curator4	Lennox-Gastaut syndrome			
32207730		review		curator4	Lennox-Gastaut syndrome			
32350749			2021-05-09T02:01:59.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
32441821			2021-05-02T22:12:56.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32452532			2021-05-03T02:59:03.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
32452568		Review	2021-05-02T21:11:21.000Z	curator4	Lennox-Gastaut syndrome			
32477256				curator4	Lennox-Gastaut syndrome			
32502686				curator4	Lennox-Gastaut syndrome			
32543253				curator4	Lennox-Gastaut syndrome			
32544421				curator4	Lennox-Gastaut syndrome			
32592183			2021-05-09T01:56:40.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
32615417			2021-05-09T02:01:14.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32657695				curator4	Lennox-Gastaut syndrome			
32715412				curator4	Lennox-Gastaut syndrome			
32827745			2021-05-03T02:07:31.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32850532		participants are physicians		curator4	Lennox-Gastaut syndrome			
32851114			2021-05-10T02:19:53.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32854045			2021-05-09T02:15:57.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32860345			2021-05-10T02:04:03.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32920379			2021-05-10T02:43:25.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
32928027		"After GB asked to check:
Added CC+DP

Left disease mechanism because GB's previous comment:
""sometimes authors will treat patient genotype as a clinical characteristic, but we put it into the mechanism bucket"""	2021-05-09T01:33:15.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
32944944			2021-05-10T02:31:43.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
32945607			2021-05-03T02:55:10.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
32959794		review		curator4	Lennox-Gastaut syndrome			
32969022			2021-05-02T20:57:24.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
33026899		review		curator4	Lennox-Gastaut syndrome			
33046417			2021-05-03T02:36:11.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33113098				curator4	Lennox-Gastaut syndrome			
33144805			2021-05-03T02:27:27.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33188523			2021-05-10T01:29:38.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33189068			2021-05-09T02:16:50.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33224689		"review? or similar to other retrospective studies we evaluate?
treatment of patient and OFF label/non-prescription use- also PBT?"	2021-05-03T02:05:18.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33241408				curator4	Lennox-Gastaut syndrome			
33313501			2021-05-09T02:43:27.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33344590			2021-05-10T01:44:00.000Z	curator4	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
33358132				curator4	Lennox-Gastaut syndrome			
33372033			2021-05-02T21:31:14.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
33372424			2021-05-10T02:21:19.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33391157			2021-05-10T02:19:28.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
33398534			2021-05-09T02:05:03.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33406966			2021-05-09T02:39:54.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33482642			2021-05-10T01:31:46.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33584793			2021-05-09T02:06:13.000Z	curator4	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
33626200			2021-05-10T01:31:04.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33681663			2021-05-09T02:14:10.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
33693596				curator4	Lennox-Gastaut syndrome			
33718684			2021-05-02T22:08:59.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33746760			2021-05-02T20:51:09.000Z	curator4	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33764203			2021-05-02T22:12:06.000Z	curator4	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
19308961		"1.1: 45%
1.3: 96%
2.1: 86%
3.4: 95%"	2021-05-12T15:14:38.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
19703826		"1.1: 90%
1.3: 26%
2.1: 97%
3.4: 82%"	2021-05-11T05:10:03.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
20030794		"outcomes of transplantation for CF

1.1: 13%
1.3: 93%
2.1: 36%
3.4: 98%"	2021-05-12T00:37:45.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
20052366		"1.1: 67%
1.3: 96%
2.1: 84%
3.4: 95%"	2021-05-12T01:11:42.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
20093376		"1.1: 78%
1.3: 97%
2.1: 52%
3.4: 96%"	2021-05-12T04:37:00.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
20141637		"1.1: 86%
1.3: 96%
2.1: 69%
3.4: 95%"	2021-05-12T14:24:46.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	0.3. OTHER
20142516		"1.1: 87%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-12T00:26:28.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
20167933		"1.1: 88%
1.3: 95%
2.1: 82%
3.4: 93%"	2021-05-12T15:16:27.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
20309575		"and 2.3. Non in-vivo Human or non-human model system

1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-12T04:17:54.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	0.3. OTHER
20481640		"3.2. Drug Mechanism (adverse drug effect)

1.1: 88%
1.3: 92%
2.1: 6%
3.4: 94%"	2021-05-12T01:37:53.000Z	curator1	cystic fibrosis		0.3. OTHER	
20495106		"not sure. 

1.1: 53%
1.3: 87%
2.1: 94%
3.4: 96%"	2021-05-12T15:34:35.000Z	curator1	cystic fibrosis			
20569877		"1.1: 91%
1.3: 53%
2.1: 94%
3.4: 80%"	2021-05-11T02:48:07.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
20597077		"1.1: 77%
1.3: 90%
2.1: 93%
3.4: 96%"	2021-05-12T04:11:55.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20651854		"1.1: 82%
1.3: 96%
2.1: 76%
3.4: 95%"	2021-05-12T04:17:33.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
20692461		"1.1: 75%
1.3: 76%
2.1: 97%
3.4: 91%"	2021-05-12T01:12:46.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
20696868		"3.2. Drug Mechanism

1.1: 91%
1.3: 94%
2.1: 69%
3.4: 93%"	2021-05-12T01:53:21.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	0.3. OTHER
20714107		"and 3.1. Therapeutic Hypothesis 

1.1: 89%
1.3: 94%
2.1: 76%
3.4: 93%"	2021-05-13T18:22:53.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	0.3. OTHER
20718961		"1.1: 59%
1.3: 3%
2.1: 98%
3.4: 96%"	2021-05-13T18:20:18.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20831811		"1.2. Quality of Life?

1.1: 59%
1.3: 92%
2.1: 92%
3.4: 96%"	2021-05-12T04:29:38.000Z	curator1	cystic fibrosis		0.3. OTHER	
20927127		"1.1: 80%
1.3: 96%
2.1: 82%
3.4: 95%"	2021-05-12T15:33:58.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
20933420		"1.1: 88%
1.3: 96%
2.1: 79%
3.4: 94%"	2021-05-12T00:23:55.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
20936184		"not very sure about this one, maybe only 2.3. Non in-vivo Human or non-human model system. But 2.1 was the best fit out of the 4 categories we are working with.

1.1: 91%
1.3: 93%
2.1: 56%
3.4: 94%"	2021-05-11T02:39:57.000Z	curator1	cystic fibrosis			
20947455		"1.1: 67%
1.3: 55%
2.1: 98%
3.4: 92%"	2021-05-12T00:26:44.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
21030607		"1.1: 89%
1.3: 94%
2.1: 79%
3.4: 93%"	2021-05-12T01:15:58.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
21039067		"1.1: 85%
1.3: 74%
2.1: 97%
3.4: 87%"	2021-05-12T00:48:30.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
21050065		"3.2. Drug Mechanism

1.1: 90%
1.3: 95%
2.1: 60%
3.4: 95%"	2021-05-12T14:23:14.000Z	curator1	cystic fibrosis		0.3. OTHER	
21073547		"3.2. Drug Mechanism

1.1: 95%
1.3: 81%
2.1: 15%
3.4: 88%"	2021-05-12T01:29:59.000Z	curator1	cystic fibrosis		0.3. OTHER	
21086027		"closest tag is 1.2. Quality of Life but not quite

1.1: 71%
1.3: 89%
2.1: 95%
3.4: 96%"	2021-05-12T00:33:15.000Z	curator1	cystic fibrosis		0.3. OTHER	
21209785	True	"review

1.1: 53%
1.3: 22%
2.1: 98%
3.4: 96%"	2021-05-12T01:12:30.000Z	curator1	cystic fibrosis			
21220217		"1.1: 38%
1.3: 74%
2.1: 96%
3.4: 93%"	2021-05-11T05:06:24.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
21238636		"2.3. Non in-vivo Human or non-human model system AND 2.2. Normal Biology 

1.1: 89%
1.3: 95%
2.1: 56%
3.4: 95%"	2021-05-13T18:13:43.000Z	curator1	cystic fibrosis		0.3. OTHER	
21317431		"Not sure. effect of type of health care on health outcomes ...


1.1: 46%
1.3: 10%
2.1: 98%
3.4: 94%"	2021-05-13T18:15:38.000Z	curator1	cystic fibrosis			
21323339		"1.1: 86%
1.3: 96%
2.1: 69%
3.4: 96%"	2021-05-12T04:29:17.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21330456		"1.1: 96%
1.3: 62%
2.1: 45%
3.4: 89%"	2021-05-13T18:06:18.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
21361784		"3.2. Drug Mechanism (PK)

1.1: 90%
1.3: 1%
2.1: 95%
3.4: 88%"	2021-05-11T02:47:32.000Z	curator1	cystic fibrosis		0.3. OTHER	
21398685		"1.1: 70%
1.3: 85%
2.1: 95%
3.4: 96%"	2021-05-12T00:23:39.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21420082		"1.1: 88%
1.3: 95%
2.1: 78%
3.4: 93%"	2021-05-11T03:04:42.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
21422040		"1.1: 87%
1.3: 89%
2.1: 93%
3.4: 94%"	2021-05-12T02:03:39.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21507732		"1.1: 39%
1.3: 96%
2.1: 81%
3.4: 95%"	2021-05-12T00:30:24.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
21547736	True	"sounds like a review

1.1: 83%
1.3: 96%
2.1: 30%
3.4: 97%"	2021-05-12T01:56:13.000Z	curator1	cystic fibrosis			
21547740	True	"chapter - like a review

1.1: 89%
1.3: 94%
2.1: 3%
3.4: 96%"	2021-05-12T04:40:44.000Z	curator1	cystic fibrosis			
21556203		"1.1: 28%
1.3: 80%
2.1: 89%
3.4: 96%"	2021-05-11T05:04:16.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21779371		"1.1: 88%
1.3: 95%
2.1: 70%
3.4: 95%"	2021-05-11T12:17:12.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
21804191		"3.2. Drug Mechanism

1.1: 95%
1.3: 74%
2.1: 33%
3.4: 91%"	2021-05-12T15:14:08.000Z	curator1	cystic fibrosis		0.3. OTHER	
21829484		"1.1: 34%
1.3: 97%
2.1: 26%
3.4: 97%"	2021-05-12T00:45:15.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
21955319		"1.1: 81%
1.3: 91%
2.1: 92%
3.4: 95%"	2021-05-11T12:50:26.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21980493		"biomarkers

1.1: 88%
1.3: 95%
2.1: 74%
3.4: 94%"	2021-05-11T02:58:24.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21984237		"1.1: 86%
1.3: 95%
2.1: 81%
3.4: 94%"	2021-05-12T04:39:12.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
22007982		"no category for this

1.1: 47%
1.3: 81%
2.1: 94%
3.4: 97%"	2021-05-11T05:03:44.000Z	curator1	cystic fibrosis			
22024822		"3.2. Drug Mechanism

1.1: 94%
1.3: 44%
2.1: 89%
3.4: 58%"	2021-05-12T04:41:00.000Z	curator1	cystic fibrosis		0.3. OTHER	
22059807		"1.1: 83%
1.3: 96%
2.1: 76%
3.4: 95%"	2021-05-12T14:23:09.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
22070931		"1.1: 89%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-12T15:35:53.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
22146482		"not sure, this paper is about antibiotic resistance patterns

1.1: 38%
1.3: 93%
2.1: 56%
3.4: 97%"	2021-05-12T01:13:13.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
22256443		"1.1: 81%
1.3: 84%
2.1: 94%
3.4: 95%"	2021-05-12T01:06:14.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22333903		"no label for this currently (~influences on health care delivery)

1.1: 15%
1.3: 93%
2.1: 88%
3.4: 98%"	2021-05-13T18:12:04.000Z	curator1	cystic fibrosis			
22416231		"1.2. Quality of Life

1.1: 64%
1.3: 90%
2.1: 95%
3.4: 95%"	2021-05-13T18:09:15.000Z	curator1	cystic fibrosis		0.3. OTHER	
22554673		"1.1: 88%
1.3: 49%
2.1: 97%
3.4: 83%"	2021-05-13T18:06:21.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
22559811		"and 0.2. Related Diseases 

1.1: 80%
1.3: 85%
2.1: 95%
3.4: 97%"	2021-05-12T14:16:36.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.3. OTHER
22607714		"1.1: 86%
1.3: 88%
2.1: 93%
3.4: 94%"	2021-05-12T15:33:45.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22660986		"1.1: 85%
1.3: 64%
2.1: 96%
3.4: 90%"	2021-05-12T04:45:02.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
22679004		"1.1: 86%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-12T01:16:12.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
22727329		"1.1: 47%
1.3: 90%
2.1: 96%
3.4: 96%"	2021-05-12T01:40:16.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22747419		"1.1: 89%
1.3: 95%
2.1: 44%
3.4: 95%"	2021-05-12T15:11:51.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
22747891		"1.1: 35%
1.3: 95%
2.1: 53%
3.4: 97%"	2021-05-11T12:13:47.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22841006		"maybe 3.2. Drug Mechanism

1.1: 91%
1.3: 93%
2.1: 34%
3.4: 94%"	2021-05-11T12:19:42.000Z	curator1	cystic fibrosis		0.3. OTHER	
22859374		"1.1: 89%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-12T04:26:54.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
22898134		"1.1: 78%
1.3: 95%
2.1: 67%
3.4: 95%"	2021-05-13T18:10:22.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
22923315		"3.2. Drug Mechanism and maybe 0.2. Related Diseases 

1.1: 89%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-12T01:52:24.000Z	curator1	cystic fibrosis		0.3. OTHER	
22930931	True	"guidelines=review

1.1: 91%
1.3: 14%
2.1: 92%
3.4: 92%"	2021-05-12T15:09:35.000Z	curator1	cystic fibrosis			
22936895	True	"review

1.1: 95%
1.3: 56%
2.1: 82%
3.4: 88%"	2021-05-13T18:20:03.000Z	curator1	cystic fibrosis			
22937715		"1.1: 30%
1.3: 96%
2.1: 40%
3.4: 97%"	2021-05-12T01:41:27.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22946777		"1.1: 65%
1.3: 44%
2.1: 97%
3.4: 94%"	2021-05-11T05:08:01.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
23060444		"1.1: 88%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-12T14:35:25.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
23090599		"1.1: 91%
1.3: 93%
2.1: 64%
3.4: 94%"	2021-05-12T04:22:32.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
23104983		"3.2. Drug Mechanism

1.1: 91%
1.3: 95%
2.1: 70%
3.4: 93%"	2021-05-12T01:54:16.000Z	curator1	cystic fibrosis		0.3. OTHER	
23140956		"1.1: 74%
1.3: 93%
2.1: 90%
3.4: 95%"	2021-05-12T14:08:28.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23169612		"1.1: 87%
1.3: 86%
2.1: 95%
3.4: 94%"	2021-05-12T00:29:05.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23192669		"1.1: 86%
1.3: 88%
2.1: 94%
3.4: 95%"	2021-05-11T02:53:29.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23215638		"3.2. Drug Mechanism

1.1: 89%
1.3: 95%
2.1: 68%
3.4: 95%"	2021-05-12T00:40:44.000Z	curator1	cystic fibrosis		0.3. OTHER	
23217263		"1.1: 84%
1.3: 88%
2.1: 93%
3.4: 95%"	2021-05-12T00:25:37.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23219705	True	"MA=review

1.1: 72%
1.3: 89%
2.1: 95%
3.4: 96%"	2021-05-12T15:13:39.000Z	curator1	cystic fibrosis			
23223798		"1.1: 89%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-12T14:29:45.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
23289454		"kind of 1.2. Quality of Life

1.1: 28%
1.3: 78%
2.1: 95%
3.4: 97%"	2021-05-11T12:16:53.000Z	curator1	cystic fibrosis		0.3. OTHER	
23316740		"3.2. Drug Mechanism

1.1: 87%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-12T01:16:50.000Z	curator1	cystic fibrosis		0.3. OTHER	
23361110		"1.1: 85%
1.3: 90%
2.1: 93%
3.4: 95%"	2021-05-11T12:42:13.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23365473		"1.1: 86%
1.3: 87%
2.1: 95%
3.4: 93%"	2021-05-13T18:08:23.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23390474		"1.1: 84%
1.3: 87%
2.1: 95%
3.4: 94%"	2021-05-12T04:42:07.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23504457		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-12T00:27:54.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
23527104		"and 3.2. Drug Mechanism

1.1: 89%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-11T04:56:24.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	0.3. OTHER
23528342		"1.1: 67%
1.3: 97%
2.1: 67%
3.4: 96%"	2021-05-12T14:30:28.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23532242		"1.1: 93%
1.3: 9%
2.1: 96%
3.4: 63%"	2021-05-12T01:57:42.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
23636454		"1.1: 88%
1.3: 95%
2.1: 82%
3.4: 94%"	2021-05-12T01:48:21.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
23789012		"and 0.2. Related Diseases 

1.1: 77%
1.3: 78%
2.1: 95%
3.4: 96%"	2021-05-11T03:02:33.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.3. OTHER
23815177		"1.1: 87%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-12T04:30:46.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
23820266		"1.1: 89%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-12T04:41:14.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
23910813		"1.1: 71%
1.3: 64%
2.1: 98%
3.4: 93%"	2021-05-12T00:37:19.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24004189		"1.1: 85%
1.3: 71%
2.1: 97%
3.4: 88%"	2021-05-13T18:09:46.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
24144711		"Assessing transfer of care, we don't have a category for that but 1.3 probably best describes it (not 1.1)

1.1: 35%
1.3: 73%
2.1: 97%
3.4: 96%"	2021-05-11T03:01:21.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24209388		"3.2. Drug Mechanism

1.1: 88%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-12T00:49:04.000Z	curator1	cystic fibrosis		0.3. OTHER	
24431198		"1.1: 41%
1.3: 66%
2.1: 98%
3.4: 93%"	2021-05-12T14:08:48.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24520658	True	"seems like a review

1.1: 81%
1.3: 82%
2.1: 95%
3.4: 96%"	2021-05-12T04:11:34.000Z	curator1	cystic fibrosis			
24529962		"2.2. Normal Biology

1.1: 60%
1.3: 87%
2.1: 95%
3.4: 96%"	2021-05-12T15:30:49.000Z	curator1	cystic fibrosis		0.3. OTHER	
24570764		"3.2. Drug Mechanism

1.1: 83%
1.3: 12%
2.1: 96%
3.4: 89%"	2021-05-12T01:10:03.000Z	curator1	cystic fibrosis		0.3. OTHER	
24576297		"1.1: 46%
1.3: 96%
2.1: 55%
3.4: 97%"	2021-05-12T00:30:48.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24591578		"1.1: 85%
1.3: 95%
2.1: 83%
3.4: 93%"	2021-05-11T05:03:06.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
24608547		"evaluating a patient network?

1.1: 79%
1.3: 89%
2.1: 86%
3.4: 97%"	2021-05-11T05:08:23.000Z	curator1	cystic fibrosis			
24608551		"1.1: 57%
1.3: 78%
2.1: 94%
3.4: 95%"	2021-05-12T14:26:00.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24608905		"1.1: 87%
1.3: 96%
2.1: 76%
3.4: 95%"	2021-05-12T14:32:20.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
24655065	True	"seems like a review

1.1: 82%
1.3: 75%
2.1: 97%
3.4: 90%"	2021-05-12T15:12:39.000Z	curator1	cystic fibrosis			
24660703		"1.1: 81%
1.3: 93%
2.1: 55%
3.4: 96%"	2021-05-13T18:09:40.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24680115		"agree, we don't have a category for this type of study (qualitative assessment of attitudes toward decision making)

1.1: 62%
1.3: 10%
2.1: 98%
3.4: 95%"	2021-05-11T02:57:34.000Z	curator1	cystic fibrosis			
24762087		"not sure

1.1: 51%
1.3: 96%
2.1: 43%
3.4: 96%"	2021-05-12T04:33:33.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24782693		"1.1: 88%
1.3: 62%
2.1: 96%
3.4: 89%"	2021-05-11T02:53:47.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24811243		"3.2. Drug Mechanism

1.1: 90%
1.3: 95%
2.1: 62%
3.4: 95%"	2021-05-12T04:12:18.000Z	curator1	cystic fibrosis		0.3. OTHER	
24811693		"1.1: 75%
1.3: 81%
2.1: 95%
3.4: 96%"	2021-05-11T04:56:45.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24816489		"3.2. Drug Mechanism

1.1: 89%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-12T15:30:34.000Z	curator1	cystic fibrosis		0.3. OTHER	
24821546	True	"opinion piece?

1.1: 68%
1.3: 37%
2.1: 97%
3.4: 97%"	2021-05-12T04:26:37.000Z	curator1	cystic fibrosis			
24914212		"1.1: 89%
1.3: 95%
2.1: 77%
3.4: 94%"	2021-05-11T12:13:37.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
24927234		"1.1: 84%
1.3: 58%
2.1: 95%
3.4: 91%"	2021-05-12T14:15:18.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
24973281		"1.1: 96%
1.3: 46%
2.1: 83%
3.4: 60%"	2021-05-12T01:48:23.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
25010405		"1.1: 72%
1.3: 84%
2.1: 96%
3.4: 93%"	2021-05-13T18:18:13.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25046147		"3.3. Preclinical Therapeutics

1.1: 90%
1.3: 95%
2.1: 72%
3.4: 94%"	2021-05-12T04:37:14.000Z	curator1	cystic fibrosis		0.3. OTHER	
25048732		"1.1: 85%
1.3: 87%
2.1: 94%
3.4: 95%"	2021-05-12T01:11:51.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25065395		"3.2. Drug Mechanism

1.1: 90%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-13T18:04:02.000Z	curator1	cystic fibrosis		0.3. OTHER	
25076714		"1.4. Epidemiology

1.1: 20%
1.3: 49%
2.1: 97%
3.4: 97%"	2021-05-12T14:21:26.000Z	curator1	cystic fibrosis		0.3. OTHER	
25187182		"and 1.2. Quality of Life 

1.1: 2%
1.3: 53%
2.1: 98%
3.4: 95%"	2021-05-12T14:23:09.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.3. OTHER
25219836		"1.1: 85%
1.3: 91%
2.1: 92%
3.4: 94%"	2021-05-12T04:42:48.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25245859		"and 0.2. Related Diseases

1.1: 54%
1.3: 87%
2.1: 94%
3.4: 95%"	2021-05-12T00:26:24.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.3. OTHER
25249647		"1.1: 79%
1.3: 86%
2.1: 81%
3.4: 96%"	2021-05-12T00:33:43.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25287046		"1.1: 87%
1.3: 95%
2.1: 74%
3.4: 95%"	2021-05-11T12:19:07.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
25301526		"1.1: 66%
1.3: 97%
2.1: 72%
3.4: 96%"	2021-05-12T00:34:06.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
25387861		"1.1: 89%
1.3: 70%
2.1: 96%
3.4: 88%"	2021-05-11T02:52:40.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
25404599	True	"CF mentioned in passing, but this study reviews a pharmacy residency program

1.1: 77%
1.3: 76%
2.1: 92%
3.4: 96%"	2021-05-12T04:19:09.000Z	curator1	cystic fibrosis			
25433587		"1.1: 87%
1.3: 64%
2.1: 97%
3.4: 86%"	2021-05-13T18:22:53.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
25445528		"3.2. Drug Mechanism

1.1: 91%
1.3: 90%
2.1: 10%
3.4: 93%"	2021-05-12T04:24:58.000Z	curator1	cystic fibrosis		0.3. OTHER	
25459563		"Methodological study. Maybe 2.3. Non in-vivo Human or non-human model system, but not a model

1.1: 72%
1.3: 91%
2.1: 91%
3.4: 96%"	2021-05-12T01:51:06.000Z	curator1	cystic fibrosis		0.3. OTHER	
25466700		"3.2. Drug Mechanism (PK)

1.1: 94%
1.3: 29%
2.1: 95%
3.4: 76%"	2021-05-12T00:29:17.000Z	curator1	cystic fibrosis		0.3. OTHER	
25481442		"3.2. Drug Mechanism

1.1: 93%
1.3: 88%
2.1: 25%
3.4: 91%"	2021-05-11T12:41:13.000Z	curator1	cystic fibrosis		0.3. OTHER	
25512598		"3.2. Drug Mechanism

1.1: 89%
1.3: 95%
2.1: 75%
3.4: 93%"	2021-05-12T04:43:31.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	0.3. OTHER
25681074		"1.1: 84%
1.3: 85%
2.1: 94%
3.4: 95%"	2021-05-11T05:05:23.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25714328		"3.2. Drug Mechanism

1.1: 83%
1.3: 96%
2.1: 50%
3.4: 96%"	2021-05-11T12:48:50.000Z	curator1	cystic fibrosis		0.3. OTHER	
25725797		"1.1: 88%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-13T18:19:37.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
25742660		"1.1: 45%
1.3: 95%
2.1: 31%
3.4: 97%"	2021-05-12T15:35:33.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25825042		"1.1: 78%
1.3: 96%
2.1: 80%
3.4: 95%"	2021-05-11T03:05:36.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
25865196	True	"review (but 2.1 would be correct)

1.1: 65%
1.3: 97%
2.1: 45%
3.4: 98%"	2021-05-11T02:49:17.000Z	curator1	cystic fibrosis			
25869324		"1.1: 64%
1.3: 82%
2.1: 94%
3.4: 86%"	2021-05-12T02:03:35.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
25884905		"1.1: 88%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-12T01:50:35.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
25952747		"1.1: 69%
1.3: 84%
2.1: 95%
3.4: 93%"	2021-05-12T04:42:55.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
26002942		"1.5. Influence of Geography or the Environment 

1.1: 45%
1.3: 97%
2.1: 42%
3.4: 97%"	2021-05-12T00:35:45.000Z	curator1	cystic fibrosis		0.3. OTHER	
26324893		"closest would be 3.2. Drug Mechanism but this paper is broadly about a drug delivery method (CF is mentioned as an example disease that could benefit)

1.1: 91%
1.3: 69%
2.1: 84%
3.4: 93%"	2021-05-12T00:25:04.000Z	curator1	cystic fibrosis		0.3. OTHER	
26336603		"1.1: 39%
1.3: 95%
2.1: 50%
3.4: 97%"	2021-05-12T04:40:09.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26432887		"and 2.3. Non in-vivo Human or non-human model system

1.1: 90%
1.3: 95%
2.1: 72%
3.4: 94%"	2021-05-13T18:11:44.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	0.3. OTHER
26459101		"1.1: 87%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-11T03:02:24.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
26545902		"3.2. Drug Mechanism

1.1: 91%
1.3: 95%
2.1: 77%
3.4: 93%"	2021-05-11T05:04:51.000Z	curator1	cystic fibrosis		0.3. OTHER	
26566905		"3.2. Drug Mechanism

1.1: 90%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-12T14:35:47.000Z	curator1	cystic fibrosis		0.3. OTHER	
26615753		"1.1: 88%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-11T05:06:47.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
26823603		"3.2. Drug Mechanism

1.1: 90%
1.3: 95%
2.1: 77%
3.4: 93%"	2021-05-12T15:29:03.000Z	curator1	cystic fibrosis		0.3. OTHER	
26824272		"1.1: 69%
1.3: 95%
2.1: 80%
3.4: 97%"	2021-05-12T04:24:24.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26866983		"3.2. Drug Mechanism

1.1: 91%
1.3: 92%
2.1: 35%
3.4: 93%"	2021-05-11T03:02:03.000Z	curator1	cystic fibrosis		0.3. OTHER	
26874684		"1.1: 87%
1.3: 95%
2.1: 82%
3.4: 93%"	2021-05-12T15:08:30.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
26902541		"1.1: 70%
1.3: 90%
2.1: 96%
3.4: 95%"	2021-05-13T18:13:41.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26912180		"and 3.1. Therapeutic Hypothesis

1.1: 91%
1.3: 95%
2.1: 27%
3.4: 95%"	2021-05-12T04:44:03.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	0.3. OTHER
27104944		"3.2. Drug Mechanism

1.1: 93%
1.3: 94%
2.1: 44%
3.4: 93%"	2021-05-12T04:16:27.000Z	curator1	cystic fibrosis		0.3. OTHER	
27131402		"1.1: 83%
1.3: 95%
2.1: 73%
3.4: 96%"	2021-05-12T01:06:29.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27146408		"1.1: 88%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-11T03:02:57.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
27216780		"1.1: 75%
1.3: 92%
2.1: 87%
3.4: 96%"	2021-05-12T00:30:56.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27244789		"1.1: 83%
1.3: 90%
2.1: 90%
3.4: 95%"	2021-05-12T04:18:22.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27273679		"1.1: 77%
1.3: 69%
2.1: 98%
3.4: 89%"	2021-05-13T18:17:50.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
27309270		"1.1: 83%
1.3: 86%
2.1: 94%
3.4: 95%"	2021-05-12T04:42:00.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27334591		"1.1: 88%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-12T01:41:40.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
27383205		"3.2. Drug Mechanism

1.1: 93%
1.3: 90%
2.1: 8%
3.4: 92%"	2021-05-12T00:48:48.000Z	curator1	cystic fibrosis		0.3. OTHER	
27585963		"3.2. Drug Mechanism (PK and tox)

1.1: 53%
1.3: 42%
2.1: 97%
3.4: 92%"	2021-05-12T13:53:14.000Z	curator1	cystic fibrosis		0.3. OTHER	
27586172		"1.1: 79%
1.3: 96%
2.1: 60%
3.4: 96%"	2021-05-13T18:04:46.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27590641		"1.1: 57%
1.3: 7%
2.1: 98%
3.4: 94%"	2021-05-13T18:17:42.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
27640901		"1.1: 82%
1.3: 17%
2.1: 89%
3.4: 96%"	2021-05-12T04:18:36.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
27784762		"and 3.2. Drug Mechanism

1.1: 89%
1.3: 94%
2.1: 64%
3.4: 95%"	2021-05-11T05:02:46.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	0.3. OTHER
27799352		"1.1: 88%
1.3: 95%
2.1: 80%
3.4: 94%"	2021-05-12T01:16:00.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
27820964	True	"review

1.1: 88%
1.3: 57%
2.1: 96%
3.4: 87%"	2021-05-12T00:30:05.000Z	curator1	cystic fibrosis			
27895116		"3.2. Drug Mechanism

1.1: 89%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-12T04:39:14.000Z	curator1	cystic fibrosis		0.3. OTHER	
27908697		"1.1: 38%
1.3: 96%
2.1: 33%
3.4: 97%"	2021-05-12T01:39:51.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28040058		"1.1: 74%
1.3: 96%
2.1: 85%
3.4: 94%"	2021-05-11T02:49:03.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
28231891	True	"review

1.1: 84%
1.3: 47%
2.1: 97%
3.4: 91%"	2021-05-12T00:45:04.000Z	curator1	cystic fibrosis			
28245352		"1.1: 76%
1.3: 78%
2.1: 94%
3.4: 89%"	2021-05-12T14:28:59.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
28633068		"tough, this could be 1.1 because it describes a system that could be used for diagnostics maybe

1.1: 83%
1.3: 95%
2.1: 4%
3.4: 96%"	2021-05-11T12:48:06.000Z	curator1	cystic fibrosis			
28726496		"3.3. Preclinical Therapeutics

1.1: 88%
1.3: 96%
2.1: 72%
3.4: 95%"	2021-05-12T01:33:04.000Z	curator1	cystic fibrosis		0.3. OTHER	
28819878		"1.1: 3%
1.3: 6%
2.1: 98%
3.4: 95%"	2021-05-11T12:48:47.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
28856720		"1.1: 74%
1.3: 86%
2.1: 96%
3.4: 95%"	2021-05-12T00:42:31.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28974743		"1.1: 89%
1.3: 95%
2.1: 77%
3.4: 94%"	2021-05-11T03:05:47.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
29091392		"3.2. Drug Mechanism

1.1: 89%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-12T14:24:53.000Z	curator1	cystic fibrosis		0.3. OTHER	
29099689		"1.1: 88%
1.3: 96%
2.1: 78%
3.4: 94%"	2021-05-12T04:45:07.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
29122084		"1.1: 66%
1.3: 95%
2.1: 76%
3.4: 97%"	2021-05-12T15:11:54.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29146575		"3.2. Drug Mechanism

1.1: 93%
1.3: 92%
2.1: 60%
3.4: 92%"	2021-05-11T02:34:18.000Z	curator1	cystic fibrosis		0.3. OTHER	
29154969		"1.1: 81%
1.3: 88%
2.1: 93%
3.4: 95%"	2021-05-12T14:27:55.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	3.4. PATIENT-BASED THERAPEUTICS
29155399		"3.2. Drug Mechanism

1.1: 90%
1.3: 93%
2.1: 40%
3.4: 94%"	2021-05-11T03:00:27.000Z	curator1	cystic fibrosis		0.3. OTHER	
29155707		"analytical method --> 3.2. Drug Mechanism

1.1: 91%
1.3: 94%
2.1: 23%
3.4: 94%"	2021-05-12T00:28:46.000Z	curator1	cystic fibrosis		0.3. OTHER	
29217756	True	"paper about cataracts

1.1: 88%
1.3: 92%
2.1: 24%
3.4: 96%"	2021-05-12T04:25:55.000Z	curator1	cystic fibrosis			
29377174		"1.5. Influence of Geography or the Environment

1.1: 31%
1.3: 95%
2.1: 61%
3.4: 97%"	2021-05-12T04:14:12.000Z	curator1	cystic fibrosis		0.3. OTHER	
29405664		"1.1: 82%
1.3: 90%
2.1: 91%
3.4: 96%"	2021-05-12T04:30:31.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29429040		"1.1: 47%
1.3: 90%
2.1: 94%
3.4: 97%"	2021-05-11T12:45:38.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29437698		"1.1: 20%
1.3: 95%
2.1: 40%
3.4: 98%"	2021-05-13T18:19:11.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29557081		"1.1: 29%
1.3: 48%
2.1: 98%
3.4: 96%"	2021-05-11T02:41:51.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
29560543		"1.1: 94%
1.3: 72%
2.1: 75%
3.4: 92%"	2021-05-12T14:25:50.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
29572268		"1.1: 89%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-12T00:44:29.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
29573520		"1.1: 9%
1.3: 21%
2.1: 98%
3.4: 94%"	2021-05-11T02:59:58.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29685813		"1.1: 93%
1.3: 10%
2.1: 94%
3.4: 53%"	2021-05-11T05:10:26.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
29709046		"and/or 1.2. Quality of Life

1.1: 72%
1.3: 51%
2.1: 97%
3.4: 95%"	2021-05-12T14:11:55.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.3. OTHER
29720874		"1.2. Quality of Life

1.1: 76%
1.3: 57%
2.1: 96%
3.4: 94%"	2021-05-12T01:30:22.000Z	curator1	cystic fibrosis		0.3. OTHER	
29720915		"Not sure, this is 1.3 (sort of ) but also 1.4. Epidemiology but also just health care utilization associated with a new formulation of a drug

1.1: 77%
1.3: 64%
2.1: 91%
3.4: 95%"	2021-05-12T15:24:35.000Z	curator1	cystic fibrosis			
29788934		"and 0.2. Related Diseases 

1.1: 58%
1.3: 97%
2.1: 45%
3.4: 97%"	2021-05-13T18:18:16.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.3. OTHER
29799376		"This one is very weird, but seems to be evaluating the effectiveness of therapeutic education programs

1.1: 49%
1.3: 81%
2.1: 95%
3.4: 95%"	2021-05-11T02:51:45.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
29941318		"1.1: 50%
1.3: 97%
2.1: 59%
3.4: 97%"	2021-05-12T01:45:07.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30005381		"1.1: 72%
1.3: 97%
2.1: 56%
3.4: 97%"	2021-05-13T18:04:25.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30165811		"1.1: 79%
1.3: 96%
2.1: 80%
3.4: 96%"	2021-05-12T01:44:37.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
30212240		"1.1: 93%
1.3: 94%
2.1: 58%
3.4: 92%"	2021-05-12T04:35:53.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
30244592	True	"SR=review

1.1: 53%
1.3: 88%
2.1: 92%
3.4: 97%"	2021-05-12T04:12:03.000Z	curator1	cystic fibrosis			
30315867	True	"irrelevant study (picked up because of CFTR) about fish acclimating to salinity

1.1: 87%
1.3: 96%
2.1: 77%
3.4: 95%"	2021-05-12T04:15:38.000Z	curator1	cystic fibrosis			
30416447		"3.2. Drug Mechanism

1.1: 90%
1.3: 95%
2.1: 65%
3.4: 94%"	2021-05-11T02:59:12.000Z	curator1	cystic fibrosis		0.3. OTHER	
30538676		"1.1: 88%
1.3: 95%
2.1: 82%
3.4: 93%"	2021-05-12T15:13:02.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
30620050		"1.1: 63%
1.3: 77%
2.1: 90%
3.4: 98%"	2021-05-12T15:35:37.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30624737		"3.2. Drug Mechanism

1.1: 92%
1.3: 93%
2.1: 59%
3.4: 93%"	2021-05-12T15:24:00.000Z	curator1	cystic fibrosis		0.3. OTHER	
30770405		"3.2. Drug Mechanism

1.1: 88%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-12T01:35:24.000Z	curator1	cystic fibrosis		0.3. OTHER	
30787964		"1.1: 80%
1.3: 79%
2.1: 97%
3.4: 89%"	2021-05-11T12:15:52.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
30853372		"1.5. Influence of Geography or the Environment

1.1: 59%
1.3: 93%
2.1: 82%
3.4: 98%"	2021-05-12T01:57:45.000Z	curator1	cystic fibrosis		0.3. OTHER	
30897407		"3.2. Drug Mechanism (drug delivery)

1.1: 91%
1.3: 95%
2.1: 55%
3.4: 95%"	2021-05-12T15:12:04.000Z	curator1	cystic fibrosis		0.3. OTHER	
30910901		"3.2. Drug Mechanism

1.1: 93%
1.3: 85%
2.1: 14%
3.4: 92%"	2021-05-12T14:17:25.000Z	curator1	cystic fibrosis		0.3. OTHER	
30968646		"1.1: 43%
1.3: 20%
2.1: 98%
3.4: 96%"	2021-05-12T04:12:40.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
31027440		"1.1: 75%
1.3: 93%
2.1: 90%
3.4: 97%"	2021-05-11T03:03:36.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31123864		"3.2. Drug Mechanism

1.1: 89%
1.3: 95%
2.1: 67%
3.4: 95%"	2021-05-12T00:45:33.000Z	curator1	cystic fibrosis		0.3. OTHER	
31166553		"1.1: 14%
1.3: 80%
2.1: 92%
3.4: 96%"	2021-05-12T14:29:10.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
31181018		"Not sure about this one, maybe 1.2. Quality of Life?? or 1.1???

1.1: 5%
1.3: 61%
2.1: 97%
3.4: 96%"	2021-05-13T18:05:29.000Z	curator1	cystic fibrosis			
31214142		"1.1: 87%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-11T04:58:13.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
31227724		"2.3. Non in-vivo Human or non-human model system

1.1: 92%
1.3: 94%
2.1: 57%
3.4: 95%"	2021-05-12T04:42:21.000Z	curator1	cystic fibrosis		0.3. OTHER	
31234038		"1.1: 75%
1.3: 39%
2.1: 98%
3.4: 91%"	2021-05-11T03:03:12.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
31234848		"not sure what category fits best here, maybe 1.2. Quality of Life 

1.1: 26%
1.3: 84%
2.1: 96%
3.4: 96%"	2021-05-12T15:22:40.000Z	curator1	cystic fibrosis			
31405730		"not completely clear if 1.3 vs 3.4 

1.1: 90%
1.3: 59%
2.1: 96%
3.4: 81%"	2021-05-11T12:49:33.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
31413336		"and 2.3. Non in-vivo Human or non-human model system

1.1: 89%
1.3: 96%
2.1: 77%
3.4: 95%"	2021-05-11T05:01:26.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	0.3. OTHER
31420175		"1.1: 77%
1.3: 75%
2.1: 97%
3.4: 92%"	2021-05-12T00:44:41.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
31767727		"2.3. Non in-vivo Human or non-human model system

1.1: 91%
1.3: 90%
2.1: 29%
3.4: 92%"	2021-05-12T04:20:03.000Z	curator1	cystic fibrosis		0.3. OTHER	
31851705		"biomarkers

1.1: 47%
1.3: 97%
2.1: 43%
3.4: 95%"	2021-05-11T12:18:42.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31955962		"1.1: 67%
1.3: 82%
2.1: 96%
3.4: 95%"	2021-05-11T02:53:42.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32096543		"1.1: 90%
1.3: 95%
2.1: 73%
3.4: 94%"	2021-05-11T05:10:13.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
32115388	True	"guidelines=review

1.1: 62%
1.3: 72%
2.1: 96%
3.4: 96%"	2021-05-12T01:30:29.000Z	curator1	cystic fibrosis			
32147452		"1.1: 79%
1.3: 69%
2.1: 97%
3.4: 91%"	2021-05-11T12:19:21.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
32202999		"and 1.4. Epidemiology

1.1: 84%
1.3: 90%
2.1: 93%
3.4: 95%"	2021-05-11T03:05:24.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.3. OTHER
32206879		"1.1: 81%
1.3: 97%
2.1: 75%
3.4: 96%"	2021-05-12T01:36:13.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
32217535		"seems like a study protocol, no data provided

1.1: 67%
1.3: 87%
2.1: 96%
3.4: 96%"	2021-05-12T00:47:38.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32286879		"1.1: 70%
1.3: 97%
2.1: 81%
3.4: 96%"	2021-05-11T05:00:00.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
32443033		"0.2. Related Diseases

1.1: 35%
1.3: 70%
2.1: 97%
3.4: 96%"	2021-05-12T01:11:59.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.3. OTHER
32443413		"1.1: 86%
1.3: 95%
2.1: 49%
3.4: 94%"	2021-05-12T04:20:45.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
32446590		"1.1: 46%
1.3: 59%
2.1: 98%
3.4: 94%"	2021-05-13T18:15:07.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
32457736		"1.1: 88%
1.3: 94%
2.1: 79%
3.4: 93%"	2021-05-12T14:35:16.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
32496469	True	"like a review (position statement/expert opinion)

1.1: 81%
1.3: 45%
2.1: 94%
3.4: 96%"	2021-05-11T05:05:49.000Z	curator1	cystic fibrosis			
32496689	True	"seems like a review

1.1: 93%
1.3: 90%
2.1: 31%
3.4: 94%"	2021-05-12T14:28:38.000Z	curator1	cystic fibrosis			
32528528		"1.1: 86%
1.3: 96%
2.1: 70%
3.4: 96%"	2021-05-12T14:32:16.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
32540806		"1.1: 79%
1.3: 83%
2.1: 78%
3.4: 75%"	2021-05-12T00:42:42.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
32550075		"and 1.3?

1.1: 72%
1.3: 68%
2.1: 96%
3.4: 96%"	2021-05-12T15:17:19.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32578674		"and 1.2. Quality of Life

1.1: 81%
1.3: 86%
2.1: 96%
3.4: 94%"	2021-05-12T14:16:28.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.3. OTHER
32583228		"1.1: 54%
1.3: 52%
2.1: 98%
3.4: 93%"	2021-05-12T04:36:49.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
32634088		"1.1: 87%
1.3: 96%
2.1: 78%
3.4: 95%"	2021-05-12T14:09:16.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
32636299	True	"guideline=review

1.1: 69%
1.3: 86%
2.1: 90%
3.4: 97%"	2021-05-11T12:40:55.000Z	curator1	cystic fibrosis			
32649218		"1.4. Epidemiology ... access to health care based on socioeconomic factors

1.1: 15%
1.3: 28%
2.1: 98%
3.4: 96%"	2021-05-12T15:33:03.000Z	curator1	cystic fibrosis		0.3. OTHER	
32673287		"3.2. Drug Mechanism

1.1: 93%
1.3: 93%
2.1: 48%
3.4: 93%"	2021-05-12T02:03:52.000Z	curator1	cystic fibrosis		0.3. OTHER	
32678679		"1.1: 73%
1.3: 87%
2.1: 93%
3.4: 96%"	2021-05-12T15:14:27.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32777524		"1.1: 83%
1.3: 96%
2.1: 82%
3.4: 95%"	2021-05-12T00:28:08.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
32779423		"1.1: 10%
1.3: 40%
2.1: 98%
3.4: 96%"	2021-05-12T04:13:33.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32802823		"1.1: 94%
1.3: 17%
2.1: 95%
3.4: 68%"	2021-05-12T14:35:29.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
32819967		"1.1: 86%
1.3: 95%
2.1: 81%
3.4: 94%"	2021-05-12T00:44:42.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
32841845		"1.1: 83%
1.3: 87%
2.1: 94%
3.4: 95%"	2021-05-11T04:57:02.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32873215		"1.1: 89%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-12T04:43:56.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
32900780		"1.1: 6%
1.3: 78%
2.1: 97%
3.4: 96%"	2021-05-12T15:18:22.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32920566		"SR/MA=review

1.1: 45%
1.3: 94%
2.1: 88%
3.4: 97%"	2021-05-12T15:33:45.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32923987		"1.1: 89%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-11T02:47:52.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
32936026		"and 3.2. Drug Mechanism

1.1: 89%
1.3: 95%
2.1: 78%
3.4: 93%"	2021-05-12T15:26:49.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	0.3. OTHER
32973305		"1.1: 60%
1.3: 89%
2.1: 93%
3.4: 97%"	2021-05-13T18:21:00.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33065460		"2.3. Non in-vivo Human or non-human model system

1.1: 59%
1.3: 88%
2.1: 95%
3.4: 96%"	2021-05-12T01:10:40.000Z	curator1	cystic fibrosis		0.3. OTHER	
33093640		"1.1: 68%
1.3: 96%
2.1: 85%
3.4: 95%"	2021-05-12T04:46:33.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
33126875		"1.1: 67%
1.3: 86%
2.1: 96%
3.4: 93%"	2021-05-12T01:52:19.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33225638		"1.1: 90%
1.3: 41%
2.1: 97%
3.4: 81%"	2021-05-12T04:35:50.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
33341406		"1.1: 95%
1.3: 2%
2.1: 92%
3.4: 47%"	2021-05-12T14:13:12.000Z	curator1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
33381950		"1.1: 84%
1.3: 85%
2.1: 95%
3.4: 94%"	2021-05-13T18:16:48.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33445178		"1.1: 75%
1.3: 89%
2.1: 94%
3.4: 95%"	2021-05-11T03:04:19.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33464574		"1.1: 44%
1.3: 12%
2.1: 98%
3.4: 96%"	2021-05-12T00:43:18.000Z	curator1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
33480170		"this one is weird, could almost be 1.3

1.1: 19%
1.3: 78%
2.1: 96%
3.4: 96%"	2021-05-11T12:15:28.000Z	curator1	cystic fibrosis			
33656158		"1.1: 82%
1.3: 89%
2.1: 93%
3.4: 95%"	2021-05-12T00:41:33.000Z	curator1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33677604	True	"seems like a review

1.1: 69%
1.3: 97%
2.1: 40%
3.4: 97%"	2021-05-13T18:08:39.000Z	curator1	cystic fibrosis			
33684254		"1.1: 88%
1.3: 96%
2.1: 70%
3.4: 95%"	2021-05-12T15:15:53.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
33684631		"Maybe 3.2. Drug Mechanism ? Proof of concept toward patient-derived stem cell therapy

1.1: 88%
1.3: 95%
2.1: 50%
3.4: 96%"	2021-05-12T01:56:29.000Z	curator1	cystic fibrosis		0.3. OTHER	
33707642		"1.1: 90%
1.3: 95%
2.1: 70%
3.4: 95%"	2021-05-11T12:41:25.000Z	curator1	cystic fibrosis		2.1. DISEASE MECHANISM	
33713665		"3.2. Drug Mechanism

1.1: 89%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-12T04:27:22.000Z	curator1	cystic fibrosis		0.3. OTHER	
33716293	True	"review

1.1: 51%
1.3: 91%
2.1: 95%
3.4: 97%"	2021-05-12T00:36:29.000Z	curator1	cystic fibrosis			
19703826		"1.1: 90%
1.3: 26%
2.1: 97%
3.4: 82%"	2021-05-11T00:24:07.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
19762476		"1.1: 85%
1.3: 95%
2.1: 26%
3.4: 96%"	2021-05-09T21:54:37.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
19808995		"1.1: 91%
1.3: 94%
2.1: 73%
3.4: 93%"	2021-05-11T01:03:11.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
19923167		"1.1: 86%
1.3: 95%
2.1: 74%
3.4: 95%"	2021-05-11T00:41:19.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20030794		"1.1: 13%
1.3: 93%
2.1: 36%
3.4: 98%

surgery = treatment"	2021-05-11T01:02:37.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
20031113		"1.1: 75%
1.3: 85%
2.1: 91%
3.4: 97%

It discusses a novel c.4434insA mutation in exon 24 of CFTR"	2021-05-09T21:36:48.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20032308		"1.1: 85%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-09T21:44:21.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20052366		"1.1: 67%
1.3: 96%
2.1: 84%
3.4: 95%"	2021-05-11T01:09:21.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20080093		"1.1: 95%
1.3: 71%
2.1: 35%
3.4: 92%"	2021-05-11T01:27:58.000Z	curator2	cystic fibrosis			
20093376		"1.1: 78%
1.3: 97%
2.1: 52%
3.4: 96%"	2021-05-11T01:31:35.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20099136		"1.1: 86%
1.3: 96%
2.1: 63%
3.4: 96%"	2021-05-11T01:03:20.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20142516		"1.1: 87%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-11T00:49:40.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20309575		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-11T01:23:57.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20346358		"1.1: 87%
1.3: 96%
2.1: 82%
3.4: 94%"	2021-05-11T00:39:33.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20495106		"1.1: 53%
1.3: 87%
2.1: 94%
3.4: 96%"	2021-05-11T02:05:39.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20519934		"1.1: 88%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-11T01:17:54.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20569877		"1.1: 91%
1.3: 53%
2.1: 94%
3.4: 80%"	2021-05-09T21:41:53.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
20692461		"1.1: 75%
1.3: 76%
2.1: 97%
3.4: 91%"	2021-05-11T01:11:12.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
20714107		"1.1: 89%
1.3: 94%
2.1: 76%
3.4: 93%"	2021-05-11T02:20:43.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20717170		"1.1: 59%
1.3: 96%
2.1: 87%
3.4: 94%"	2021-05-11T01:29:03.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20718961		"1.1: 59%
1.3: 3%
2.1: 98%
3.4: 96%"	2021-05-11T02:19:16.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20802934		"1.1: 67%
1.3: 85%
2.1: 91%
3.4: 96%"	2021-05-11T01:10:23.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20858417		"1.1: 89%
1.3: 93%
2.1: 46%
3.4: 93%"	2021-05-11T00:24:19.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20927127		"1.1: 80%
1.3: 96%
2.1: 82%
3.4: 95%"	2021-05-11T02:05:12.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20933420		"1.1: 88%
1.3: 96%
2.1: 79%
3.4: 94%"	2021-05-11T00:44:16.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
20947455		"1.1: 67%
1.3: 55%
2.1: 98%
3.4: 92%"	2021-05-11T00:50:32.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
20961363		"1.1: 90%
1.3: 95%
2.1: 69%
3.4: 93%"	2021-05-11T02:17:56.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
21038076		"1.1: 91%
1.3: 94%
2.1: 45%
3.4: 94%"	2021-05-11T01:23:32.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
21086027		"1.1: 71%
1.3: 89%
2.1: 95%
3.4: 96%"	2021-05-11T00:55:07.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21220217		"1.1: 38%
1.3: 74%
2.1: 96%
3.4: 93%

I actually think this is a clinical trial - they have controls, treatment. is exercise (cycle ergometry)."	2021-05-09T21:58:19.000Z	curator2	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
21238636		"1.1: 89%
1.3: 95%
2.1: 56%
3.4: 95%"	2021-05-11T02:11:42.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
21317431		"1.1: 46%
1.3: 10%
2.1: 98%
3.4: 94%"	2021-05-11T02:13:28.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21323339		"1.1: 86%
1.3: 96%
2.1: 69%
3.4: 96%"	2021-05-11T01:28:24.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
21361784		"1.1: 90%
1.3: 1%
2.1: 95%
3.4: 88%"	2021-05-09T21:37:26.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
21383017		"1.1: 89%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-11T02:01:33.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
21398685		"1.1: 70%
1.3: 85%
2.1: 95%
3.4: 96%"	2021-05-11T00:44:12.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21420082		"1.1: 88%
1.3: 95%
2.1: 78%
3.4: 93%"	2021-05-09T21:53:02.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
21507732		"1.1: 39%
1.3: 96%
2.1: 81%
3.4: 95%"	2021-05-11T00:53:15.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
21518885		"1.1: 80%
1.3: 96%
2.1: 51%
3.4: 97%"	2021-05-11T01:35:16.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
21547740		"1.1: 89%
1.3: 94%
2.1: 3%
3.4: 96%"	2021-05-11T01:33:27.000Z	curator2	cystic fibrosis			
21562128		"1.1: 89%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-11T01:05:32.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
21620114		"1.1: 84%
1.3: 78%
2.1: 96%
3.4: 89%"	2021-05-09T21:55:41.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
21627902		"1.1: 77%
1.3: 86%
2.1: 95%
3.4: 96%"	2021-05-11T02:09:37.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21629788		"1.1: 57%
1.3: 92%
2.1: 94%
3.4: 97%

Does not fit in a specific category - the paper examines ""the application of a two-part statistic to identify taxa that differ between two group"""	2021-05-09T21:50:49.000Z	curator2	cystic fibrosis			
21779371		"1.1: 88%
1.3: 95%
2.1: 70%
3.4: 95%"	2021-05-11T00:38:33.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
21829484		"1.1: 34%
1.3: 97%
2.1: 26%
3.4: 97%"	2021-05-11T01:06:15.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
21883527		"1.1: 88%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-11T01:10:02.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
21966295		"1.1: 83%
1.3: 96%
2.1: 75%
3.4: 96%"	2021-05-11T01:29:11.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
21984237		"1.1: 86%
1.3: 95%
2.1: 81%
3.4: 94%"	2021-05-11T01:32:25.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22070931		"1.1: 89%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-11T02:06:41.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22174830		"1.1: 91%
1.3: 94%
2.1: 62%
3.4: 95%"	2021-05-11T01:30:24.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22191729		"1.1: 0%
1.3: 96%
2.1: 77%
3.4: 96%"	2021-05-11T02:01:15.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22194755		"1.1: 49%
1.3: 96%
2.1: 86%
3.4: 94%"	2021-05-11T00:34:14.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22256443		"1.1: 81%
1.3: 84%
2.1: 94%
3.4: 95%"	2021-05-11T01:07:43.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22298109		"1.1: 84%
1.3: 96%
2.1: 77%
3.4: 95%"	2021-05-11T01:23:48.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22315512		"1.1: 88%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-11T00:42:42.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22333903		"1.1: 15%
1.3: 93%
2.1: 88%
3.4: 98%

Are surveys considered as ""other"""	2021-05-11T02:10:52.000Z	curator2	cystic fibrosis			
22396015		"1.1: 87%
1.3: 96%
2.1: 75%
3.4: 95%"	2021-05-11T02:14:42.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22427533		"1.1: 29%
1.3: 97%
2.1: 55%
3.4: 97%"	2021-05-11T01:30:13.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22433258		"1.1: 42%
1.3: 78%
2.1: 96%
3.4: 93%"	2021-05-11T01:11:35.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22448327		"1.1: 50%
1.3: 97%
2.1: 49%
3.4: 97%"	2021-05-11T01:11:57.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22554673		"1.1: 88%
1.3: 49%
2.1: 97%
3.4: 83%"	2021-05-11T02:07:50.000Z	curator2	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
22582115		"1.1: 90%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-11T01:23:52.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22617161		"1.1: 10%
1.3: 97%
2.1: 68%
3.4: 98%

No patients mentioned."	2021-05-11T02:00:40.000Z	curator2	cystic fibrosis			
22653767		"1.1: 83%
1.3: 85%
2.1: 94%
3.4: 94%"	2021-05-11T01:03:44.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22679004		"1.1: 86%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-11T01:13:15.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22727329		"1.1: 47%
1.3: 90%
2.1: 96%
3.4: 96%"	2021-05-11T01:16:27.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22747891		"1.1: 35%
1.3: 95%
2.1: 53%
3.4: 97%"	2021-05-11T00:25:35.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22856641		"1.1: 86%
1.3: 3%
2.1: 96%
3.4: 91%"	2021-05-11T01:15:54.000Z	curator2	cystic fibrosis			
22898134		"1.1: 78%
1.3: 95%
2.1: 67%
3.4: 95%"	2021-05-11T02:09:50.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22923315		"1.1: 89%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-11T01:20:10.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22928917		"1.1: 90%
1.3: 94%
2.1: 76%
3.4: 94%"	2021-05-09T21:54:45.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
22930931		"1.1: 91%
1.3: 14%
2.1: 92%
3.4: 92%"	2021-05-11T02:00:54.000Z	curator2	cystic fibrosis			
22936895	True	"1.1: 95%
1.3: 56%
2.1: 82%
3.4: 88%

Review"	2021-05-11T02:18:39.000Z	curator2	cystic fibrosis			
22966014		"1.1: 87%
1.3: 94%
2.1: 77%
3.4: 93%"	2021-05-09T21:46:19.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
23090599		"1.1: 91%
1.3: 93%
2.1: 64%
3.4: 94%"	2021-05-11T01:26:45.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
23104983		"1.1: 91%
1.3: 95%
2.1: 70%
3.4: 93%"	2021-05-11T01:20:13.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
23195144		"1.1: 80%
1.3: 86%
2.1: 95%
3.4: 94%"	2021-05-11T02:16:33.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23217263		"1.1: 84%
1.3: 88%
2.1: 93%
3.4: 95%"	2021-05-11T00:47:04.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23271804		"1.1: 85%
1.3: 96%
2.1: 75%
3.4: 95%"	2021-05-11T00:52:33.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
23316740		"1.1: 87%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-11T01:13:20.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
23354748		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-11T01:29:43.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
23361110		"1.1: 85%
1.3: 90%
2.1: 93%
3.4: 95%"	2021-05-11T00:41:13.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23390474		"1.1: 84%
1.3: 87%
2.1: 95%
3.4: 94%"	2021-05-11T01:34:16.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23504457		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-11T00:50:33.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
23528342		"1.1: 67%
1.3: 97%
2.1: 67%
3.4: 96%"	2021-05-11T01:59:07.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
23626828		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-11T02:20:51.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
23636454		"1.1: 88%
1.3: 95%
2.1: 82%
3.4: 94%"	2021-05-11T01:17:26.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
23651180		"1.1: 22%
1.3: 96%
2.1: 40%
3.4: 97%"	2021-05-11T01:25:56.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23719852		"1.1: 36%
1.3: 96%
2.1: 53%
3.4: 97%

I unchecked clinical characteristics as I think this is a preclinical study."	2021-05-11T00:38:29.000Z	curator2	cystic fibrosis			
23757023		"1.1: 90%
1.3: 93%
2.1: 46%
3.4: 94%"	2021-05-09T21:46:13.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
23789012		"1.1: 77%
1.3: 78%
2.1: 95%
3.4: 96%"	2021-05-09T21:48:05.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23815177		"1.1: 87%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-11T01:29:14.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
23874059		"1.1: 76%
1.3: 90%
2.1: 94%
3.4: 95%

I would leave blank. Paper is about QoL"	2021-05-09T21:44:52.000Z	curator2	cystic fibrosis			
23910813		"1.1: 71%
1.3: 64%
2.1: 98%
3.4: 93%"	2021-05-11T01:01:42.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24004189		"1.1: 85%
1.3: 71%
2.1: 97%
3.4: 88%"	2021-05-11T02:09:21.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24031533		"1.1: 81%
1.3: 96%
2.1: 78%
3.4: 95%"	2021-05-11T01:09:37.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
24068164		"1.1: 81%
1.3: 89%
2.1: 95%
3.4: 94%

I think this is treatment/intervention - inspiratory resistive loading. therefore, this should be patient-based therapeutics."	2021-05-11T02:24:04.000Z	curator2	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
24144711		"1.1: 35%
1.3: 73%
2.1: 97%
3.4: 96%"	2021-05-09T21:47:15.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24209388		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-11T01:07:26.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
24248318		"1.1: 59%
1.3: 73%
2.1: 98%
3.4: 93%"	2021-05-11T01:29:07.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24349537		"1.1: 90%
1.3: 95%
2.1: 72%
3.4: 95%"	2021-05-09T21:34:27.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
24363931		"1.1: 80%
1.3: 88%
2.1: 94%
3.4: 95%"	2021-05-09T21:52:53.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24475974		"1.1: 89%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-11T02:02:54.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
24480974		"1.1: 2%
1.3: 68%
2.1: 96%
3.4: 95%"	2021-05-11T00:43:43.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24520658		"1.1: 81%
1.3: 82%
2.1: 95%
3.4: 96%"	2021-05-11T01:21:52.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24522087		"1.1: 81%
1.3: 90%
2.1: 95%
3.4: 95%"	2021-05-11T00:39:15.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24570764		"1.1: 83%
1.3: 12%
2.1: 96%
3.4: 89%"	2021-05-11T01:09:16.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24576297		"1.1: 46%
1.3: 96%
2.1: 55%
3.4: 97%"	2021-05-11T00:54:59.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24591578		"1.1: 85%
1.3: 95%
2.1: 83%
3.4: 93%"	2021-05-09T21:54:53.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
24594704		"1.1: 88%
1.3: 57%
2.1: 90%
3.4: 94%

Focus of paper is on techniques for glycemic clamps in ferrets"	2021-05-11T02:12:21.000Z	curator2	cystic fibrosis			
24608547	True	"1.1: 79%
1.3: 89%
2.1: 86%
3.4: 97%"	2021-05-11T00:23:43.000Z	curator2	cystic fibrosis			
24608905		"1.1: 87%
1.3: 96%
2.1: 76%
3.4: 95%"	2021-05-11T01:59:24.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
24623294		"1.1: 86%
1.3: 89%
2.1: 93%
3.4: 95%"	2021-05-11T02:05:00.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24656793		"1.1: 57%
1.3: 81%
2.1: 94%
3.4: 97%"	2021-05-11T00:46:05.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24660703		"1.1: 81%
1.3: 93%
2.1: 55%
3.4: 96%"	2021-05-11T02:09:07.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
24716008		"1.1: 88%
1.3: 69%
2.1: 97%
3.4: 87%"	2021-05-09T21:47:40.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24722909		"1.1: 89%
1.3: 95%
2.1: 73%
3.4: 95%"	2021-05-09T21:47:22.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
24762087		"1.1: 51%
1.3: 96%
2.1: 43%
3.4: 96%"	2021-05-11T01:29:34.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
24811693		"1.1: 75%
1.3: 81%
2.1: 95%
3.4: 96%"	2021-05-09T21:53:50.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24816489		"1.1: 89%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-11T02:03:36.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
24908055		"1.1: 50%
1.3: 93%
2.1: 87%
3.4: 98%"	2021-05-11T01:22:03.000Z	curator2	cystic fibrosis			
24927234		"1.1: 84%
1.3: 58%
2.1: 95%
3.4: 91%

drug mechanism"	2021-05-11T01:44:10.000Z	curator2	cystic fibrosis			
24945463		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-11T00:55:32.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
24958810		"1.1: 77%
1.3: 96%
2.1: 86%
3.4: 94%"	2021-05-11T02:10:19.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
24973281		"1.1: 96%
1.3: 46%
2.1: 83%
3.4: 60%"	2021-05-11T01:16:38.000Z	curator2	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
25046147		"1.1: 90%
1.3: 95%
2.1: 72%
3.4: 94%"	2021-05-11T01:31:43.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
25093082	True	"1.1: 91%
1.3: 42%
2.1: 95%
3.4: 88%

Review paper"	2021-05-09T21:42:44.000Z	curator2	cystic fibrosis			
25098631		"1.1: 89%
1.3: 75%
2.1: 96%
3.4: 87%"	2021-05-11T01:58:00.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
25114233		"1.1: 90%
1.3: 94%
2.1: 75%
3.4: 93%"	2021-05-11T00:50:33.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
25125390		"1.1: 93%
1.3: 93%
2.1: 61%
3.4: 91%"	2021-05-11T01:06:48.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
25219836		"1.1: 85%
1.3: 91%
2.1: 92%
3.4: 94%"	2021-05-11T01:34:44.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25222606		"1.1: 44%
1.3: 53%
2.1: 97%
3.4: 94%

Nothing was selected before. This is a paper that looks at breathing aids in CF patients."	2021-05-09T21:52:07.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
25245859		"1.1: 54%
1.3: 87%
2.1: 94%
3.4: 95%"	2021-05-11T00:49:35.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25387861		"1.1: 89%
1.3: 70%
2.1: 96%
3.4: 88%"	2021-05-09T21:44:15.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
25447156		"1.1: 92%
1.3: 95%
2.1: 70%
3.4: 93%

Could also be drug mechanism."	2021-05-09T21:54:59.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
25512598		"1.1: 89%
1.3: 95%
2.1: 75%
3.4: 93%"	2021-05-11T01:35:05.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
25584105		"1.1: 58%
1.3: 92%
2.1: 90%
3.4: 98%"	2021-05-11T02:19:58.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25592657		"1.1: 32%
1.3: 79%
2.1: 96%
3.4: 97%"	2021-05-11T00:50:35.000Z	curator2	cystic fibrosis			
25714328		"1.1: 83%
1.3: 96%
2.1: 50%
3.4: 96%"	2021-05-11T00:41:25.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
25725797		"1.1: 88%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-11T02:17:51.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
25742660		"1.1: 45%
1.3: 95%
2.1: 31%
3.4: 97%"	2021-05-11T02:06:18.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25781545		"1.1: 76%
1.3: 97%
2.1: 82%
3.4: 96%"	2021-05-11T00:53:21.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
25825042		"1.1: 78%
1.3: 96%
2.1: 80%
3.4: 95%"	2021-05-09T21:53:07.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
25865196	True	"1.1: 65%
1.3: 97%
2.1: 45%
3.4: 98%

Review"	2021-05-09T21:42:25.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
25869324		"1.1: 64%
1.3: 82%
2.1: 94%
3.4: 86%"	2021-05-11T01:20:42.000Z	curator2	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
25956447		"1.1: 66%
1.3: 96%
2.1: 86%
3.4: 94%"	2021-05-11T00:36:29.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
25980570		"1.1: 37%
1.3: 55%
2.1: 98%
3.4: 93%

Or could be QoL"	2021-05-11T02:09:59.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26024338		"1.1: 87%
1.3: 96%
2.1: 76%
3.4: 95%"	2021-05-11T01:07:18.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
26093634		"1.1: 74%
1.3: 91%
2.1: 91%
3.4: 97%"	2021-05-11T00:55:26.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26121472		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-11T00:25:39.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
26336603		"1.1: 39%
1.3: 95%
2.1: 50%
3.4: 97%"	2021-05-11T01:33:20.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26361332		"1.1: 87%
1.3: 96%
2.1: 73%
3.4: 95%"	2021-05-11T01:23:37.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
26368820		"1.1: 88%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-11T01:35:11.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
26383784		"1.1: 66%
1.3: 75%
2.1: 98%
3.4: 95%"	2021-05-11T01:21:02.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26432887		"1.1: 90%
1.3: 95%
2.1: 72%
3.4: 94%"	2021-05-11T02:09:54.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
26467139		"1.1: 77%
1.3: 88%
2.1: 93%
3.4: 95%

would likely fall into the QoL category."	2021-05-11T02:21:13.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26566905		"1.1: 90%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-11T02:00:28.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
26633362		"1.1: 88%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-09T21:47:31.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
26635857		"1.1: 90%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-11T01:11:17.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
26715741		"1.1: 71%
1.3: 56%
2.1: 94%
3.4: 95%"	2021-05-09T21:38:04.000Z	curator2	cystic fibrosis			
26824272		"1.1: 69%
1.3: 95%
2.1: 80%
3.4: 97%"	2021-05-11T01:27:13.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26874684		"1.1: 87%
1.3: 95%
2.1: 82%
3.4: 93%"	2021-05-11T02:00:51.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
26879174		"1.1: 90%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-11T02:00:59.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
26902541		"1.1: 70%
1.3: 90%
2.1: 96%
3.4: 95%

Validation of test/tool - is that considered as other?"	2021-05-11T02:11:39.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26990263		"1.1: 62%
1.3: 63%
2.1: 96%
3.4: 92%"	2021-05-11T02:16:19.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
27093165		"1.1: 92%
1.3: 73%
2.1: 59%
3.4: 94%

""Tyr446Asn alteration in penicillin binding protein 2 that appeared responsible for resistance"" identifies a mechanism for resistance to MRSA. Not sure what category this falls into. Drug mechanism?"	2021-05-09T21:35:25.000Z	curator2	cystic fibrosis			
27131402		"1.1: 83%
1.3: 95%
2.1: 73%
3.4: 96%

disease mutations discussed."	2021-05-11T01:08:45.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
27146408		"1.1: 88%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-09T21:49:13.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
27273679		"1.1: 77%
1.3: 69%
2.1: 98%
3.4: 89%"	2021-05-11T02:14:18.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
27324553	True	"1.1: 70%
1.3: 95%
2.1: 72%
3.4: 97%

meta analysis"	2021-05-11T01:39:29.000Z	curator2	cystic fibrosis			
27408752		"1.1: 80%
1.3: 97%
2.1: 78%
3.4: 96%"	2021-05-11T01:57:37.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
27582639		"1.1: 78%
1.3: 95%
2.1: 35%
3.4: 97%"	2021-05-11T02:05:53.000Z	curator2	cystic fibrosis			
27585963		"1.1: 53%
1.3: 42%
2.1: 97%
3.4: 92%"	2021-05-11T01:43:25.000Z	curator2	cystic fibrosis			
27590641		"1.1: 57%
1.3: 7%
2.1: 98%
3.4: 94%"	2021-05-11T02:14:09.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
27628957		"1.1: 73%
1.3: 89%
2.1: 96%
3.4: 95%"	2021-05-11T01:27:25.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27629435		"1.1: 89%
1.3: 94%
2.1: 79%
3.4: 93%"	2021-05-11T01:34:49.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
27784762		"1.1: 89%
1.3: 94%
2.1: 64%
3.4: 95%"	2021-05-09T21:54:49.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
27820964	True	"1.1: 88%
1.3: 57%
2.1: 96%
3.4: 87%

Appears to be a review/ expert commentary"	2021-05-11T00:51:49.000Z	curator2	cystic fibrosis			
27925453		"1.1: 83%
1.3: 91%
2.1: 91%
3.4: 95%"	2021-05-09T21:39:20.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28040058		"1.1: 74%
1.3: 96%
2.1: 85%
3.4: 94%"	2021-05-09T21:42:06.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
28114922		"1.1: 22%
1.3: 75%
2.1: 98%
3.4: 95%

Could also be therapeutics in the clinic b/c there's mention of antibiotics."	2021-05-11T01:19:09.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28178337		"1.1: 6%
1.3: 97%
2.1: 8%
3.4: 98%"	2021-05-11T01:14:39.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28231891	True	"1.1: 84%
1.3: 47%
2.1: 97%
3.4: 91%

review"	2021-05-11T01:05:56.000Z	curator2	cystic fibrosis			
28245352		"1.1: 76%
1.3: 78%
2.1: 94%
3.4: 89%"	2021-05-11T01:57:55.000Z	curator2	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
28348728		"1.1: 62%
1.3: 93%
2.1: 74%
3.4: 97%"	2021-05-11T01:39:52.000Z	curator2	cystic fibrosis			
28406713		"1.1: 93%
1.3: 15%
2.1: 95%
3.4: 75%"	2021-05-11T02:14:48.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
28455785		"1.1: 62%
1.3: 84%
2.1: 95%
3.4: 95%"	2021-05-11T01:22:47.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28523349		"1.1: 86%
1.3: 89%
2.1: 93%
3.4: 94%"	2021-05-11T02:14:36.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28552668		"1.1: 90%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-11T01:01:30.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
28633068		"1.1: 83%
1.3: 95%
2.1: 4%
3.4: 96%"	2021-05-11T00:42:33.000Z	curator2	cystic fibrosis			
28643178		"1.1: 88%
1.3: 44%
2.1: 93%
3.4: 90%"	2021-05-11T01:21:09.000Z	curator2	cystic fibrosis			
28726496		"1.1: 88%
1.3: 96%
2.1: 72%
3.4: 95%"	2021-05-11T01:14:22.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
28756021		"1.1: 73%
1.3: 97%
2.1: 61%
3.4: 97%"	2021-05-11T01:23:43.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
28856720		"1.1: 74%
1.3: 86%
2.1: 96%
3.4: 95%"	2021-05-11T01:03:03.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28926942		"1.1: 91%
1.3: 94%
2.1: 60%
3.4: 93%"	2021-05-11T00:59:38.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
28974743		"1.1: 89%
1.3: 95%
2.1: 77%
3.4: 94%"	2021-05-09T21:53:14.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
29037538		"1.1: 80%
1.3: 85%
2.1: 94%
3.4: 94%"	2021-05-08T20:12:44.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29091392		"1.1: 89%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-11T01:57:12.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
29099689		"1.1: 88%
1.3: 96%
2.1: 78%
3.4: 94%"	2021-05-11T01:40:00.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
29146575		"1.1: 93%
1.3: 92%
2.1: 60%
3.4: 92%"	2021-05-09T21:32:04.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
29154969		"1.1: 81%
1.3: 88%
2.1: 93%
3.4: 95%"	2021-05-11T01:58:15.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29155399		"1.1: 90%
1.3: 93%
2.1: 40%
3.4: 94%"	2021-05-09T21:46:43.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
29168366		"1.1: 82%
1.3: 92%
2.1: 80%
3.4: 97%"	2021-05-11T01:45:05.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
29217756		"1.1: 88%
1.3: 92%
2.1: 24%
3.4: 96%"	2021-05-11T01:27:30.000Z	curator2	cystic fibrosis			
29240302		"1.1: 22%
1.3: 12%
2.1: 98%
3.4: 95%"	2021-05-11T01:45:26.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
29313709		"1.1: 81%
1.3: 31%
2.1: 98%
3.4: 88%"	2021-05-11T02:06:03.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
29520692		"1.1: 13%
1.3: 96%
2.1: 71%
3.4: 96%"	2021-05-11T01:33:54.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
29572268		"1.1: 89%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-11T01:05:27.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
29573520		"1.1: 9%
1.3: 21%
2.1: 98%
3.4: 94%"	2021-05-08T20:13:14.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
29596479		"1.1: 56%
1.3: 84%
2.1: 94%
3.4: 95%"	2021-05-11T02:07:13.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29685813		"1.1: 93%
1.3: 10%
2.1: 94%
3.4: 53%"	2021-05-11T00:24:37.000Z	curator2	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
29709046		"1.1: 72%
1.3: 51%
2.1: 97%
3.4: 95%"	2021-05-11T01:43:30.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29720918		"1.1: 90%
1.3: 54%
2.1: 97%
3.4: 80%"	2021-05-11T02:08:31.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
29728782		"1.1: 41%
1.3: 78%
2.1: 96%
3.4: 97%

These patients received treatment - palivizumab"	2021-05-09T21:41:32.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
29743243		"1.1: 88%
1.3: 94%
2.1: 81%
3.4: 93%"	2021-05-11T02:05:56.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
29788934		"1.1: 58%
1.3: 97%
2.1: 45%
3.4: 97%"	2021-05-11T02:16:50.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29799376		"1.1: 49%
1.3: 81%
2.1: 95%
3.4: 95%

Quality of life?"	2021-05-09T21:43:46.000Z	curator2	cystic fibrosis			
29886024		"1.1: 91%
1.3: 31%
2.1: 96%
3.4: 81%

Phase 3 clinical study."	2021-05-09T21:49:02.000Z	curator2	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
29985939		"1.1: 60%
1.3: 94%
2.1: 89%
3.4: 97%"	2021-05-11T01:12:54.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30034717		"1.1: 86%
1.3: 95%
2.1: 73%
3.4: 94%"	2021-05-11T02:06:36.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
30062052		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-11T02:21:15.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
30100257		"1.1: 88%
1.3: 96%
2.1: 78%
3.4: 95%"	2021-05-11T02:17:59.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
30105497		"1.1: 87%
1.3: 82%
2.1: 82%
3.4: 94%"	2021-05-11T01:20:25.000Z	curator2	cystic fibrosis			
30244233		"1.1: 86%
1.3: 89%
2.1: 93%
3.4: 95%"	2021-05-11T00:35:43.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30244592	True	"1.1: 53%
1.3: 88%
2.1: 92%
3.4: 97%"	2021-05-11T01:21:58.000Z	curator2	cystic fibrosis			
30282922		"1.1: 92%
1.3: 94%
2.1: 29%
3.4: 92%"	2021-05-09T21:55:46.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
30620050		"1.1: 63%
1.3: 77%
2.1: 90%
3.4: 98%"	2021-05-11T02:06:31.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
30689761		"1.1: 17%
1.3: 95%
2.1: 36%
3.4: 98%"	2021-05-11T01:17:43.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30847789		"1.1: 77%
1.3: 91%
2.1: 93%
3.4: 96%

Discusses recent advances using capillary electrophoresis-mass spectrometry"	2021-05-11T01:13:48.000Z	curator2	cystic fibrosis			
31027440		"1.1: 75%
1.3: 93%
2.1: 90%
3.4: 97%"	2021-05-09T21:52:25.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31087253		"1.1: 82%
1.3: 90%
2.1: 93%
3.4: 96%"	2021-05-11T01:13:08.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31117286		"1.1: 88%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-11T01:12:19.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
31122509		"1.1: 1%
1.3: 82%
2.1: 97%
3.4: 97%"	2021-05-11T01:33:47.000Z	curator2	cystic fibrosis			
31127555		"1.1: 86%
1.3: 96%
2.1: 49%
3.4: 96%"	2021-05-11T01:16:05.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
31166553		"1.1: 14%
1.3: 80%
2.1: 92%
3.4: 96%"	2021-05-11T01:58:31.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31181018		"1.1: 5%
1.3: 61%
2.1: 97%
3.4: 96%"	2021-05-11T02:07:45.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31214142		"1.1: 87%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-09T21:53:57.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
31227724		"1.1: 92%
1.3: 94%
2.1: 57%
3.4: 95%"	2021-05-11T01:34:32.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
31234038		"1.1: 75%
1.3: 39%
2.1: 98%
3.4: 91%"	2021-05-09T21:51:11.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
31234848		"1.1: 26%
1.3: 84%
2.1: 96%
3.4: 96%

Nebulizer treatment"	2021-05-11T02:02:49.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
31294114		"1.1: 92%
1.3: 95%
2.1: 70%
3.4: 94%"	2021-05-11T01:09:30.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
31386863		"1.1: 81%
1.3: 93%
2.1: 86%
3.4: 96%"	2021-05-11T01:15:33.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31402602		"1.1: 93%
1.3: 0%
2.1: 94%
3.4: 73%"	2021-05-11T02:03:32.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
31413336		"1.1: 89%
1.3: 96%
2.1: 77%
3.4: 95%"	2021-05-09T21:54:07.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
31420175		"1.1: 77%
1.3: 75%
2.1: 97%
3.4: 92%"	2021-05-11T00:59:33.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
31428412		"1.1: 67%
1.3: 87%
2.1: 96%
3.4: 96%

Could also be disease mechanism - patients were ""p.Phe508del homozygous""."	2021-05-11T01:29:01.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31501050		"1.1: 87%
1.3: 43%
2.1: 97%
3.4: 84%

This paper is more about the pharmacokinetics - drug mechanism."	2021-05-11T02:13:34.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
31613648		"1.1: 93%
1.3: 93%
2.1: 66%
3.4: 92%"	2021-05-11T01:34:54.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
31685468		"1.1: 89%
1.3: 29%
2.1: 95%
3.4: 84%

Drug mechanism"	2021-05-11T00:56:00.000Z	curator2	cystic fibrosis			
31706070		"1.1: 10%
1.3: 81%
2.1: 96%
3.4: 97%"	2021-05-11T01:57:30.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31767727		"1.1: 91%
1.3: 90%
2.1: 29%
3.4: 92%"	2021-05-11T01:24:02.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
31941715		"1.1: 14%
1.3: 92%
2.1: 91%
3.4: 97%"	2021-05-11T01:28:11.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32096543		"1.1: 90%
1.3: 95%
2.1: 73%
3.4: 94%"	2021-05-11T00:24:13.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
32151568		"1.1: 75%
1.3: 42%
2.1: 98%
3.4: 92%"	2021-05-11T02:03:27.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
32162080		"1.1: 74%
1.3: 83%
2.1: 96%
3.4: 95%"	2021-05-11T01:22:53.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32217535		"1.1: 67%
1.3: 87%
2.1: 96%
3.4: 96%"	2021-05-11T01:07:07.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32269886		"1.1: 83%
1.3: 80%
2.1: 96%
3.4: 96%"	2021-05-11T00:36:53.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32443413		"1.1: 86%
1.3: 95%
2.1: 49%
3.4: 94%"	2021-05-11T01:24:51.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
32446590		"1.1: 46%
1.3: 59%
2.1: 98%
3.4: 94%"	2021-05-11T02:11:47.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
32457736		"1.1: 88%
1.3: 94%
2.1: 79%
3.4: 93%"	2021-05-11T01:59:28.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
32466623		"1.1: 83%
1.3: 87%
2.1: 95%
3.4: 94%"	2021-05-11T02:08:13.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32496469	True	"1.1: 81%
1.3: 45%
2.1: 94%
3.4: 96%

reads like a review paper/ expert opinion paper."	2021-05-09T21:56:06.000Z	curator2	cystic fibrosis			
32528528		"1.1: 86%
1.3: 96%
2.1: 70%
3.4: 96%"	2021-05-11T01:59:16.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
32578674		"1.1: 81%
1.3: 86%
2.1: 96%
3.4: 94%"	2021-05-11T01:44:41.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32583228		"1.1: 54%
1.3: 52%
2.1: 98%
3.4: 93%"	2021-05-11T01:31:28.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
32597860		"1.1: 91%
1.3: 92%
2.1: 3%
3.4: 94%"	2021-05-11T02:01:28.000Z	curator2	cystic fibrosis			
32636299	True	"1.1: 69%
1.3: 86%
2.1: 90%
3.4: 97%"	2021-05-11T00:39:24.000Z	curator2	cystic fibrosis			
32673237		"1.1: 75%
1.3: 81%
2.1: 93%
3.4: 93%"	2021-05-11T01:23:27.000Z	curator2	cystic fibrosis			
32802823		"1.1: 94%
1.3: 17%
2.1: 95%
3.4: 68%"	2021-05-11T01:59:55.000Z	curator2	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
32841519	True	"1.1: 80%
1.3: 43%
2.1: 96%
3.4: 92%

commentary"	2021-05-11T02:03:51.000Z	curator2	cystic fibrosis			
32873215		"1.1: 89%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-11T01:39:24.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
32899792		"1.1: 89%
1.3: 95%
2.1: 78%
3.4: 93%"	2021-05-11T01:13:12.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
32900780		"1.1: 6%
1.3: 78%
2.1: 97%
3.4: 96%

Do you consider surveys as clin characteristics or as other?"	2021-05-11T02:02:05.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32933106		"1.1: 87%
1.3: 96%
2.1: 77%
3.4: 95%"	2021-05-11T02:20:46.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
32973305		"1.1: 60%
1.3: 89%
2.1: 93%
3.4: 97%"	2021-05-11T02:19:51.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33010097		"1.1: 79%
1.3: 87%
2.1: 95%
3.4: 95%"	2021-05-11T01:09:58.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33093640		"1.1: 68%
1.3: 96%
2.1: 85%
3.4: 95%"	2021-05-11T01:43:06.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
33126875		"1.1: 67%
1.3: 86%
2.1: 96%
3.4: 93%"	2021-05-11T01:20:06.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33144490		"1.1: 95%
1.3: 90%
2.1: 30%
3.4: 92%"	2021-05-11T00:50:48.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
33202772		"1.1: 89%
1.3: 95%
2.1: 77%
3.4: 94%"	2021-05-11T01:20:47.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
33228110		"1.1: 88%
1.3: 96%
2.1: 72%
3.4: 95%"	2021-05-11T02:09:13.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
33257262	True	"1.1: 33%
1.3: 84%
2.1: 95%
3.4: 97%

guidelines paper"	2021-05-11T01:00:20.000Z	curator2	cystic fibrosis			
33346630		"1.1: 89%
1.3: 55%
2.1: 93%
3.4: 84%

Pharmacokinetics model"	2021-05-11T01:16:47.000Z	curator2	cystic fibrosis			
33390080		"1.1: 28%
1.3: 88%
2.1: 93%
3.4: 94%"	2021-05-11T02:20:39.000Z	curator2	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
33430044		"1.1: 77%
1.3: 97%
2.1: 38%
3.4: 97%"	2021-05-11T02:04:29.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
33445178		"1.1: 75%
1.3: 89%
2.1: 94%
3.4: 95%"	2021-05-09T21:52:38.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33464574		"1.1: 44%
1.3: 12%
2.1: 98%
3.4: 96%

surgery = treatment
also discusses mutations/variants"	2021-05-11T01:05:02.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	2.1. DISEASE MECHANISM
33544657		"1.1: 74%
1.3: 59%
2.1: 93%
3.4: 92%"	2021-05-11T00:33:21.000Z	curator2	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
33553007		"1.1: 78%
1.3: 91%
2.1: 92%
3.4: 96%"	2021-05-11T02:08:38.000Z	curator2	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33569502		"1.1: 82%
1.3: 55%
2.1: 98%
3.4: 88%"	2021-05-11T01:12:55.000Z	curator2	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
33707642		"1.1: 90%
1.3: 95%
2.1: 70%
3.4: 95%"	2021-05-11T00:41:00.000Z	curator2	cystic fibrosis		2.1. DISEASE MECHANISM	
19762476		"1.1: 85%
1.3: 95% testing drug not in humans, drug mech
2.1: 26%
3.4: 96%"	2021-05-12T13:24:56.000Z	curator3	cystic fibrosis			
20032308		"1.1: 85%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-12T13:06:31.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
20858417		"1.1: 89%
1.3: 93%
2.1: 46%
3.4: 93%"	2021-05-12T13:36:15.000Z	curator3	cystic fibrosis			
20936184		"1.1: 91%
1.3: 93%
2.1: 56%
3.4: 94%"	2021-05-12T12:37:53.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
21220217		"1.1: 38%
1.3: 74%
2.1: 96%
3.4: 93%"	2021-05-12T13:32:22.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21259449		"1.1: 76%
1.3: 86%
2.1: 95%
3.4: 96%"	2021-05-12T13:24:08.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21420082		"1.1: 88%
1.3: 95%
2.1: 78%
3.4: 93%"	2021-05-12T13:20:41.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
21556203		"1.1: 28%
1.3: 80%
2.1: 89%
3.4: 96%"	2021-05-12T13:29:40.000Z	curator3	cystic fibrosis			
21620114		"1.1: 84%
1.3: 78%
2.1: 96%
3.4: 89%"	2021-05-12T13:28:56.000Z	curator3	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
21629788		"1.1: 57%
1.3: 92%
2.1: 94%
3.4: 97%
Stats? computation?"	2021-05-12T13:16:23.000Z	curator3	cystic fibrosis			
22007982		"1.1: 47%
1.3: 81%
2.1: 94%
3.4: 97%"	2021-05-12T13:27:59.000Z	curator3	cystic fibrosis			
22194755		"1.1: 49%
1.3: 96%
2.1: 86%
3.4: 94%"	2021-05-12T13:40:15.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
22747891		"1.1: 35%
1.3: 95%
2.1: 53%
3.4: 97%"	2021-05-12T13:37:03.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22946777		"1.1: 65%
1.3: 44%
2.1: 97%
3.4: 94%"	2021-05-12T13:34:19.000Z	curator3	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
23192669		"1.1: 86%
1.3: 88%
2.1: 94%
3.4: 95%"	2021-05-12T13:05:35.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23789012		"1.1: 77%
1.3: 78%
2.1: 95%
3.4: 96%"	2021-05-12T13:12:06.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24106034		"1.1: 63%
1.3: 95%
2.1: 40%
3.4: 97%"	2021-05-12T13:11:29.000Z	curator3	cystic fibrosis			
24144711		"1.1: 35%
1.3: 73%
2.1: 97%
3.4: 96%"	2021-05-12T13:08:29.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24349537		"1.1: 90%
1.3: 95%
2.1: 72%
3.4: 95%"	2021-05-12T12:42:43.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
24363931		"1.1: 80%
1.3: 88%
2.1: 94%
3.4: 95%"	2021-05-12T13:20:11.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24608547		"1.1: 79%
1.3: 89%
2.1: 86%
3.4: 97%"	2021-05-12T13:35:08.000Z	curator3	cystic fibrosis			
24716008		"1.1: 88%
1.3: 69%
2.1: 97%
3.4: 87%"	2021-05-12T13:10:52.000Z	curator3	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24722909		"1.1: 89%
1.3: 95%
2.1: 73%
3.4: 95%"	2021-05-12T13:08:52.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
24782693		"1.1: 88%
1.3: 62%
2.1: 96%
3.4: 89%"	2021-05-12T13:07:07.000Z	curator3	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24811693		"1.1: 75%
1.3: 81%
2.1: 95%
3.4: 96%"	2021-05-12T13:23:07.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25219816		"1.1: 75%
1.3: 84%
2.1: 97%
3.4: 96%"	2021-05-12T12:34:46.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25222606		"1.1: 44%
1.3: 53%
2.1: 97%
3.4: 94%"	2021-05-12T13:19:31.000Z	curator3	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
25825042		"1.1: 78%
1.3: 96%
2.1: 80%
3.4: 95%"	2021-05-12T13:22:34.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
25865196		"1.1: 65%
1.3: 97%
2.1: 45%
3.4: 98%"	2021-05-12T12:48:09.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
26121472		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-12T13:37:31.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
26545902		"1.1: 91%
1.3: 95% drug mech
2.1: 77%
3.4: 93%"	2021-05-12T13:30:38.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
26633362		"1.1: 88%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-12T13:10:26.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
26715741		"1.1: 71%
1.3: 56%
2.1: 94%
3.4: 95%"	2021-05-12T12:45:30.000Z	curator3	cystic fibrosis			
26846474		"1.1: 84%
1.3: 95%
2.1: 82%
3.4: 93%"	2021-05-12T13:21:08.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
26866983		"1.1: 91%
1.3: 92%
2.1: 35%
3.4: 93%
drug mechanism"	2021-05-12T13:09:53.000Z	curator3	cystic fibrosis			
27084387		"1.1: 79%
1.3: 87%
2.1: 94%
3.4: 95%"	2021-05-12T13:47:07.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27146408		"1.1: 88%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-12T13:14:31.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
27784762		"1.1: 89%
1.3: 94%
2.1: 64%
3.4: 95%"	2021-05-12T13:26:40.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
27925453		"1.1: 83%
1.3: 91%
2.1: 91%
3.4: 95%"	2021-05-12T12:46:02.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28087700		"1.1: 88%
1.3: 94% DRUG MECHANISM
2.1: 78%
3.4: 93%"	2021-05-12T13:18:32.000Z	curator3	cystic fibrosis			
28167114		"1.1: 89%
1.3: 95% drug mechanism
2.1: 79%
3.4: 94%"	2021-05-12T13:26:16.000Z	curator3	cystic fibrosis			
29037538		"1.1: 80%
1.3: 85%
2.1: 94%
3.4: 94%"	2021-05-12T12:34:08.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29112089		"1.1: 86%
1.3: 87%
2.1: 94%
3.4: 95%"	2021-05-12T12:43:17.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29158263		"1.1: 88%
1.3: 96%
2.1: 80%
3.4: 94%"	2021-05-12T13:21:53.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
29557081		"1.1: 29%
1.3: 48%
2.1: 98%
3.4: 96%"	2021-05-12T12:40:15.000Z	curator3	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
29799376		"1.1: 49%
1.3: 81%
2.1: 95%
3.4: 95%"	2021-05-12T12:57:56.000Z	curator3	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
30131514		"1.1: 84%
1.3: 96%
2.1: 76%
3.4: 95%"	2021-05-12T13:47:29.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
30282922		"1.1: 92%
1.3: 94% 
2.1: 29% drug mech
3.4: 92%"	2021-05-12T13:31:30.000Z	curator3	cystic fibrosis			
30416447		"1.1: 90%
1.3: 95%
2.1: 65%
3.4: 94%"	2021-05-12T13:07:54.000Z	curator3	cystic fibrosis			
30565008		"1.1: 87%
1.3: 77%
2.1: 96%
3.4: 86%"	2021-05-12T13:46:06.000Z	curator3	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
30787964		"1.1: 80%
1.3: 79%
2.1: 97%
3.4: 89%"	2021-05-12T14:09:54.000Z	curator3	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
31214142		"1.1: 87%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-12T13:23:38.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
31243019		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-12T12:32:50.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
31955962		"1.1: 67%
1.3: 82%
2.1: 96%
3.4: 95%"	2021-05-12T13:06:02.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32202999		"1.1: 84%
1.3: 90%
2.1: 93%
3.4: 95%"	2021-05-12T13:21:33.000Z	curator3	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32811866		"1.1: 89%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-12T13:38:16.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
32923987		"1.1: 89%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-12T12:47:16.000Z	curator3	cystic fibrosis		2.1. DISEASE MECHANISM	
33213453		"1.1: 79%
1.3: 83%
2.1: 90%
3.4: 96%"	2021-05-12T12:56:37.000Z	curator3	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
33480170		"1.1: 19%
1.3: 78%
2.1: 96%
3.4: 96%"	2021-05-12T13:39:03.000Z	curator3	cystic fibrosis			
33544657		"1.1: 74%
1.3: 59%
2.1: 93%
3.4: 92%"	2021-05-12T13:39:50.000Z	curator3	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
19703826		"1.1: 90%
1.3: 26%
2.1: 97%
3.4: 82%"	2021-05-15T15:30:55.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
19808995		"1.1: 91%
1.3: 94%
2.1: 73%
3.4: 93%"	2021-05-16T12:34:47.000Z	curator4	cystic fibrosis		0.3. OTHER	
19923167		"1.1: 86%
1.3: 95%
2.1: 74%
3.4: 95%"	2021-05-15T15:46:07.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
20031113		"1.1: 75%
1.3: 85%
2.1: 91%
3.4: 97%"	2021-05-15T13:37:31.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
20032308		"1.1: 85%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-15T13:48:18.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
20141637		"1.1: 86%
1.3: 96%
2.1: 69%
3.4: 95%"	2021-05-16T14:51:57.000Z	curator4	cystic fibrosis		0.3. OTHER	
20309575		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-16T13:54:49.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
20346358		"1.1: 87%
1.3: 96%
2.1: 82%
3.4: 94%"	2021-05-15T15:43:46.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
20519934		"1.1: 88%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-16T13:36:33.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
20597077		"1.1: 77%
1.3: 90%
2.1: 93%
3.4: 96%"	2021-05-16T13:46:35.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20667149		"1.1: 82%
1.3: 88%
2.1: 95%
3.4: 93%"	2021-05-16T12:34:05.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20717170		"1.1: 59%
1.3: 96%
2.1: 87%
3.4: 94%"	2021-05-16T14:04:46.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
20802934		"1.1: 67%
1.3: 85%
2.1: 91%
3.4: 96%"	2021-05-16T12:50:44.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20831811		"1.1: 59%
1.3: 92%
2.1: 92%
3.4: 96%"	2021-05-16T14:04:05.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20933420		"1.1: 88%
1.3: 96%
2.1: 79%
3.4: 94%"	2021-05-15T15:52:30.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
20936184		"1.1: 91%
1.3: 93%
2.1: 56%
3.4: 94%"	2021-05-15T13:34:34.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
20947455		"1.1: 67%
1.3: 55%
2.1: 98%
3.4: 92%"	2021-05-15T15:56:32.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
21030607		"1.1: 89%
1.3: 94%
2.1: 79%
3.4: 93%"	2021-05-16T13:00:28.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
21073547		"1.1: 95%
1.3: 81%
2.1: 15%
3.4: 88%
drug mech"	2021-05-16T13:10:38.000Z	curator4	cystic fibrosis		0.3. OTHER	
21086027		"1.1: 71%
1.3: 89%
2.1: 95%
3.4: 96%"	2021-05-15T16:09:09.000Z	curator4	cystic fibrosis			
21169497		"1.1: 90%
1.3: 96%
2.1: 74%
3.4: 95%"	2021-05-16T12:32:41.000Z	curator4	cystic fibrosis		0.3. OTHER	
21209785		"1.1: 53%
1.3: 22%
2.1: 98%
3.4: 96%"	2021-05-16T12:50:33.000Z	curator4	cystic fibrosis			
21259449		"1.1: 76%
1.3: 86%
2.1: 95%
3.4: 96%"	2021-05-15T14:11:16.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21300824		"1.1: 88%
1.3: 94%
2.1: 81%
3.4: 93%"	2021-05-16T13:43:45.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
21324226		"1.1: 77%
1.3: 94%
2.1: 52%
3.4: 94%"	2021-05-16T14:53:13.000Z	curator4	cystic fibrosis			
21361784		"1.1: 90%
1.3: 1%
2.1: 95%
3.4: 88%"	2021-05-15T13:40:11.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
21398685		"1.1: 70%
1.3: 85%
2.1: 95%
3.4: 96%"	2021-05-15T15:50:59.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21422040		"1.1: 87%
1.3: 89%
2.1: 93%
3.4: 94%"	2021-05-16T13:45:35.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21507732		"1.1: 39%
1.3: 96%
2.1: 81%
3.4: 95%"	2021-05-15T16:05:05.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
21518885		"1.1: 80%
1.3: 96%
2.1: 51%
3.4: 97%"	2021-05-16T14:32:42.000Z	curator4	cystic fibrosis		0.3. OTHER	
21547736		"1.1: 83%
1.3: 96%
2.1: 30%
3.4: 97%
review"	2021-05-16T13:39:57.000Z	curator4	cystic fibrosis			
21547740		"1.1: 89%
1.3: 94%
2.1: 3%
3.4: 96%"	2021-05-16T14:17:30.000Z	curator4	cystic fibrosis			
21556203		"1.1: 28%
1.3: 80%
2.1: 89%
3.4: 96%"	2021-05-15T15:28:54.000Z	curator4	cystic fibrosis		0.3. OTHER	
21620114		"1.1: 84%
1.3: 78%
2.1: 96%
3.4: 89%"	2021-05-15T14:17:50.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
21629788		"1.1: 57%
1.3: 92%
2.1: 94%
3.4: 97%"	2021-05-15T14:05:55.000Z	curator4	cystic fibrosis		0.3. OTHER	
21829484		"1.1: 34%
1.3: 97%
2.1: 26%
3.4: 97%"	2021-05-16T12:37:33.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
21883527		"1.1: 88%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-16T12:49:31.000Z	curator4	cystic fibrosis		0.3. OTHER	
21955319		"1.1: 81%
1.3: 91%
2.1: 92%
3.4: 95%"	2021-05-15T15:50:44.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21966295		"1.1: 83%
1.3: 96%
2.1: 75%
3.4: 96%"	2021-05-16T14:06:12.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
21980493		"1.1: 88%
1.3: 95%
2.1: 74%
3.4: 94%"	2021-05-15T13:55:14.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
22024822		"1.1: 94%
1.3: 44%
2.1: 89%
3.4: 58%"	2021-05-16T14:19:01.000Z	curator4	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
22059807		"1.1: 83%
1.3: 96%
2.1: 76%
3.4: 95%"	2021-05-16T14:50:57.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
22146482		"1.1: 38%
1.3: 93%
2.1: 56%
3.4: 97%"	2021-05-16T12:53:30.000Z	curator4	cystic fibrosis		0.3. OTHER	
22174830		"1.1: 91%
1.3: 94%
2.1: 62%
3.4: 95%"	2021-05-16T14:11:53.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
22298109		"1.1: 84%
1.3: 96%
2.1: 77%
3.4: 95%"	2021-05-16T13:54:02.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
22315512		"1.1: 88%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-15T15:47:41.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
22427533		"1.1: 29%
1.3: 97%
2.1: 55%
3.4: 97%"	2021-05-16T14:10:03.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22448327		"1.1: 50%
1.3: 97%
2.1: 49%
3.4: 97%"	2021-05-16T12:55:36.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22559811		"1.1: 80%
1.3: 85%
2.1: 95%
3.4: 97%"	2021-05-16T14:49:03.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22582115		"1.1: 90%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-16T13:54:36.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
22617161		"1.1: 10%
1.3: 97%
2.1: 68%
3.4: 98%"	2021-05-16T15:03:29.000Z	curator4	cystic fibrosis		0.3. OTHER	
22653767		"1.1: 83%
1.3: 85%
2.1: 94%
3.4: 94%"	2021-05-16T12:35:06.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22660986		"1.1: 85%
1.3: 64%
2.1: 96%
3.4: 90%"	2021-05-16T14:35:24.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
22679004		"1.1: 86%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-16T13:00:52.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
22841006		"1.1: 91%
1.3: 93%
2.1: 34%
3.4: 94%"	2021-05-15T15:39:34.000Z	curator4	cystic fibrosis		0.3. OTHER	
22856641		"1.1: 86%
1.3: 3%
2.1: 96%
3.4: 91%"	2021-05-16T13:20:39.000Z	curator4	cystic fibrosis			
22859374		"1.1: 89%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-16T14:01:00.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
22928917		"1.1: 90%
1.3: 94%
2.1: 76%
3.4: 94%"	2021-05-15T14:11:26.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
22930931		"1.1: 91%
1.3: 14%
2.1: 92%
3.4: 92%"	2021-05-16T15:04:33.000Z	curator4	cystic fibrosis			
22946777		"1.1: 65%
1.3: 44%
2.1: 97%
3.4: 94%"	2021-05-15T15:30:44.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
22966014		"1.1: 87%
1.3: 94%
2.1: 77%
3.4: 93%"	2021-05-15T13:55:08.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
23060444		"1.1: 88%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-16T15:02:30.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
23169612		"1.1: 87%
1.3: 86%
2.1: 95%
3.4: 94%"	2021-05-15T15:57:02.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23217263		"1.1: 84%
1.3: 88%
2.1: 93%
3.4: 95%"	2021-05-15T15:54:57.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23223798		"1.1: 89%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-16T14:57:54.000Z	curator4	cystic fibrosis		0.3. OTHER	
23271804		"1.1: 85%
1.3: 96%
2.1: 75%
3.4: 95%"	2021-05-15T16:04:58.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
23289454		"1.1: 28%
1.3: 78%
2.1: 95%
3.4: 97%"	2021-05-15T15:39:03.000Z	curator4	cystic fibrosis			
23504457		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-15T15:56:48.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
23527104		"1.1: 89%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-15T14:10:07.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
23528342		"1.1: 67%
1.3: 97%
2.1: 67%
3.4: 96%"	2021-05-16T14:58:38.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
23532242		"1.1: 93%
1.3: 9%
2.1: 96%
3.4: 63%"	2021-05-16T13:41:30.000Z	curator4	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
23651180		"1.1: 22%
1.3: 96%
2.1: 40%
3.4: 97%"	2021-05-16T13:57:17.000Z	curator4	cystic fibrosis		0.3. OTHER	
23719852		"1.1: 36%
1.3: 96%
2.1: 53%
3.4: 97%"	2021-05-15T15:37:52.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
23726365		"1.1: 83%
1.3: 90%
2.1: 93%
3.4: 95%"	2021-05-16T14:13:41.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23757023		"1.1: 90%
1.3: 93%
2.1: 46%
3.4: 94%"	2021-05-15T13:54:30.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
23820266		"1.1: 89%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-16T14:20:27.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
23874059		"1.1: 76%
1.3: 90%
2.1: 94%
3.4: 95%"	2021-05-15T13:51:29.000Z	curator4	cystic fibrosis		0.3. OTHER	
23910813		"1.1: 71%
1.3: 64%
2.1: 98%
3.4: 93%"	2021-05-16T12:31:48.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24031533		"1.1: 81%
1.3: 96%
2.1: 78%
3.4: 95%"	2021-05-16T12:46:08.000Z	curator4	cystic fibrosis		0.3. OTHER	
24106034		"1.1: 63%
1.3: 95%
2.1: 40%
3.4: 97%"	2021-05-15T14:03:35.000Z	curator4	cystic fibrosis		0.3. OTHER	
24209388		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-16T12:42:32.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
24248318		"1.1: 59%
1.3: 73%
2.1: 98%
3.4: 93%"	2021-05-16T14:05:05.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24363931		"1.1: 80%
1.3: 88%
2.1: 94%
3.4: 95%"	2021-05-15T14:09:45.000Z	curator4	cystic fibrosis			
24608551		"1.1: 57%
1.3: 78%
2.1: 94%
3.4: 95%"	2021-05-16T14:57:03.000Z	curator4	cystic fibrosis			
24656793		"1.1: 57%
1.3: 81%
2.1: 94%
3.4: 97%"	2021-05-15T15:53:42.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24680115		"1.1: 62%
1.3: 10%
2.1: 98%
3.4: 95%"	2021-05-15T13:54:58.000Z	curator4	cystic fibrosis		0.3. OTHER	
24722909		"1.1: 89%
1.3: 95%
2.1: 73%
3.4: 95%"	2021-05-15T13:55:58.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
24790091		"1.1: 88%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-16T14:00:32.000Z	curator4	cystic fibrosis		0.3. OTHER	
24821546		"1.1: 68%
1.3: 37%
2.1: 97%
3.4: 97%"	2021-05-16T13:57:55.000Z	curator4	cystic fibrosis			
24841205		"1.1: 90%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-16T12:51:01.000Z	curator4	cystic fibrosis		0.3. OTHER	
24908055		"1.1: 50%
1.3: 93%
2.1: 87%
3.4: 98%"	2021-05-16T13:46:56.000Z	curator4	cystic fibrosis			
24914212		"1.1: 89%
1.3: 95%
2.1: 77%
3.4: 94%"	2021-05-15T15:32:25.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
24927234		"1.1: 84%
1.3: 58%
2.1: 95%
3.4: 91%
+drug mech"	2021-05-16T14:48:50.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24945463		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-15T16:10:11.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
25046147		"1.1: 90%
1.3: 95%
2.1: 72%
3.4: 94%"	2021-05-16T14:14:51.000Z	curator4	cystic fibrosis		0.3. OTHER	
25048732		"1.1: 85%
1.3: 87%
2.1: 94%
3.4: 95%"	2021-05-16T12:42:39.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25076714		"1.1: 20%
1.3: 49%
2.1: 97%
3.4: 97%"	2021-05-16T14:50:15.000Z	curator4	cystic fibrosis		0.3. OTHER	
25093082		"1.1: 91%
1.3: 42%
2.1: 95%
3.4: 88%"	2021-05-15T13:37:12.000Z	curator4	cystic fibrosis			
25125390		"1.1: 93%
1.3: 93%
2.1: 61%
3.4: 91%"	2021-05-16T12:38:29.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
25219816		"1.1: 75%
1.3: 84%
2.1: 97%
3.4: 96%"	2021-05-15T13:34:11.000Z	curator4	cystic fibrosis			
25249647		"1.1: 79%
1.3: 86%
2.1: 81%
3.4: 96%"	2021-05-16T12:27:24.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25287046		"1.1: 87%
1.3: 95%
2.1: 74%
3.4: 95%"	2021-05-15T15:39:09.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
25387861		"1.1: 89%
1.3: 70%
2.1: 96%
3.4: 88%"	2021-05-15T13:48:01.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
25404599		"1.1: 77%
1.3: 76%
2.1: 92%
3.4: 96%"	2021-05-16T13:56:38.000Z	curator4	cystic fibrosis			
25445528		"1.1: 91%
1.3: 90%
2.1: 10%
3.4: 93%"	2021-05-16T13:57:47.000Z	curator4	cystic fibrosis		0.3. OTHER	
25447156		"1.1: 92%
1.3: 95%
2.1: 70%
3.4: 93%"	2021-05-15T14:12:42.000Z	curator4	cystic fibrosis		0.3. OTHER	
25466700		"1.1: 94%
1.3: 29%
2.1: 95%
3.4: 76%"	2021-05-15T15:58:54.000Z	curator4	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
25481442		"1.1: 93%
1.3: 88%
2.1: 25%
3.4: 91%"	2021-05-15T15:43:22.000Z	curator4	cystic fibrosis		0.3. OTHER	
25512598		"1.1: 89%
1.3: 95%
2.1: 75%
3.4: 93%"	2021-05-16T14:30:48.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
25592657		"1.1: 32%
1.3: 79%
2.1: 96%
3.4: 97%"	2021-05-15T15:58:25.000Z	curator4	cystic fibrosis			
25681074		"1.1: 84%
1.3: 85%
2.1: 94%
3.4: 95%"	2021-05-15T15:29:34.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25884905		"1.1: 88%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-16T13:35:53.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
25952747		"1.1: 69%
1.3: 84%
2.1: 95%
3.4: 93%"	2021-05-16T14:30:15.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25956447		"1.1: 66%
1.3: 96%
2.1: 86%
3.4: 94%"	2021-05-15T15:36:13.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
26002942		"1.1: 45%
1.3: 97%
2.1: 42%
3.4: 97%"	2021-05-16T12:29:04.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26093634		"1.1: 74%
1.3: 91%
2.1: 91%
3.4: 97%"	2021-05-15T16:09:58.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26361332		"1.1: 87%
1.3: 96%
2.1: 73%
3.4: 95%"	2021-05-16T13:52:25.000Z	curator4	cystic fibrosis		0.3. OTHER	
26383784		"1.1: 66%
1.3: 75%
2.1: 98%
3.4: 95%"	2021-05-16T13:45:05.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
26459101		"1.1: 87%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-15T13:58:06.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
26545902		"1.1: 91%
1.3: 95%
2.1: 77%
3.4: 93%"	2021-05-15T15:29:03.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
26615753		"1.1: 88%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-15T15:30:08.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
26633362		"1.1: 88%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-15T13:58:00.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
26635857		"1.1: 90%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-16T12:52:19.000Z	curator4	cystic fibrosis		0.3. OTHER	
26715741		"1.1: 71%
1.3: 56%
2.1: 94%
3.4: 95%"	2021-05-15T15:27:35.000Z	curator4	cystic fibrosis			
26846474		"1.1: 84%
1.3: 95%
2.1: 82%
3.4: 93%"	2021-05-15T14:09:53.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
26866983		"1.1: 91%
1.3: 92%
2.1: 35%
3.4: 93%"	2021-05-15T13:57:34.000Z	curator4	cystic fibrosis		0.3. OTHER	
26912180		"1.1: 91%
1.3: 95%
2.1: 27%
3.4: 95%"	2021-05-16T14:34:46.000Z	curator4	cystic fibrosis		0.3. OTHER	
27034411		"1.1: 90%
1.3: 95%
2.1: 70%
3.4: 94%"	2021-05-16T14:03:02.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
27084387		"1.1: 79%
1.3: 87%
2.1: 94%
3.4: 95%"	2021-05-15T15:36:38.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27093165		"1.1: 92%
1.3: 73%
2.1: 59%
3.4: 94%"	2021-05-15T13:36:00.000Z	curator4	cystic fibrosis			
27216780		"1.1: 75%
1.3: 92%
2.1: 87%
3.4: 96%"	2021-05-15T16:08:51.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27244789		"1.1: 83%
1.3: 90%
2.1: 90%
3.4: 95%"	2021-05-16T13:54:59.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27309270		"1.1: 83%
1.3: 86%
2.1: 94%
3.4: 95%"	2021-05-16T14:21:02.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27324553		"1.1: 70%
1.3: 95%
2.1: 72%
3.4: 97%"	2021-05-16T14:33:29.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27334591		"1.1: 88%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-16T13:22:34.000Z	curator4	cystic fibrosis		0.3. OTHER	
27394157		"1.1: 96%
1.3: 27%
2.1: 86%
3.4: 66%"	2021-05-16T14:42:59.000Z	curator4	cystic fibrosis			
27640901		"1.1: 82%
1.3: 17%
2.1: 89%
3.4: 96%"	2021-05-16T13:56:29.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
27799352		"1.1: 88%
1.3: 95%
2.1: 80%
3.4: 94%"	2021-05-16T13:00:37.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
27895116		"1.1: 89%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-16T14:16:56.000Z	curator4	cystic fibrosis		0.3. OTHER	
28040058		"1.1: 74%
1.3: 96%
2.1: 85%
3.4: 94%"	2021-05-15T13:46:09.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
28049404		"1.1: 62%
1.3: 97%
2.1: 36%
3.4: 97%"	2021-05-16T13:11:33.000Z	curator4	cystic fibrosis		0.3. OTHER	
28087700		"1.1: 88%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-15T14:06:43.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
28114922		"1.1: 22%
1.3: 75%
2.1: 98%
3.4: 95%"	2021-05-16T13:37:22.000Z	curator4	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
28167114		"1.1: 89%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-15T14:11:21.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
28178337		"1.1: 6%
1.3: 97%
2.1: 8%
3.4: 98%"	2021-05-16T13:19:25.000Z	curator4	cystic fibrosis		0.3. OTHER	
28245352		"1.1: 76%
1.3: 78%
2.1: 94%
3.4: 89%"	2021-05-16T14:54:21.000Z	curator4	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
28280235		"1.1: 80%
1.3: 93%
2.1: 80%
3.4: 96%"	2021-05-15T15:40:46.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28288488		"1.1: 54%
1.3: 73%
2.1: 96%
3.4: 95%"	2021-05-16T14:41:48.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28455785		"1.1: 62%
1.3: 84%
2.1: 95%
3.4: 95%"	2021-05-16T13:48:02.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
28516396		"1.1: 20%
1.3: 89%
2.1: 95%
3.4: 97%"	2021-05-15T16:01:03.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28552668		"1.1: 90%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-16T12:31:34.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
28662657		"1.1: 55%
1.3: 56%
2.1: 97%
3.4: 96%"	2021-05-16T12:40:32.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28822728		"1.1: 84%
1.3: 88%
2.1: 94%
3.4: 94%"	2021-05-16T14:03:17.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28926942		"1.1: 91%
1.3: 94%
2.1: 60%
3.4: 93%"	2021-05-16T12:29:59.000Z	curator4	cystic fibrosis		0.3. OTHER	
29037538		"1.1: 80%
1.3: 85%
2.1: 94%
3.4: 94%"	2021-05-15T13:33:12.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29054758		"1.1: 52%
1.3: 96%
2.1: 87%
3.4: 94%"	2021-05-16T15:03:44.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
29099689		"1.1: 88%
1.3: 96%
2.1: 78%
3.4: 94%"	2021-05-16T14:40:37.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
29112089		"1.1: 86%
1.3: 87%
2.1: 94%
3.4: 95%"	2021-05-15T13:40:25.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29158263		"1.1: 88%
1.3: 96%
2.1: 80%
3.4: 94%"	2021-05-15T14:10:00.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
29168366		"1.1: 82%
1.3: 92%
2.1: 80%
3.4: 97%"	2021-05-16T14:49:41.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29240302		"1.1: 22%
1.3: 12%
2.1: 98%
3.4: 95%"	2021-05-16T14:53:33.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
29377174		"1.1: 31%
1.3: 95%
2.1: 61%
3.4: 97%"	2021-05-16T13:50:36.000Z	curator4	cystic fibrosis			
29429040		"1.1: 47%
1.3: 90%
2.1: 94%
3.4: 97%"	2021-05-15T15:46:42.000Z	curator4	cystic fibrosis			
29520692		"1.1: 13%
1.3: 96%
2.1: 71%
3.4: 96%"	2021-05-16T14:19:43.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
29560543		"1.1: 94%
1.3: 72%
2.1: 75%
3.4: 92%"	2021-05-16T14:55:41.000Z	curator4	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
29685813		"1.1: 93%
1.3: 10%
2.1: 94%
3.4: 53%"	2021-05-15T15:32:19.000Z	curator4	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
29709046		"1.1: 72%
1.3: 51%
2.1: 97%
3.4: 95%"	2021-05-16T14:45:12.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29728782		"1.1: 41%
1.3: 78%
2.1: 96%
3.4: 97%"	2021-05-15T13:44:43.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
29886024		"1.1: 91%
1.3: 31%
2.1: 96%
3.4: 81%"	2021-05-15T14:04:05.000Z	curator4	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
29941318		"1.1: 50%
1.3: 97%
2.1: 59%
3.4: 97%
comp"	2021-05-16T13:33:50.000Z	curator4	cystic fibrosis		0.3. OTHER	
29945196		"1.1: 85%
1.3: 96%
2.1: 74%
3.4: 95%"	2021-05-15T16:06:47.000Z	curator4	cystic fibrosis		0.3. OTHER	
29985939		"1.1: 60%
1.3: 94%
2.1: 89%
3.4: 97%"	2021-05-16T12:57:12.000Z	curator4	cystic fibrosis		0.3. OTHER	
30105497		"1.1: 87%
1.3: 82%
2.1: 82%
3.4: 94%"	2021-05-16T13:40:58.000Z	curator4	cystic fibrosis		0.3. OTHER	
30131514		"1.1: 84%
1.3: 96%
2.1: 76%
3.4: 95%"	2021-05-15T15:38:39.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
30165811		"1.1: 79%
1.3: 96%
2.1: 80%
3.4: 96%"	2021-05-16T13:24:13.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
30212240		"1.1: 93%
1.3: 94%
2.1: 58%
3.4: 92%"	2021-05-16T14:13:25.000Z	curator4	cystic fibrosis		0.3. OTHER	
30244233		"1.1: 86%
1.3: 89%
2.1: 93%
3.4: 95%"	2021-05-15T15:35:37.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30315867		"1.1: 87%
1.3: 96%
2.1: 77%
3.4: 95%"	2021-05-16T13:51:30.000Z	curator4	cystic fibrosis			
30565008		"1.1: 87%
1.3: 77%
2.1: 96%
3.4: 86%"	2021-05-15T15:35:52.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
30770405		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-16T13:16:44.000Z	curator4	cystic fibrosis		0.3. OTHER	
30847789		"1.1: 77%
1.3: 91%
2.1: 93%
3.4: 96%"	2021-05-16T13:13:04.000Z	curator4	cystic fibrosis			
30853372		"1.1: 59%
1.3: 93%
2.1: 82%
3.4: 98%"	2021-05-16T13:43:00.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30854150		"1.1: 74%
1.3: 32%
2.1: 97%
3.4: 89%

+QOL"	2021-05-16T13:14:55.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
30897407		"1.1: 91%
1.3: 95%
2.1: 55%
3.4: 95%"	2021-05-16T15:04:59.000Z	curator4	cystic fibrosis		0.3. OTHER	
30968646		"1.1: 43%
1.3: 20%
2.1: 98%
3.4: 96%"	2021-05-16T13:49:30.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
31027440		"1.1: 75%
1.3: 93%
2.1: 90%
3.4: 97%"	2021-05-15T14:07:36.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31087253		"1.1: 82%
1.3: 90%
2.1: 93%
3.4: 96%"	2021-05-16T12:59:31.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31117286		"1.1: 88%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-16T12:56:36.000Z	curator4	cystic fibrosis		0.3. OTHER	
31122509		"1.1: 1%
1.3: 82%
2.1: 97%
3.4: 97%"	2021-05-16T14:17:47.000Z	curator4	cystic fibrosis			
31123864		"1.1: 89%
1.3: 95%
2.1: 67%
3.4: 95%"	2021-05-16T12:38:55.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
31127555		"1.1: 86%
1.3: 96%
2.1: 49%
3.4: 96%"	2021-05-16T13:21:48.000Z	curator4	cystic fibrosis		0.3. OTHER	
31178266		"1.1: 79%
1.3: 74%
2.1: 96%
3.4: 95%"	2021-05-16T14:06:22.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31227724		"1.1: 92%
1.3: 94%
2.1: 57%
3.4: 95%"	2021-05-16T14:24:36.000Z	curator4	cystic fibrosis		0.3. OTHER	
31243019		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-15T13:28:41.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
31386863		"1.1: 81%
1.3: 93%
2.1: 86%
3.4: 96%"	2021-05-16T13:19:37.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31405730		"1.1: 90%
1.3: 59%
2.1: 96%
3.4: 81%"	2021-05-15T15:48:31.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
31413336		"1.1: 89%
1.3: 96%
2.1: 77%
3.4: 95%"	2021-05-15T14:10:54.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
31613648		"1.1: 93%
1.3: 93%
2.1: 66%
3.4: 92%"	2021-05-16T14:26:27.000Z	curator4	cystic fibrosis		0.3. OTHER	
31864360		"1.1: 90%
1.3: 95%
2.1: 75%
3.4: 94%
drug mech"	2021-05-16T12:41:56.000Z	curator4	cystic fibrosis		0.3. OTHER	
32096543		"1.1: 90%
1.3: 95%
2.1: 73%
3.4: 94%"	2021-05-15T15:31:30.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
32115388		"1.1: 62%
1.3: 72%
2.1: 96%
3.4: 96%"	2021-05-16T13:13:14.000Z	curator4	cystic fibrosis			
32162080		"1.1: 74%
1.3: 83%
2.1: 96%
3.4: 95%"	2021-05-16T13:49:06.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32206879		"1.1: 81%
1.3: 97%
2.1: 75%
3.4: 96%"	2021-05-16T13:17:34.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
32217535		"1.1: 67%
1.3: 87%
2.1: 96%
3.4: 96%"	2021-05-16T12:40:07.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32269886		"1.1: 83%
1.3: 80%
2.1: 96%
3.4: 96%"	2021-05-15T15:36:55.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32286879		"1.1: 70%
1.3: 97%
2.1: 81%
3.4: 96%"	2021-05-15T14:10:44.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
32496689		"1.1: 93%
1.3: 90%
2.1: 31%
3.4: 94%"	2021-05-16T14:57:29.000Z	curator4	cystic fibrosis			
32528528		"1.1: 86%
1.3: 96%
2.1: 70%
3.4: 96%"	2021-05-16T15:02:25.000Z	curator4	cystic fibrosis		0.3. OTHER	
32540806		"1.1: 79%
1.3: 83%
2.1: 78%
3.4: 75%"	2021-05-16T12:33:52.000Z	curator4	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
32634088		"1.1: 87%
1.3: 96%
2.1: 78%
3.4: 95%"	2021-05-16T14:44:29.000Z	curator4	cystic fibrosis		0.3. OTHER	
32636299		"1.1: 69%
1.3: 86%
2.1: 90%
3.4: 97%"	2021-05-15T15:41:46.000Z	curator4	cystic fibrosis			
32673287		"1.1: 93%
1.3: 93%
2.1: 48%
3.4: 93%"	2021-05-16T13:46:17.000Z	curator4	cystic fibrosis		0.3. OTHER	
32800486		"1.1: 81%
1.3: 89%
2.1: 94%
3.4: 96%"	2021-05-16T13:01:01.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32811866		"1.1: 89%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-15T15:32:51.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
32819967		"1.1: 86%
1.3: 95%
2.1: 81%
3.4: 94%"	2021-05-16T12:35:41.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
32841845		"1.1: 83%
1.3: 87%
2.1: 94%
3.4: 95%"	2021-05-15T14:10:28.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33010097		"1.1: 79%
1.3: 87%
2.1: 95%
3.4: 95%"	2021-05-16T12:47:55.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33093640		"1.1: 68%
1.3: 96%
2.1: 85%
3.4: 95%"	2021-05-16T14:41:39.000Z	curator4	cystic fibrosis		2.1. DISEASE MECHANISM	
33144490		"1.1: 95%
1.3: 90%
2.1: 30%
3.4: 92%"	2021-05-15T16:02:08.000Z	curator4	cystic fibrosis		0.3. OTHER	
33213453		"1.1: 79%
1.3: 83%
2.1: 90%
3.4: 96%"	2021-05-15T13:46:38.000Z	curator4	cystic fibrosis			
33225638		"1.1: 90%
1.3: 41%
2.1: 97%
3.4: 81%"	2021-05-16T14:06:38.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
33257262		"1.1: 33%
1.3: 84%
2.1: 95%
3.4: 97%"	2021-05-16T12:30:54.000Z	curator4	cystic fibrosis			
33341406		"1.1: 95%
1.3: 2%
2.1: 92%
3.4: 47%"	2021-05-16T14:45:26.000Z	curator4	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
33346630		"1.1: 89%
1.3: 55%
2.1: 93%
3.4: 84%"	2021-05-16T13:38:56.000Z	curator4	cystic fibrosis		0.3. OTHER	
33544657		"1.1: 74%
1.3: 59%
2.1: 93%
3.4: 92%"	2021-05-15T15:35:23.000Z	curator4	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
33569502		"1.1: 82%
1.3: 55%
2.1: 98%
3.4: 88%"	2021-05-16T12:58:56.000Z	curator4	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
33656158		"1.1: 82%
1.3: 89%
2.1: 93%
3.4: 95%"	2021-05-16T12:33:13.000Z	curator4	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33707642		"1.1: 90%
1.3: 95%
2.1: 70%
3.4: 95%"	2021-05-15T15:46:00.000Z	curator4	cystic fibrosis		0.3. OTHER	
33713665		"1.1: 89%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-16T14:01:33.000Z	curator4	cystic fibrosis		0.3. OTHER	
19762476		"1.1: 85%
1.3: 95%
2.1: 26%
3.4: 96%"	2021-05-10T23:38:29.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
19808995		"1.1: 91%
1.3: 94%
2.1: 73%
3.4: 93%"	2021-05-12T01:12:43.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
19923167		"1.1: 86%
1.3: 95%
2.1: 74%
3.4: 95%"	2021-05-11T23:28:32.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
20031113		"1.1: 75%
1.3: 85%
2.1: 91%
3.4: 97%"	2021-05-10T21:42:49.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20080093		"1.1: 95%
1.3: 71%
2.1: 35%
3.4: 92%"	2021-05-13T00:08:26.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
20093376		"1.1: 78%
1.3: 97%
2.1: 52%
3.4: 96%"	2021-05-13T00:24:47.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
20099136	True	"1.1: 86%
1.3: 96%
2.1: 63%
3.4: 96%"	2021-05-12T01:12:45.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
20463179		"1.1: 82%
1.3: 73%
2.1: 97%
3.4: 87%"	2021-05-13T21:13:30.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
20481640		"1.1: 88%
1.3: 92%
2.1: 6%
3.4: 94%"	2021-05-12T02:55:18.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
20519934		"1.1: 88%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-12T03:05:19.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
20569877		"1.1: 91%
1.3: 53%
2.1: 94%
3.4: 80%"	2021-05-10T22:54:32.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
20597077		"1.1: 77%
1.3: 90%
2.1: 93%
3.4: 96%"	2021-05-12T23:48:14.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20651854		"1.1: 82%
1.3: 96%
2.1: 76%
3.4: 95%"	2021-05-13T00:01:07.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
20667149		"1.1: 82%
1.3: 88%
2.1: 95%
3.4: 93%"	2021-05-12T00:07:42.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20692461		"1.1: 75%
1.3: 76%
2.1: 97%
3.4: 91%"	2021-05-12T01:32:54.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
20696868		"1.1: 91%
1.3: 94%
2.1: 69%
3.4: 93%"	2021-05-12T03:07:20.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
20717170		"1.1: 59%
1.3: 96%
2.1: 87%
3.4: 94%"	2021-05-13T00:15:30.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
20718961		"1.1: 59%
1.3: 3%
2.1: 98%
3.4: 96%"	2021-05-13T21:34:59.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
20802934		"1.1: 67%
1.3: 85%
2.1: 91%
3.4: 96%"	2021-05-12T01:30:30.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20857389		"1.1: 83%
1.3: 92%
2.1: 14%
3.4: 94%"	2021-05-13T21:08:48.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
20858417		"1.1: 89%
1.3: 93%
2.1: 46%
3.4: 93%"	2021-05-11T22:54:23.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
20961363		"1.1: 90%
1.3: 95%
2.1: 69%
3.4: 93%"	2021-05-13T21:33:44.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
21030607		"1.1: 89%
1.3: 94%
2.1: 79%
3.4: 93%"	2021-05-12T01:45:21.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
21038076		"1.1: 91%
1.3: 94%
2.1: 45%
3.4: 94%"	2021-05-12T23:51:56.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
21039067		"1.1: 85%
1.3: 74%
2.1: 97%
3.4: 87%"	2021-05-12T01:21:56.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
21050065		"1.1: 90%
1.3: 95%
2.1: 60%
3.4: 95%"	2021-05-13T18:09:07.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
21169497		"1.1: 90%
1.3: 96%
2.1: 74%
3.4: 95%"	2021-05-12T00:05:21.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
21259449		"1.1: 76%
1.3: 86%
2.1: 95%
3.4: 96%"	2021-05-10T23:37:19.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21300824		"1.1: 88%
1.3: 94%
2.1: 81%
3.4: 93%"	2021-05-12T23:46:19.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
21323339		"1.1: 86%
1.3: 96%
2.1: 69%
3.4: 96%"	2021-05-13T00:10:16.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
21324226		"1.1: 77%
1.3: 94%
2.1: 52%
3.4: 94%"	2021-05-13T18:09:34.000Z	curator5	cystic fibrosis			
21330456		"1.1: 96%
1.3: 62%
2.1: 45%
3.4: 89%"	2021-05-13T21:08:17.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
21547736	True	"1.1: 83%
1.3: 96%
2.1: 30%
3.4: 97%"	2021-05-12T03:07:54.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
21562128		"1.1: 89%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-12T01:14:56.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
21627902		"1.1: 77%
1.3: 86%
2.1: 95%
3.4: 96%"	2021-05-13T21:12:09.000Z	curator5	cystic fibrosis			
21955319		"1.1: 81%
1.3: 91%
2.1: 92%
3.4: 95%"	2021-05-11T23:34:25.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21966295	True	"1.1: 83%
1.3: 96%
2.1: 75%
3.4: 96%"	2021-05-13T00:17:27.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
21980493		"1.1: 88%
1.3: 95%
2.1: 74%
3.4: 94%"	2021-05-10T23:06:06.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
21984237		"1.1: 86%
1.3: 95%
2.1: 81%
3.4: 94%"	2021-05-13T00:26:39.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
22007982		"1.1: 47%
1.3: 81%
2.1: 94%
3.4: 97%"	2021-05-10T23:45:55.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22070931		"1.1: 89%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-13T21:03:33.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
22174830		"1.1: 91%
1.3: 94%
2.1: 62%
3.4: 95%"	2021-05-13T00:23:25.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
22194755		"1.1: 49%
1.3: 96%
2.1: 86%
3.4: 94%"	2021-05-11T22:57:20.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22256443		"1.1: 81%
1.3: 84%
2.1: 94%
3.4: 95%"	2021-05-12T01:26:09.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22298109		"1.1: 84%
1.3: 96%
2.1: 77%
3.4: 95%"	2021-05-12T23:58:28.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
22396015		"1.1: 87%
1.3: 96%
2.1: 75%
3.4: 95%"	2021-05-13T21:20:32.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
22399668		"1.1: 89%
1.3: 94%
2.1: 79%
3.4: 92%"	2021-05-13T21:35:20.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
22416231		"1.1: 64%
1.3: 90%
2.1: 95%
3.4: 95%"	2021-05-13T21:11:00.000Z	curator5	cystic fibrosis			
22433258		"1.1: 42%
1.3: 78%
2.1: 96%
3.4: 93%"	2021-05-12T01:36:45.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22448327		"1.1: 50%
1.3: 97%
2.1: 49%
3.4: 97%"	2021-05-12T01:40:57.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
22554673		"1.1: 88%
1.3: 49%
2.1: 97%
3.4: 83%"	2021-05-13T21:08:18.000Z	curator5	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
22582115		"1.1: 90%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-13T00:00:10.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
22660986		"1.1: 85%
1.3: 64%
2.1: 96%
3.4: 90%"	2021-05-13T17:55:03.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
22841006		"1.1: 91%
1.3: 93%
2.1: 34%
3.4: 94%"	2021-05-11T23:23:29.000Z	curator5	cystic fibrosis			
22923315		"1.1: 89%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-12T03:07:08.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
22928917		"1.1: 90%
1.3: 94%
2.1: 76%
3.4: 94%"	2021-05-10T23:40:37.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
22937715		"1.1: 30%
1.3: 96%
2.1: 40%
3.4: 97%"	2021-05-12T02:58:59.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22966014		"1.1: 87%
1.3: 94%
2.1: 77%
3.4: 93%"	2021-05-10T23:05:52.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
23060444		"1.1: 88%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-13T18:34:35.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
23140956		"1.1: 74%
1.3: 93%
2.1: 90%
3.4: 95%"	2021-05-13T17:57:14.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23169612		"1.1: 87%
1.3: 86%
2.1: 95%
3.4: 94%"	2021-05-11T23:51:16.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23192669		"1.1: 86%
1.3: 88%
2.1: 94%
3.4: 95%"	2021-05-10T22:57:39.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23195144		"1.1: 80%
1.3: 86%
2.1: 95%
3.4: 94%"	2021-05-13T21:32:58.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23215638		"1.1: 89%
1.3: 95%
2.1: 68%
3.4: 95%"	2021-05-12T00:07:15.000Z	curator5	cystic fibrosis			
23223798		"1.1: 89%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-13T18:30:53.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
23316740		"1.1: 87%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-12T01:46:49.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
23354748		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-13T00:19:24.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
23371324		"1.1: 22%
1.3: 97%
2.1: 46%
3.4: 98%"	2021-05-13T21:17:13.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23390474		"1.1: 84%
1.3: 87%
2.1: 95%
3.4: 94%"	2021-05-13T00:28:45.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23527104		"1.1: 89%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-10T23:33:24.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
23636454		"1.1: 88%
1.3: 95%
2.1: 82%
3.4: 94%"	2021-05-12T02:59:45.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
23719852		"1.1: 36%
1.3: 96%
2.1: 53%
3.4: 97%"	2021-05-11T23:13:24.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23726365		"1.1: 83%
1.3: 90%
2.1: 93%
3.4: 95%"	2021-05-13T00:26:06.000Z	curator5	cystic fibrosis			
23757023		"1.1: 90%
1.3: 93%
2.1: 46%
3.4: 94%"	2021-05-10T23:02:16.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
23820266		"1.1: 89%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-13T00:28:02.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
23874059		"1.1: 76%
1.3: 90%
2.1: 94%
3.4: 95%"	2021-05-10T22:59:58.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24106034		"1.1: 63%
1.3: 95%
2.1: 40%
3.4: 97%"	2021-05-10T23:13:09.000Z	curator5	cystic fibrosis			
24248318		"1.1: 59%
1.3: 73%
2.1: 98%
3.4: 93%"	2021-05-13T00:16:09.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24349537		"1.1: 90%
1.3: 95%
2.1: 72%
3.4: 95%"	2021-05-10T21:24:49.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
24431198		"1.1: 41%
1.3: 66%
2.1: 98%
3.4: 93%"	2021-05-13T17:58:12.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24480974		"1.1: 2%
1.3: 68%
2.1: 96%
3.4: 95%"	2021-05-11T23:32:59.000Z	curator5	cystic fibrosis			
24522087		"1.1: 81%
1.3: 90%
2.1: 95%
3.4: 95%"	2021-05-11T23:21:55.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24591578		"1.1: 85%
1.3: 95%
2.1: 83%
3.4: 93%"	2021-05-10T23:41:02.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
24594704		"1.1: 88%
1.3: 57%
2.1: 90%
3.4: 94%"	2021-05-13T21:17:12.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
24608551		"1.1: 57%
1.3: 78%
2.1: 94%
3.4: 95%"	2021-05-13T18:13:19.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24608905		"1.1: 87%
1.3: 96%
2.1: 76%
3.4: 95%"	2021-05-13T18:33:52.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
24660703		"1.1: 81%
1.3: 93%
2.1: 55%
3.4: 96%"	2021-05-13T21:11:18.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24680115		"1.1: 62%
1.3: 10%
2.1: 98%
3.4: 95%"	2021-05-10T23:04:48.000Z	curator5	cystic fibrosis			
24716008		"1.1: 88%
1.3: 69%
2.1: 97%
3.4: 87%"	2021-05-10T23:10:13.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24762087		"1.1: 51%
1.3: 96%
2.1: 43%
3.4: 96%"	2021-05-13T00:18:39.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
24782693		"1.1: 88%
1.3: 62%
2.1: 96%
3.4: 89%"	2021-05-10T22:58:59.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
24790091		"1.1: 88%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-13T00:06:18.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
24811243		"1.1: 90%
1.3: 95%
2.1: 62%
3.4: 95%"	2021-05-12T23:50:43.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
24816489		"1.1: 89%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-13T20:52:38.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
24821546	True	"1.1: 68%
1.3: 37%
2.1: 97%
3.4: 97%"	2021-05-13T00:05:57.000Z	curator5	cystic fibrosis			
24841205		"1.1: 90%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-12T01:30:51.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
24914212		"1.1: 89%
1.3: 95%
2.1: 77%
3.4: 94%"	2021-05-11T22:54:23.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
24958810		"1.1: 77%
1.3: 96%
2.1: 86%
3.4: 94%"	2021-05-13T21:13:51.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
24998896		"1.1: 83%
1.3: 91%
2.1: 92%
3.4: 95%"	2021-05-13T21:32:40.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25010405		"1.1: 72%
1.3: 84%
2.1: 96%
3.4: 93%"	2021-05-13T21:21:04.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25048732		"1.1: 85%
1.3: 87%
2.1: 94%
3.4: 95%"	2021-05-12T01:29:31.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25065395		"1.1: 90%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-13T21:05:54.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
25093082	True	"1.1: 91%
1.3: 42%
2.1: 95%
3.4: 88%"	2021-05-10T21:41:22.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
25098631		"1.1: 89%
1.3: 75%
2.1: 96%
3.4: 87%"	2021-05-13T18:25:04.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
25114233		"1.1: 90%
1.3: 94%
2.1: 75%
3.4: 93%"	2021-05-11T23:35:59.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
25125390		"1.1: 93%
1.3: 93%
2.1: 61%
3.4: 91%"	2021-05-12T01:15:46.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
25187182		"1.1: 2%
1.3: 53%
2.1: 98%
3.4: 95%"	2021-05-13T18:09:07.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25219816	True	"1.1: 75%
1.3: 84%
2.1: 97%
3.4: 96%"	2021-05-10T21:19:07.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25222606		"1.1: 44%
1.3: 53%
2.1: 97%
3.4: 94%"	2021-05-10T23:20:12.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
25287046		"1.1: 87%
1.3: 95%
2.1: 74%
3.4: 95%"	2021-05-11T23:18:55.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
25301526		"1.1: 66%
1.3: 97%
2.1: 72%
3.4: 96%"	2021-05-12T00:01:14.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
25447156		"1.1: 92%
1.3: 95%
2.1: 70%
3.4: 93%"	2021-05-10T23:46:10.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
25459563		"1.1: 72%
1.3: 91%
2.1: 91%
3.4: 96%"	2021-05-12T03:06:55.000Z	curator5	cystic fibrosis			
25481442		"1.1: 93%
1.3: 88%
2.1: 25%
3.4: 91%"	2021-05-11T23:27:34.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
25592657		"1.1: 32%
1.3: 79%
2.1: 96%
3.4: 97%"	2021-05-11T23:53:01.000Z	curator5	cystic fibrosis			
25681074		"1.1: 84%
1.3: 85%
2.1: 94%
3.4: 95%"	2021-05-10T23:46:32.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25693903	True	"1.1: 77%
1.3: 96%
2.1: 69%
3.4: 96%"	2021-05-13T18:48:49.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
25714328		"1.1: 83%
1.3: 96%
2.1: 50%
3.4: 96%"	2021-05-11T23:29:15.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
25742660		"1.1: 45%
1.3: 95%
2.1: 31%
3.4: 97%"	2021-05-13T21:00:10.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25781545		"1.1: 76%
1.3: 97%
2.1: 82%
3.4: 96%"	2021-05-11T23:58:39.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
25884905		"1.1: 88%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-12T03:00:00.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
25956447		"1.1: 66%
1.3: 96%
2.1: 86%
3.4: 94%"	2021-05-11T23:06:14.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26024338		"1.1: 87%
1.3: 96%
2.1: 76%
3.4: 95%"	2021-05-12T01:23:52.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
26121472		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-11T22:54:23.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
26324893		"1.1: 91%
1.3: 69%
2.1: 84%
3.4: 93%"	2021-05-11T23:35:46.000Z	curator5	cystic fibrosis			
26336603		"1.1: 39%
1.3: 95%
2.1: 50%
3.4: 97%"	2021-05-13T00:27:12.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26361332		"1.1: 87%
1.3: 96%
2.1: 73%
3.4: 95%"	2021-05-12T23:56:44.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
26368820		"1.1: 88%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-13T00:29:51.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
26432887		"1.1: 90%
1.3: 95%
2.1: 72%
3.4: 94%"	2021-05-13T21:12:17.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
26459101		"1.1: 87%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-10T23:09:05.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
26615753		"1.1: 88%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-11T22:54:22.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
26635857		"1.1: 90%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-12T01:34:00.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
26846474		"1.1: 84%
1.3: 95%
2.1: 82%
3.4: 93%"	2021-05-10T23:21:26.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
26874684		"1.1: 87%
1.3: 95%
2.1: 82%
3.4: 93%"	2021-05-13T18:35:27.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
26879174		"1.1: 90%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-13T18:38:32.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
26912180		"1.1: 91%
1.3: 95%
2.1: 27%
3.4: 95%"	2021-05-13T00:32:28.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
26990263		"1.1: 62%
1.3: 63%
2.1: 96%
3.4: 92%"	2021-05-13T21:22:19.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27034411		"1.1: 90%
1.3: 95%
2.1: 70%
3.4: 94%"	2021-05-13T00:10:33.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
27084387		"1.1: 79%
1.3: 87%
2.1: 94%
3.4: 95%"	2021-05-11T23:08:26.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27093165		"1.1: 92%
1.3: 73%
2.1: 59%
3.4: 94%"	2021-05-10T21:36:37.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
27104944		"1.1: 93%
1.3: 94%
2.1: 44%
3.4: 93%"	2021-05-12T23:55:46.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
27131402		"1.1: 83%
1.3: 95%
2.1: 73%
3.4: 96%"	2021-05-12T01:26:30.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27244789		"1.1: 83%
1.3: 90%
2.1: 90%
3.4: 95%"	2021-05-13T00:04:28.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27309270		"1.1: 83%
1.3: 86%
2.1: 94%
3.4: 95%"	2021-05-13T00:28:28.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27324553	True	"1.1: 70%
1.3: 95%
2.1: 72%
3.4: 97%"	2021-05-13T00:31:45.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27334591		"1.1: 88%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-12T02:59:18.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
27383205		"1.1: 93%
1.3: 90%
2.1: 8%
3.4: 92%"	2021-05-12T01:24:07.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
27394157	True	"1.1: 96%
1.3: 27%
2.1: 86%
3.4: 66%"	2021-05-13T17:57:43.000Z	curator5	cystic fibrosis			
27408752		"1.1: 80%
1.3: 97%
2.1: 78%
3.4: 96%"	2021-05-13T18:23:42.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
27582639		"1.1: 78%
1.3: 95%
2.1: 35%
3.4: 97%"	2021-05-13T20:58:32.000Z	curator5	cystic fibrosis			
27628957		"1.1: 73%
1.3: 89%
2.1: 96%
3.4: 95%"	2021-05-13T00:05:40.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27629435		"1.1: 89%
1.3: 94%
2.1: 79%
3.4: 93%"	2021-05-13T00:29:22.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
27799352		"1.1: 88%
1.3: 95%
2.1: 80%
3.4: 94%"	2021-05-12T01:46:12.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
27820964	True	"1.1: 88%
1.3: 57%
2.1: 96%
3.4: 87%"	2021-05-11T23:57:28.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
27895116		"1.1: 89%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-13T00:26:19.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
27908697		"1.1: 38%
1.3: 96%
2.1: 33%
3.4: 97%"	2021-05-12T02:58:05.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27925453		"1.1: 83%
1.3: 91%
2.1: 91%
3.4: 95%"	2021-05-10T22:48:53.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28049404		"1.1: 62%
1.3: 97%
2.1: 36%
3.4: 97%"	2021-05-12T02:51:00.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
28087700		"1.1: 88%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-10T23:18:22.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
28167114		"1.1: 89%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-10T23:39:56.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
28231891	True	"1.1: 84%
1.3: 47%
2.1: 97%
3.4: 91%"	2021-05-12T01:15:10.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
28280235		"1.1: 80%
1.3: 93%
2.1: 80%
3.4: 96%"	2021-05-11T23:25:14.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28288488		"1.1: 54%
1.3: 73%
2.1: 96%
3.4: 95%"	2021-05-13T17:56:35.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
28348728		"1.1: 62%
1.3: 93%
2.1: 74%
3.4: 97%"	2021-05-13T17:54:45.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28406713		"1.1: 93%
1.3: 15%
2.1: 95%
3.4: 75%"	2021-05-13T21:20:46.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
28455785		"1.1: 62%
1.3: 84%
2.1: 95%
3.4: 95%"	2021-05-12T23:49:59.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28516396		"1.1: 20%
1.3: 89%
2.1: 95%
3.4: 97%"	2021-05-11T23:54:56.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
28523349		"1.1: 86%
1.3: 89%
2.1: 93%
3.4: 94%"	2021-05-13T21:20:18.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28633068		"1.1: 83%
1.3: 95%
2.1: 4%
3.4: 96%"	2021-05-11T23:31:06.000Z	curator5	cystic fibrosis			
28643178		"1.1: 88%
1.3: 44%
2.1: 93%
3.4: 90%"	2021-05-12T23:47:34.000Z	curator5	cystic fibrosis			
28662657		"1.1: 55%
1.3: 56%
2.1: 97%
3.4: 96%"	2021-05-12T01:21:22.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28726496		"1.1: 88%
1.3: 96%
2.1: 72%
3.4: 95%"	2021-05-12T02:52:36.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
28756021		"1.1: 73%
1.3: 97%
2.1: 61%
3.4: 97%"	2021-05-12T23:57:39.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
28819878		"1.1: 3%
1.3: 6%
2.1: 98%
3.4: 95%"	2021-05-11T23:31:59.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
28822728		"1.1: 84%
1.3: 88%
2.1: 94%
3.4: 94%"	2021-05-13T00:12:35.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28926942		"1.1: 91%
1.3: 94%
2.1: 60%
3.4: 93%"	2021-05-12T00:02:57.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
28974743		"1.1: 89%
1.3: 95%
2.1: 77%
3.4: 94%"	2021-05-10T23:33:08.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
29054758		"1.1: 52%
1.3: 96%
2.1: 87%
3.4: 94%"	2021-05-13T18:37:45.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
29091392		"1.1: 89%
1.3: 94%
2.1: 78%
3.4: 93%"	2021-05-13T18:11:06.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
29112089		"1.1: 86%
1.3: 87%
2.1: 94%
3.4: 95%"	2021-05-10T21:43:32.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29122084		"1.1: 66%
1.3: 95%
2.1: 76%
3.4: 97%"	2021-05-13T18:50:10.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29146575		"1.1: 93%
1.3: 92%
2.1: 60%
3.4: 92%"	2021-05-10T21:08:05.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
29154969		"1.1: 81%
1.3: 88%
2.1: 93%
3.4: 95%"	2021-05-13T18:26:15.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29155399		"1.1: 90%
1.3: 93%
2.1: 40%
3.4: 94%"	2021-05-10T23:08:52.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
29155707		"1.1: 91%
1.3: 94%
2.1: 23%
3.4: 94%"	2021-05-11T23:50:55.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
29158263		"1.1: 88%
1.3: 96%
2.1: 80%
3.4: 94%"	2021-05-10T23:32:48.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
29241892		"1.1: 68%
1.3: 20%
2.1: 98%
3.4: 93%"	2021-05-13T21:36:21.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
29313709		"1.1: 81%
1.3: 31%
2.1: 98%
3.4: 88%"	2021-05-13T20:59:53.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
29377174		"1.1: 31%
1.3: 95%
2.1: 61%
3.4: 97%"	2021-05-12T23:54:43.000Z	curator5	cystic fibrosis			
29405664		"1.1: 82%
1.3: 90%
2.1: 91%
3.4: 96%"	2021-05-13T00:15:53.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29557081		"1.1: 29%
1.3: 48%
2.1: 98%
3.4: 96%"	2021-05-10T21:23:16.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
29572268		"1.1: 89%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-12T01:13:17.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
29573520		"1.1: 9%
1.3: 21%
2.1: 98%
3.4: 94%"	2021-05-10T21:18:03.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
29596479		"1.1: 56%
1.3: 84%
2.1: 94%
3.4: 95%"	2021-05-13T21:04:31.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
29720874		"1.1: 76%
1.3: 57%
2.1: 96%
3.4: 94%"	2021-05-12T02:52:24.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
29720915		"1.1: 77%
1.3: 64%
2.1: 91%
3.4: 95%"	2021-05-13T20:52:00.000Z	curator5	cystic fibrosis			
29728782		"1.1: 41%
1.3: 78%
2.1: 96%
3.4: 97%"	2021-05-10T22:53:26.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
29743243		"1.1: 88%
1.3: 94%
2.1: 81%
3.4: 93%"	2021-05-13T20:59:03.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
29788934		"1.1: 58%
1.3: 97%
2.1: 45%
3.4: 97%"	2021-05-13T21:33:24.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29886024		"1.1: 91%
1.3: 31%
2.1: 96%
3.4: 81%"	2021-05-10T23:14:18.000Z	curator5	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
29945196		"1.1: 85%
1.3: 96%
2.1: 74%
3.4: 95%"	2021-05-11T23:58:52.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
29985939		"1.1: 60%
1.3: 94%
2.1: 89%
3.4: 97%"	2021-05-12T01:44:41.000Z	curator5	cystic fibrosis			
30034717		"1.1: 86%
1.3: 95%
2.1: 73%
3.4: 94%"	2021-05-13T21:02:53.000Z	curator5	cystic fibrosis			
30062052		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 94%"	2021-05-13T21:35:29.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
30100257		"1.1: 88%
1.3: 96%
2.1: 78%
3.4: 95%"	2021-05-13T21:33:51.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
30105497		"1.1: 87%
1.3: 82%
2.1: 82%
3.4: 94%"	2021-05-12T23:43:43.000Z	curator5	cystic fibrosis			
30131514		"1.1: 84%
1.3: 96%
2.1: 76%
3.4: 95%"	2021-05-11T23:16:32.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
30165811		"1.1: 79%
1.3: 96%
2.1: 80%
3.4: 96%"	2021-05-12T02:59:35.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
30212240		"1.1: 93%
1.3: 94%
2.1: 58%
3.4: 92%"	2021-05-13T00:24:05.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
30244233		"1.1: 86%
1.3: 89%
2.1: 93%
3.4: 95%"	2021-05-11T22:57:52.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30244592	True	"1.1: 53%
1.3: 88%
2.1: 92%
3.4: 97%"	2021-05-12T23:48:36.000Z	curator5	cystic fibrosis			
30282922		"1.1: 92%
1.3: 94%
2.1: 29%
3.4: 92%"	2021-05-10T23:46:43.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
30315867	True	"1.1: 87%
1.3: 96%
2.1: 77%
3.4: 95%"	2021-05-12T23:55:16.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
30416447		"1.1: 90%
1.3: 95%
2.1: 65%
3.4: 94%"	2021-05-10T23:06:21.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
30565008		"1.1: 87%
1.3: 77%
2.1: 96%
3.4: 86%"	2021-05-11T22:59:16.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
30624737		"1.1: 92%
1.3: 93%
2.1: 59%
3.4: 93%"	2021-05-13T20:51:37.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
30689761		"1.1: 17%
1.3: 95%
2.1: 36%
3.4: 98%"	2021-05-12T03:04:50.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
30709744		"1.1: 79%
1.3: 8%
2.1: 97%
3.4: 92%"	2021-05-13T21:01:14.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
30770405		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-12T02:53:37.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
30787964		"1.1: 80%
1.3: 79%
2.1: 97%
3.4: 89%"	2021-05-11T23:17:40.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
30853372		"1.1: 59%
1.3: 93%
2.1: 82%
3.4: 98%"	2021-05-12T23:45:41.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30854150		"1.1: 74%
1.3: 32%
2.1: 97%
3.4: 89%"	2021-05-12T02:53:09.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
30897407		"1.1: 91%
1.3: 95%
2.1: 55%
3.4: 95%"	2021-05-13T18:42:20.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
30910901		"1.1: 93%
1.3: 85%
2.1: 14%
3.4: 92%"	2021-05-13T18:02:21.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
30915480		"1.1: 88%
1.3: 95%
2.1: 80%
3.4: 94%"	2021-05-13T21:04:50.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
30968646		"1.1: 43%
1.3: 20%
2.1: 98%
3.4: 96%"	2021-05-12T23:53:13.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
31087253		"1.1: 82%
1.3: 90%
2.1: 93%
3.4: 96%"	2021-05-12T01:45:05.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31117286		"1.1: 88%
1.3: 95%
2.1: 78%
3.4: 94%"	2021-05-12T01:41:43.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
31122509		"1.1: 1%
1.3: 82%
2.1: 97%
3.4: 97%"	2021-05-13T00:27:40.000Z	curator5	cystic fibrosis			
31166553		"1.1: 14%
1.3: 80%
2.1: 92%
3.4: 96%"	2021-05-13T18:30:00.000Z	curator5	cystic fibrosis			
31178266		"1.1: 79%
1.3: 74%
2.1: 96%
3.4: 95%"	2021-05-13T00:19:06.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31234038		"1.1: 75%
1.3: 39%
2.1: 98%
3.4: 91%"	2021-05-10T23:16:13.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
31243019		"1.1: 88%
1.3: 95%
2.1: 79%
3.4: 93%"	2021-05-10T21:08:39.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
31294114		"1.1: 92%
1.3: 95%
2.1: 70%
3.4: 94%"	2021-05-12T01:29:18.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
31386863		"1.1: 81%
1.3: 93%
2.1: 86%
3.4: 96%"	2021-05-12T02:55:36.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31387378		"1.1: 72%
1.3: 73%
2.1: 93%
3.4: 97%"	2021-05-13T20:52:27.000Z	curator5	cystic fibrosis			
31420175		"1.1: 77%
1.3: 75%
2.1: 97%
3.4: 92%"	2021-05-12T00:02:35.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
31428412		"1.1: 67%
1.3: 87%
2.1: 96%
3.4: 96%"	2021-05-13T00:14:40.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31501050		"1.1: 87%
1.3: 43%
2.1: 97%
3.4: 84%"	2021-05-13T21:17:31.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
31613648		"1.1: 93%
1.3: 93%
2.1: 66%
3.4: 92%"	2021-05-13T00:29:37.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
31685468		"1.1: 89%
1.3: 29%
2.1: 95%
3.4: 84%"	2021-05-12T00:00:54.000Z	curator5	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
31706070		"1.1: 10%
1.3: 81%
2.1: 96%
3.4: 97%"	2021-05-13T18:12:55.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31851705		"1.1: 47%
1.3: 97%
2.1: 43%
3.4: 95%"	2021-05-11T23:18:30.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
31864360		"1.1: 90%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-12T01:22:36.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
31941715		"1.1: 14%
1.3: 92%
2.1: 91%
3.4: 97%"	2021-05-13T00:09:55.000Z	curator5	cystic fibrosis			
31955962		"1.1: 67%
1.3: 82%
2.1: 96%
3.4: 95%"	2021-05-10T22:58:41.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32147452		"1.1: 79%
1.3: 69%
2.1: 97%
3.4: 91%"	2021-05-11T23:23:04.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
32202999		"1.1: 84%
1.3: 90%
2.1: 93%
3.4: 95%"	2021-05-10T23:32:37.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32206879		"1.1: 81%
1.3: 97%
2.1: 75%
3.4: 96%"	2021-05-12T02:54:05.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
32269886		"1.1: 83%
1.3: 80%
2.1: 96%
3.4: 96%"	2021-05-11T23:11:00.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32286879		"1.1: 70%
1.3: 97%
2.1: 81%
3.4: 96%"	2021-05-10T23:35:34.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
32443413		"1.1: 86%
1.3: 95%
2.1: 49%
3.4: 94%"	2021-05-13T00:04:52.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
32446590		"1.1: 46%
1.3: 59%
2.1: 98%
3.4: 94%"	2021-05-13T21:15:08.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
32457736		"1.1: 88%
1.3: 94%
2.1: 79%
3.4: 93%"	2021-05-13T18:34:22.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
32465401		"1.1: 86%
1.3: 47%
2.1: 96%
3.4: 91%"	2021-05-13T21:18:49.000Z	curator5	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
32496469		"1.1: 81%
1.3: 45%
2.1: 94%
3.4: 96%"	2021-05-10T23:48:48.000Z	curator5	cystic fibrosis			
32550075		"1.1: 72%
1.3: 68%
2.1: 96%
3.4: 96%"	2021-05-13T18:51:20.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32597860		"1.1: 91%
1.3: 92%
2.1: 3%
3.4: 94%"	2021-05-13T18:46:04.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
32634088		"1.1: 87%
1.3: 96%
2.1: 78%
3.4: 95%"	2021-05-13T18:01:25.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
32649218		"1.1: 15%
1.3: 28%
2.1: 98%
3.4: 96%"	2021-05-13T20:52:52.000Z	curator5	cystic fibrosis			
32673237		"1.1: 75%
1.3: 81%
2.1: 93%
3.4: 93%"	2021-05-12T23:51:07.000Z	curator5	cystic fibrosis			
32673287		"1.1: 93%
1.3: 93%
2.1: 48%
3.4: 93%"	2021-05-12T23:47:15.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
32777524		"1.1: 83%
1.3: 96%
2.1: 82%
3.4: 95%"	2021-05-11T23:42:16.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
32779423		"1.1: 10%
1.3: 40%
2.1: 98%
3.4: 96%"	2021-05-12T23:53:34.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
32800486		"1.1: 81%
1.3: 89%
2.1: 94%
3.4: 96%"	2021-05-12T02:50:11.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32811866		"1.1: 89%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-11T22:54:24.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
32819967		"1.1: 86%
1.3: 95%
2.1: 81%
3.4: 94%"	2021-05-12T01:13:04.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
32841519	True	"1.1: 80%
1.3: 43%
2.1: 96%
3.4: 92%"	2021-05-13T20:53:41.000Z	curator5	cystic fibrosis			
32841845		"1.1: 83%
1.3: 87%
2.1: 94%
3.4: 95%"	2021-05-10T23:35:12.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32873215		"1.1: 89%
1.3: 95%
2.1: 76%
3.4: 94%"	2021-05-13T00:30:08.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
32899792		"1.1: 89%
1.3: 95%
2.1: 78%
3.4: 93%"	2021-05-12T01:46:36.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
32920566		"1.1: 45%
1.3: 94%
2.1: 88%
3.4: 97%"	2021-05-13T20:54:36.000Z	curator5	cystic fibrosis			
32923987		"1.1: 89%
1.3: 95%
2.1: 80%
3.4: 93%"	2021-05-10T22:53:51.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
33010097		"1.1: 79%
1.3: 87%
2.1: 95%
3.4: 95%"	2021-05-12T01:30:11.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33065460		"1.1: 59%
1.3: 88%
2.1: 95%
3.4: 96%"	2021-05-12T01:28:12.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33123317		"1.1: 88%
1.3: 95%
2.1: 81%
3.4: 93%"	2021-05-13T21:35:01.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
33144490		"1.1: 95%
1.3: 90%
2.1: 30%
3.4: 92%"	2021-05-11T23:56:54.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
33202772		"1.1: 89%
1.3: 95%
2.1: 77%
3.4: 94%"	2021-05-12T23:46:35.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
33213453		"1.1: 79%
1.3: 83%
2.1: 90%
3.4: 96%"	2021-05-10T22:56:29.000Z	curator5	cystic fibrosis			
33257262	True	"1.1: 33%
1.3: 84%
2.1: 95%
3.4: 97%"	2021-05-12T00:05:06.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33341406		"1.1: 95%
1.3: 2%
2.1: 92%
3.4: 47%"	2021-05-13T18:01:50.000Z	curator5	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
33381950		"1.1: 84%
1.3: 85%
2.1: 95%
3.4: 94%"	2021-05-13T21:18:08.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33390080		"1.1: 28%
1.3: 88%
2.1: 93%
3.4: 94%"	2021-05-13T21:34:59.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33430044		"1.1: 77%
1.3: 97%
2.1: 38%
3.4: 97%"	2021-05-13T20:53:55.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
33445178		"1.1: 75%
1.3: 89%
2.1: 94%
3.4: 95%"	2021-05-10T23:20:34.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33480170		"1.1: 19%
1.3: 78%
2.1: 96%
3.4: 96%"	2021-05-11T22:55:42.000Z	curator5	cystic fibrosis			
33553007		"1.1: 78%
1.3: 91%
2.1: 92%
3.4: 96%"	2021-05-13T21:10:15.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33656158		"1.1: 82%
1.3: 89%
2.1: 93%
3.4: 95%"	2021-05-12T00:07:28.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33684631		"1.1: 88%
1.3: 95%
2.1: 50%
3.4: 96%"	2021-05-12T03:08:12.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
33713665		"1.1: 89%
1.3: 95%
2.1: 75%
3.4: 94%"	2021-05-13T00:06:53.000Z	curator5	cystic fibrosis		2.1. DISEASE MECHANISM	
33716293	True	"1.1: 51%
1.3: 91%
2.1: 95%
3.4: 97%"	2021-05-12T00:03:30.000Z	curator5	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
3176552			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
19675306			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	
19840971			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
19924426			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.5. COMPUTATIONAL BIOLOGY + INFORMATICS	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
19953662			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20097527			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
20100611			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
20106870			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	
20167855			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20220176			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.4. IN-VIVO HUMAN BASIC SCIENCE STUDIES	
20335083			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20350728			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20421426			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.2. NORMAL BIOLOGY	
20530032			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.4. EPIDEMIOLOGY	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
20537283			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
20550487			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
20560440			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	1.3. THERAPEUTICS IN THE CLINIC
20564725			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
20618958			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20631900			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
20650983			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20682136			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20709053			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	2.1. DISEASE MECHANISM
20797703			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
20868986			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20938370			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21073540			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.2. NORMAL BIOLOGY	
21131972			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	2.3. NON IN-VIVO HUMAN MODEL SYSTEM
21225838			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21273388			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
21284095			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21406509			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21413977			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21447516			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
21508109			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21511253			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
21514598			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21534334			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.4. EPIDEMIOLOGY
21625832			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21663943			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
21684128			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21715716			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	2.3. NON IN-VIVO HUMAN MODEL SYSTEM
21718985			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
21868036			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
21907944			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22006708			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22102620			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	2.1. DISEASE MECHANISM
22121832			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22135026			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22157010			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.2. NORMAL BIOLOGY	
22218906			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	0.2. RELATED DISEASES
22243809			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22331057			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
22416021			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
22431414			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
22538046			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
22547847			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	
22551925			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
22570319			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22616346			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
22693285			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
22883987	True			checker1	primary ciliary dyskinesia			
22888088			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
22890535			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
23144323			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.5. COMPUTATIONAL BIOLOGY + INFORMATICS	2.1. DISEASE MECHANISM
23169026			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23232004		PREVENTION		checker1	primary ciliary dyskinesia			
23292041			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23299155			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23351276			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.5. COMPUTATIONAL BIOLOGY + INFORMATICS	
23354437			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
23418344			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	2.3. NON IN-VIVO HUMAN MODEL SYSTEM
23437356			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23575755			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
23772318			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23798057			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
23872636			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
23948769			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24019633			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24055112			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
24091606			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
24092478			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
24094744			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	2.3. NON IN-VIVO HUMAN MODEL SYSTEM
24150548			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
24226769			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	2.3. NON IN-VIVO HUMAN MODEL SYSTEM
24236100			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
24241099			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
24360805			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	2.4. IN-VIVO HUMAN BASIC SCIENCE STUDIES
24388318			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
24420929			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24450482			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24451115			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		3.3. PRECLINICAL THERAPEUTICS	
24454367			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24498942			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24516614			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
24533546			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24554765			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.2. NORMAL BIOLOGY	2.3. NON IN-VIVO HUMAN MODEL SYSTEM
24678221			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24742509			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24753481			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24768622			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
24773602			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	
24824133			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
25048963			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
25139857			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	2.3. NON IN-VIVO HUMAN MODEL SYSTEM
25156952	True			checker1	primary ciliary dyskinesia			
25178347			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25207108			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
25224326			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
25226371			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25232951			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.2. NORMAL BIOLOGY	2.3. NON IN-VIVO HUMAN MODEL SYSTEM
25299134			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.1. DISEASE NOMENCLATURE	
25302410			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25317630			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25386196			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
25386990			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
25422025			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25469542			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
25473808			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25489202			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25562561			2021-04-14T16:40:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
25638182			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25731630			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25764361			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
25799584			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
25802884			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.4. EPIDEMIOLOGY	2.1. DISEASE MECHANISM
25826585	True			checker1	primary ciliary dyskinesia			
25887861			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.2. QUALITY OF LIFE
25927852			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	2.4. IN-VIVO HUMAN BASIC SCIENCE STUDIES
25979076			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
26139845			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.5. COMPUTATIONAL BIOLOGY + INFORMATICS	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
26227396			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
26246169			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.5. COMPUTATIONAL BIOLOGY + INFORMATICS	2.1. DISEASE MECHANISM
26267801			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.5. COMPUTATIONAL BIOLOGY + INFORMATICS	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
26306119	True			checker1	primary ciliary dyskinesia			
26341913			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26354839			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26373788			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	2.4. IN-VIVO HUMAN BASIC SCIENCE STUDIES
26387594			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.5. COMPUTATIONAL BIOLOGY + INFORMATICS	2.1. DISEASE MECHANISM
26567984			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		3.3. PRECLINICAL THERAPEUTICS	
26824761			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
26917608			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.5. COMPUTATIONAL BIOLOGY + INFORMATICS	
26918822			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
26930919			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26976528			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
26998415	True			checker1	primary ciliary dyskinesia			
27070726			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27081490			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
27197433			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27288033			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27366497			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
27366569			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
27382041			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27435107			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	3.1. THERAPEUTIC HYPOTHESIS
27450411			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		3.4. PATIENT-BASED THERAPEUTICS	
27464304			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.2. QUALITY OF LIFE	
27476230			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27618201			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		3.2. DRUG MECHANISM	
27680603	True			checker1	primary ciliary dyskinesia			
27687975			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
27692146			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.4. EPIDEMIOLOGY	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
27779714			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
27889361			2021-04-14T16:43:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27922232			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
27979861			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	2.3. NON IN-VIVO HUMAN MODEL SYSTEM
27988889			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28029746			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
28246220			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.2. QUALITY OF LIFE	
28284321			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28290230			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28344781			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28403885			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
28501546			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28579561			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28616378			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28634892			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28638261			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
28801648			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
28813544	True			checker1	primary ciliary dyskinesia			
28891733	True			checker1	primary ciliary dyskinesia			
28922052	True			checker1	primary ciliary dyskinesia			
28922056	True			checker1	primary ciliary dyskinesia			
28925789	True			checker1	primary ciliary dyskinesia			
28925796			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28939216			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
29018009			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29056509			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
29072668			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	1.3. THERAPEUTICS IN THE CLINIC
29116124			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29121203			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
29135867			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29167384			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
29269581			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29287859			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
29316973			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
29320622			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
29322037			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
29339787			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.2. NORMAL BIOLOGY	
29362708			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
29366817			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
29402277			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
29511670			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
29511746			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29552400			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29552537			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.2. RELATED DISEASES
29601588			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
29727693			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
29748307			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29858006			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29916806			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
29940967			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29992786			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
29997923			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
30021461			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
30023402			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.2. RELATED DISEASES
30032860			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	0.2. RELATED DISEASES
30049738			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30151187			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30166424			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
30190587			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	2.3. NON IN-VIVO HUMAN MODEL SYSTEM
30230352	True			checker1	primary ciliary dyskinesia			
30238669			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
30272426	True	Review in Russian		checker1	primary ciliary dyskinesia			
30293640			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.4. EPIDEMIOLOGY	
30296669			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	
30368395			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30368402			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30431343			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		3.1. THERAPEUTIC HYPOTHESIS	
30504913			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
30573994			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30665704			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
30691261			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.4. EPIDEMIOLOGY	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
30762092			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30774648			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	2.2. NORMAL BIOLOGY
30835351			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
30881373			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
30884997			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.2. RELATED DISEASES
31012247			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
31019772			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31063320			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31092556			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
31118369			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
31128603			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
31160482			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
31213628			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
31240264			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.2. NORMAL BIOLOGY	
31273583			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31345208			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
31345831			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	3.1. THERAPEUTIC HYPOTHESIS
31366608			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
31398725			2021-04-14T16:05:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
31443223			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31468736			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.2. QUALITY OF LIFE	
31469207			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
31475479			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.2. QUALITY OF LIFE	
31479451			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	2.1. DISEASE MECHANISM
31519464	True			checker1	primary ciliary dyskinesia			
31545650			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
31549486			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31583536			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31610925			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.2. RELATED DISEASES
31650533			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT	
31696788			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	
31707647			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	
31711989			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.2. RELATED DISEASES
31772028			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
31858719			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
31863646			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
31886003			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
31925058			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
31960620			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
31978331			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
31994846			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
32111882			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
32124190			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
32170493			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
32181046			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	
32188167			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.5. COMPUTATIONAL BIOLOGY + INFORMATICS
32188719			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.5. COMPUTATIONAL BIOLOGY + INFORMATICS	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
32235794		Study of researchers understanding of the state of disease. No Category.		checker1	primary ciliary dyskinesia			
32253119			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	3.1. THERAPEUTIC HYPOTHESIS
32284045			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32299405			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
32380069			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		3.4. PATIENT-BASED THERAPEUTICS	
32384558	True			checker1	primary ciliary dyskinesia			
32431532			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
32447765			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32482850			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
32546272			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32551925			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32560490			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32603187			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.2. RELATED DISEASES
32704025			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	2.3. NON IN-VIVO HUMAN MODEL SYSTEM
32731729			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.3. THERAPEUTICS IN THE CLINIC	
32802948			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
32847546			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		0.2. RELATED DISEASES	2.1. DISEASE MECHANISM
32897366	True			checker1	primary ciliary dyskinesia			
32899853			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32946733			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.2. RELATED DISEASES
32950024			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.4. IN-VIVO HUMAN BASIC SCIENCE STUDIES	
32964004			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32977348	True		2021-04-14T16:51:00.000Z	checker1	primary ciliary dyskinesia			
32996775			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32997437			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		3.4. PATIENT-BASED THERAPEUTICS	
33005176	True			checker1	primary ciliary dyskinesia			
33036612			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
33098807			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	
33118031	True			checker1	primary ciliary dyskinesia			
33167880			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
33226018			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33233428			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33250217			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		3.4. PATIENT-BASED THERAPEUTICS	
33279757			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	2.3. NON IN-VIVO HUMAN MODEL SYSTEM
33281160			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33447612			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33452233			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
33589394			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33608380			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
33635012			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
33635866			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
33711958			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33719352			2021-04-13T04:15:00.000Z	checker1	primary ciliary dyskinesia		2.1. DISEASE MECHANISM	
19410311		The main point of this paper is the retrospective disease diagnosis based on the unusual clinical characteristics, not the therapy.		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20414677		Paper describes the use of a genetic mechanisms to support diagnosis - in these cases, use both DISEASE MECHANISM + PATHOLOGY tags together.		checker1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
20466398		Case history that provides in depth discussion of clinical characteristics + pathology combined with effects and prognosis following therapeutic measures. Use both CC+P and Therapeutics in the clinic codes.		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
20620301		Retrospective study of CC+P and therapeutics in the clinic		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
20622729				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
21290179		Natural history study => description of CC+P over time.		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
21336824				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
21344445		Focused study of a proposed therapeutic measure		checker1	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
21842025				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
22213836		Also involves RELATED DISEASES.		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
22240227				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
22281938		Measures the cost of treatment for patients (QOL?)		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.3. OTHER
22331366				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
22379273	True	Paper is a review for radiologists		checker1	hereditary hemorrhagic telangiectasia			
22469609		Potentially a very valuable paper describing the use of one methodology across a large population - effectively a clinical trial		checker1	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
22553411				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
22670022		Paper deals with causal relationships between environment + diagnosis relying on CC+P data.		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.3. OTHER
22744870				checker1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
22875690				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
22920200	True	Reads like a review.		checker1	hereditary hemorrhagic telangiectasia			
22991266				checker1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
23303231				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
23351611				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
23401183				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
24146883				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
24260769				checker1	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
24268183		This is a BIOINFORMATICS study		checker1	hereditary hemorrhagic telangiectasia		0.3. OTHER	
24986705		This is PURE therapeutic hypothesis paper.		checker1	hereditary hemorrhagic telangiectasia		0.3. OTHER	
25140883				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25420398				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
25603856		Focus is on therapeutic recommendations based on pathological evaluation for Osler-Weber-Rendu disease.		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
25847705				checker1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
25873934	True	This is a review		checker1	hereditary hemorrhagic telangiectasia			
25931195		'Chart review' = CC+P		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26204445		This would be 'RELATED DISEASE'		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
26261842				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
26448414	True	This is a review		checker1	hereditary hemorrhagic telangiectasia			
26608985		This work also involves a NON HUMAN ANIMAL MODEL		checker1	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
26998137				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
27012295				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27027094		Research contribution of this paper is mainly focused on treating and helping this patient - less to do with pathological / clinical symptoms.		checker1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
27225226		CC+P / INFUENCE OF GEOGRAPHY		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
27323484	True	This is a review		checker1	hereditary hemorrhagic telangiectasia			
27424345	True	This is a review		checker1	hereditary hemorrhagic telangiectasia			
27997001				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28267932		Main focus is interpreting and drawing conclusions from pathology measures based on various treatments		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
28578477		Epidemiology?		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28759897				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
28810087		Focus is on treatment		checker1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
28989145				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
29120072				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
29243366				checker1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29274888				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
29469958				checker1	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
30685840		Primarily a BIOINFORMATICS paper based on CLINICAL CHARACTERISTICS		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30705963	True	This is a systematic review		checker1	hereditary hemorrhagic telangiectasia			
31255500		In depth pathology / imaging study		checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
31361678	True	This is a review		checker1	hereditary hemorrhagic telangiectasia			
31441079	True	This is a systematic review		checker1	hereditary hemorrhagic telangiectasia			
31910122	True	This is a review		checker1	hereditary hemorrhagic telangiectasia			
32503579		Focus of paper is on epidemioological measures of various genetic diagnostics (which is DISEASE_MECHANISM).		checker1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
32723034	True	This is a review		checker1	hereditary hemorrhagic telangiectasia			
32723482				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32756122				checker1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY
32874383				checker1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
32899377				checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
32926701				checker1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33081831		preliminary work on developing diet-based therapies for HHT		checker1	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
33090433	True			checker1	hereditary hemorrhagic telangiectasia			
33671708				checker1	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
33677851		Influence of GEOGRAPHY with epidemiology of genetics in subpopulation.		checker1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
19308961			2021-10-02T06:09:08.000Z	checker1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.2. RELATED DISEASES
19948417			2021-10-02T06:09:44.000Z	checker1	Lennox-Gastaut syndrome		1.2. QUALITY OF LIFE	
20041940		Broadly a clinical review	2021-10-02T06:10:39.000Z	checker1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20080093			2021-10-02T06:18:03.000Z	checker1	cystic fibrosis		3.2. DRUG MECHANISM	
20167933			2021-10-02T06:19:26.000Z	checker1	cystic fibrosis		2.1. DISEASE MECHANISM	
20150505			2021-10-02T06:20:03.000Z	checker1	Lennox-Gastaut syndrome		3.2. DRUG MECHANISM	
20481640		Using a drug as a method for diagnosis.	2021-10-02T06:21:02.000Z	checker1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
20666837			2021-10-02T06:22:10.000Z	checker1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	1.3. THERAPEUTICS IN THE CLINIC
20495106			2021-10-02T06:23:01.000Z	checker1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
20463179		Investigating the effects of past interventions	2021-10-02T06:24:09.000Z	checker1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
20533249			2021-10-02T06:25:02.000Z	checker1	Lennox-Gastaut syndrome		1.4. EPIDEMIOLOGY	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
20831811		Sociology of disclosing health status	2021-10-03T06:02:31.000Z	checker1	cystic fibrosis		0.3. OTHER	
20842588		Does not appear to be a clinical trial - more anecdotal. 	2021-10-03T06:04:15.000Z	checker1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
20857389			2021-10-03T06:05:05.000Z	checker1	cystic fibrosis		2.2. NORMAL BIOLOGY	
21238636			2021-10-15T22:06:23.000Z	checker1	cystic fibrosis		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	
21169497		Disease mechanism - these are genetic pathways within the pathogen that impacts CF sufferers	2021-10-03T06:07:52.000Z	checker1	cystic fibrosis		2.1. DISEASE MECHANISM	
21086027		Psychology of caregivers directly contributing to QOL issues 	2021-10-15T21:46:43.000Z	checker1	cystic fibrosis		1.2. QUALITY OF LIFE	0.2. RELATED DISEASES
21050065			2021-10-03T06:12:02.000Z	checker1	cystic fibrosis		3.3. PRECLINICAL THERAPEUTICS	
21330456			2021-10-03T06:18:29.000Z	checker1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
21383017		Not clear whether this was in human patients or in in-vitro systems from the abstract - confirm through methods used in full text.	2021-10-03T06:22:24.000Z	checker1	cystic fibrosis		3.3. PRECLINICAL THERAPEUTICS	
33147670		Although there is a comparative diagnosis element (invoking the RELATED_DISEASES tag), the paper is still concerned with clinical symptoms and diagnosis.	2021-10-02T06:04:47.000Z	checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	0.2. RELATED DISEASES
33713665			2021-10-14T20:43:10.000Z	checker1	cystic fibrosis		3.2. DRUG MECHANISM	
33721709			2021-10-02T05:58:11.000Z	checker1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33638459	True	This is a review	2021-10-02T05:58:11.000Z	checker1	Lennox-Gastaut syndrome			
33707642			2021-10-14T20:38:04.000Z	checker1	cystic fibrosis		2.3. NON IN-VIVO HUMAN MODEL SYSTEM	
30620050			2021-10-14T20:36:12.000Z	checker1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32578674			2021-10-14T20:27:31.000Z	checker1	cystic fibrosis		1.2. QUALITY OF LIFE	
32779423			2021-10-14T20:26:47.000Z	checker1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33464574			2021-10-14T20:26:17.000Z	checker1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
29515340			2021-10-14T20:20:20.000Z	checker1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	0.2. RELATED DISEASES
29740868			2021-10-14T20:19:22.000Z	checker1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	2.1. DISEASE MECHANISM
29728782			2021-10-14T20:18:45.000Z	checker1	cystic fibrosis		1.4. EPIDEMIOLOGY	
29709046			2021-10-14T20:17:04.000Z	checker1	cystic fibrosis		1.4. EPIDEMIOLOGY	
29788934			2021-10-02T05:58:11.000Z	checker1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30279913			2021-10-02T05:58:11.000Z	checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
30787964			2021-10-02T05:58:11.000Z	checker1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
31006519			2021-10-02T05:58:11.000Z	checker1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
31413336			2021-10-02T05:58:11.000Z	checker1	cystic fibrosis		2.1. DISEASE MECHANISM	
31360828			2021-10-14T20:14:44.000Z	checker1	hereditary hemorrhagic telangiectasia		3.4. PATIENT-BASED THERAPEUTICS	
31677157			2021-10-14T20:11:33.000Z	checker1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	2.1. DISEASE MECHANISM
32020895			2021-10-02T05:58:11.000Z	checker1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
31905627			2021-10-02T05:58:11.000Z	checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32202999			2021-10-14T20:05:55.000Z	checker1	cystic fibrosis		1.4. EPIDEMIOLOGY	1.5. INFLUENCE OF GEOGRAPHY OR ENVIRONMENT
32199058			2021-10-02T05:58:11.000Z	checker1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
32774576			2021-10-02T05:58:11.000Z	checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
32736238			2021-10-02T05:58:11.000Z	checker1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
32904708			2021-10-14T20:03:19.000Z	checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	1.3. THERAPEUTICS IN THE CLINIC
32992168			2021-10-14T20:01:38.000Z	checker1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	1.3. THERAPEUTICS IN THE CLINIC
33242965			2021-10-02T05:58:11.000Z	checker1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33754658			2021-10-02T05:58:11.000Z	checker1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
29099689	True	This is not related to CF in any way.	2021-10-02T06:06:38.000Z	checker1	cystic fibrosis			
33498134			2021-10-02T05:58:11.000Z	checker1	hereditary hemorrhagic telangiectasia		2.1. DISEASE MECHANISM	
33480170			2021-10-14T19:54:41.000Z	checker1	cystic fibrosis		1.3. THERAPEUTICS IN THE CLINIC	
33539783			2021-10-02T05:58:11.000Z	checker1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33553007			2021-10-02T05:58:11.000Z	checker1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33430044			2021-10-02T05:58:11.000Z	checker1	cystic fibrosis		2.1. DISEASE MECHANISM	
33381950			2021-10-02T05:58:11.000Z	checker1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33544657			2021-10-02T05:58:11.000Z	checker1	cystic fibrosis		3.4. PATIENT-BASED THERAPEUTICS	
33391157			2021-10-02T05:58:11.000Z	checker1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
33372424			2021-10-14T19:40:19.000Z	checker1	Lennox-Gastaut syndrome		3.4. PATIENT-BASED THERAPEUTICS	
33584793			2021-10-02T05:58:11.000Z	checker1	Lennox-Gastaut syndrome		2.1. DISEASE MECHANISM	
33511041			2021-10-02T05:58:11.000Z	checker1	hereditary hemorrhagic telangiectasia		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33445178			2021-10-02T05:58:11.000Z	checker1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33626436			2021-10-02T05:58:11.000Z	checker1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33718684			2021-10-02T05:58:11.000Z	checker1	Lennox-Gastaut syndrome		1.3. THERAPEUTICS IN THE CLINIC	
33656158			2021-10-02T05:58:11.000Z	checker1	cystic fibrosis		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33681663			2021-10-02T05:58:11.000Z	checker1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
33661356			2021-10-02T05:58:11.000Z	checker1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33691924			2021-10-14T19:31:16.000Z	checker1	hereditary hemorrhagic telangiectasia		1.3. THERAPEUTICS IN THE CLINIC	
33764203			2021-10-02T05:58:11.000Z	checker1	Lennox-Gastaut syndrome		1.1. CLINICAL CHARACTERISTICS OR DISEASE PATHOLOGY	
